confidence,confidence_distribution,cui,cui_name,data_quality,data_quality_distribution,data_year,geographic_variation,groups_processed,incidence_per_100k,is_subtype,metric_type,parent_disease,parent_disease_count,prevalence_per_100k,processing_date,reasoning,source,source_type,source_url,subtypes_identified,total_cases_per_year,total_processed,year_specific
0.28,,C0000768,Congenital Abnormality,weak,,2005,high,,2500,False,incidence,,,,,"Aggregate BOTEC estimate for all birth defects. WHO estimates ~3.3% of births have major congenital anomalies (globally ~130M births/year × 0.033 ÷ 130M × 100k = ~2500 per 100k births). Extremely heterogeneous category including cardiac defects, neural tube defects, chromosomal abnormalities, limb malformations, etc. Low confidence due to vast heterogeneity.",WHO. Congenital anomalies fact sheet (2005 estimates),estimate,,,8000000,,False
0.28,,C0000772,Multiple congenital anomalies,weak,,,moderate,,60,False,incidence,,,,,"Aggregate BOTEC estimate for all congenital anomalies combined. WHO data indicates ~3-6% of births globally have congenital anomalies, translating to ~60 per 100k person-years. Umbrella term covering hundreds of specific conditions (neural tube defects, heart defects, chromosomal abnormalities, etc.), so confidence capped at 0.28.",WHO Congenital Anomalies Fact Sheet,estimate,https://www.who.int/news-room/fact-sheets/detail/congenital-anomalies,,4800000,,False
0.88,,C0001175,Acquired Immunodeficiency Syndrome,strong,,2005,high,,43.0,True,incidence,HIV Infection,,,,Reporting incidence of new AIDS diagnoses. UNAIDS 2005 data shows ~2.8 million new AIDS cases globally (~43 per 100k). AIDS represents advanced HIV infection (CD4 <200).,UNAIDS Report on the Global AIDS Epidemic 2006 (2005 data),registry,https://data.unaids.org/pub/report/2006/2006_gr_en.pdf,,3440000,,True
0.25,,C0001418,Adenocarcinoma,weak,,,high,,135,False,incidence,,,,,"Aggregate BOTEC estimate summing major adenocarcinoma types globally: colorectal (~25), lung (~15), breast (~20 overall), prostate (~30 overall), gastric (~15), pancreatic (~8), esophageal (~5), other GI/GU (~17) = ~135 per 100k. Highly heterogeneous umbrella term requiring organ specification for meaningful estimates.",,estimate,,,10800000,,False
0.45,,C0001422,Adenofibroma,moderate,,,unknown,,2.5,False,incidence,Benign Neoplasm,,,,Benign fibroepithelial tumor occurring primarily in ovary and breast. Ovarian adenofibromas estimated at ~1-2 per 100k women based on surgical pathology series. Total estimate ~2.5 per 100k accounting for multiple anatomic sites. Limited population-based incidence data.,,,,,200000,,False
0.25,,C0001430,Adenoma,weak,,,high,,350,False,incidence,,,,,"Aggregate BOTEC estimate summing major adenoma types: colorectal adenomas (~250 per 100k), pituitary adenomas (~4), thyroid adenomas (~70), parathyroid adenomas (~25), hepatic adenomas (~1). Total ~350 per 100k. Low confidence due to heterogeneity and organ-specific variation.",,,,,28000000,,False
0.72,,C0001815,Primary Myelofibrosis,moderate,,2005,low,,0.6,True,incidence,Myelofibrosis,,,,"Reporting incidence of primary myelofibrosis (PMF), a specific subtype excluding secondary myelofibrosis. PMF incidence ~0.3-1.0 per 100k person-years, using midpoint of 0.6.",Mehta J et al. (2014). Epidemiology of myeloproliferative neoplasms in the United States. Leuk Lymphoma. 55(3):595-600,literature,https://pubmed.ncbi.nlm.nih.gov/23768070/,,48000,,False
0.0,,C0002170,Alopecia,none,,,high,,,False,,,,,,"Umbrella term covering heterogeneous conditions: androgenetic alopecia (30-50% of adults), alopecia areata (1-2%), scarring alopecias (<1%), telogen effluvium (variable). Prevalence ranges from <1% to >50% depending on type, age, and definition. Too broad to provide meaningful single estimate.",,,,,,,False
0.78,,C0002395,Alzheimer's Disease,strong,,2005,moderate,,12.5,True,incidence,Dementia,,,,Reporting incidence of new Alzheimer's diagnoses. Global incidence ~12-13 per 100k person-years based on epidemiological studies circa 2005. Varies by age group with dramatic increase after age 65.,Ferri CP et al. (2005). Global prevalence of dementia: a Delphi consensus study. Lancet. 366(9503):2112-2117,literature,https://pubmed.ncbi.nlm.nih.gov/16360788/,,1000000,,False
0.68,,C0003467,Anxiety,strong,,,moderate,,,False,prevalence,,,12000,,"Prevalence is appropriate metric for anxiety disorders (chronic mental health conditions). Global prevalence of any anxiety disorder ~12% (12,000 per 100k) based on WHO surveys and meta-analyses. Includes GAD, panic disorder, social anxiety, phobias.",Kessler RC et al. (2007). Lifetime prevalence and age-of-onset distributions of mental disorders in the WHO World Mental Health Survey Initiative. World Psychiatry. 6(3):168-176,literature,https://pubmed.ncbi.nlm.nih.gov/18188442/,,960000000,,False
0.55,,C0003850,Arteriosclerosis,moderate,,,high,,,False,prevalence,,,13000,,"Arteriosclerosis is an umbrella term for arterial stiffening/hardening including atherosclerosis, arteriolosclerosis, and medial calcification. Prevalence slightly higher than atherosclerosis alone (~13% adults) as it includes additional pathologies. Chronic condition measured by prevalence.",,,,,1040000000,,False
0.28,,C0003864,Arthritis,weak,,,high,,800,False,incidence,,,,,"Aggregate BOTEC estimate summing major arthritis types: osteoarthritis (~600 per 100k), rheumatoid arthritis (~40 per 100k), gout (~150 per 100k), psoriatic arthritis (~6 per 100k), other inflammatory arthritis (~4 per 100k). Total ~800 per 100k. Low confidence due to heterogeneity and potential overlap.",,estimate,,,64000000,,False
0.85,,C0003873,Rheumatoid Arthritis,strong,,2004,moderate,,40,True,incidence,Arthritis,,,,"Reporting incidence of new RA diagnoses. Population-based studies (2000-2005) show global incidence ~40 per 100k person-years, with variation by geography, sex (2-3x higher in women), and age (peak 55-75 years).","Alamanos Y et al. (2006). Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum. 36(3):182-188",literature,https://pubmed.ncbi.nlm.nih.gov/17045630/,,3200000,,False
0.82,,C0004096,Asthma,strong,,2005,high,,400,False,both,,,4500,,"Asthma incidence of new diagnoses approximately 400 per 100k person-years, with prevalence of 4500 per 100k (4.5% global population). Data from Global Burden of Disease and WHO studies circa 2005.",Masoli M et al. (2004). The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 59(5):469-478,literature,https://pubmed.ncbi.nlm.nih.gov/15080825/,,32000000,,False
0.75,,C0004114,Astrocytoma,strong,,,moderate,,2.5,True,incidence,Glioma,,,,Reporting incidence of new astrocytoma diagnoses. Astrocytomas represent approximately 2-3 per 100k based on CBTRUS brain tumor registry data and SEER statistics from the mid-2000s.,CBTRUS Statistical Report: Primary Brain Tumors in the United States,registry,https://www.cbtrus.org/,,200000,,False
0.65,,C0004153,Atherosclerosis,moderate,,,high,,,False,prevalence,,,12000,,"Atherosclerosis is a chronic progressive condition best measured by prevalence. Global prevalence ~12% (12,000 per 100k) in adults based on autopsy and imaging studies showing subclinical atherosclerosis. Varies dramatically by age (rare <40, common >60) and geography.",,,,,960000000,,False
0.75,,C0004352,Autistic Disorder,strong,,2002,moderate,,,True,prevalence,Autism Spectrum Disorder,,660,,"Autism measured as prevalence in children, not incidence. CDC ADDM data from 2002 (published 2007) showed 6.6 per 1,000 8-year-olds (660 per 100k children).",CDC Autism and Developmental Disabilities Monitoring Network (2007). Prevalence of autism spectrum disorders. MMWR Surveill Summ. 56(1):12-28,registry,https://pubmed.ncbi.nlm.nih.gov/17287715/,,52800000,,True
0.25,,C0004364,Autoimmune Diseases,weak,,,high,,150,False,incidence,,,,,"Aggregate BOTEC estimate summing major autoimmune conditions: rheumatoid arthritis (~25), type 1 diabetes (~15), inflammatory bowel disease (~10), multiple sclerosis (~5), systemic lupus (~5), celiac disease (~20), psoriasis (~50), thyroiditis (~20). Total ~150 per 100k. Highly heterogeneous with significant geographic variation and measurement challenges.",,estimate,,,12000000,,False
0.7,,C0004509,Azoospermia,strong,,,moderate,,,False,prevalence,,,1000,,"Azoospermia measured as prevalence (chronic condition). Affects approximately 1% of all men and 10-15% of infertile men. Prevalence estimate: 1,000 per 100k men (1%).",Jarow JP et al. (1989). Evaluation of the azoospermic patient. J Urol. 142:62-65,literature,https://pubmed.ncbi.nlm.nih.gov/2659827/,,80000000,,False
0.62,,C0004943,Behcet Syndrome,moderate,,,high,,0.64,False,incidence,,,,,"Reporting incidence. Global average ~0.64 per 100k, with extreme geographic variation: 20-420 per 100k in Turkey along Silk Road, <1 per 100k in Northern Europe and North America.",Yazici H et al. (2010). Behcet syndrome: a contemporary view. Nat Rev Rheumatol. 6:261-269,literature,https://pubmed.ncbi.nlm.nih.gov/20308005/,,51200,,False
0.75,,C0005411,Biliary Atresia,strong,,2000,high,,0.7,False,incidence,,,,,"Reporting incidence at ~0.7 per 100k births (approximately 1 in 8,000-15,000 live births globally). Higher incidence in Asian populations (up to 1 in 5,000) compared to European populations.","Yoon PW et al. (1997). Biliary atresia in the United States, 1979-1989. J Pediatr. 131(4):536-40",literature,https://pubmed.ncbi.nlm.nih.gov/9386653/,,56000,,False
0.78,,C0005586,Bipolar Disorder,strong,,2004,low,,15,False,both,,,1400,,"Bipolar disorder (BD-I and BD-II combined) has global incidence ~15 per 100k person-years for first episode, prevalence ~1.4% (1400 per 100k). Data from WHO GBD 2004 and epidemiological cohorts.",Merikangas KR et al. (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the NCS-R. Arch Gen Psychiatry. 64(5):543-552,literature,https://pubmed.ncbi.nlm.nih.gov/17485606/,,1200000,,True
0.68,,C0005587,"Depression, Bipolar",moderate,,2004,low,,15,True,both,Bipolar Disorder,,800,,"Bipolar disorder incidence ~15 per 100k person-years globally, with lifetime prevalence ~0.8%. Using incidence metric for new diagnoses. Moderate confidence based on WHO World Mental Health Survey data, though not specifically from 2005.",Merikangas KR et al. (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 64(5):543-552,literature,https://pubmed.ncbi.nlm.nih.gov/17485606/,,1200000,,False
0.88,,C0005684,Malignant neoplasm of urinary bladder,strong,,2005,moderate,,10.1,False,incidence,,,,,Bladder cancer global incidence from GLOBOCAN 2005: ~10.1 per 100k (age-standardized rate). Higher in males (~15) than females (~3.5). Strong registry data from IARC.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,808000,,True
0.78,,C0005695,Bladder Neoplasm,strong,,2005,moderate,,9.2,False,incidence,,,,,"Broader term encompassing all bladder tumors (benign and malignant). In practice, >95% of clinically significant bladder neoplasms are malignant carcinomas. Incidence ~9.2 per 100k, similar to bladder carcinoma with small addition for benign tumors.",GLOBOCAN 2005 (IARC) for malignant tumors,registry,https://gco.iarc.fr/,,736000,,True
0.0,,C0005944,Metabolic Bone Disorder,none,,,high,,,False,,,,,,"Umbrella term too heterogeneous to estimate meaningfully. Includes osteoporosis, Paget's disease, osteomalacia, renal osteodystrophy - conditions with vastly different epidemiology, many better measured by prevalence than incidence.",,,,,,,False
0.92,,C0006142,Malignant neoplasm of breast,strong,,2002,high,,37.4,False,incidence,,,,,"Breast cancer incidence from GLOBOCAN 2002 (published 2005): ~37 per 100k global population (both sexes), ~66 per 100k for women only. High quality registry data.","Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,2992000,,True
0.72,,C0006413,Burkitt Lymphoma,moderate,,2005,high,,0.5,True,incidence,Non-Hodgkin Lymphoma,,,,Rare aggressive B-cell lymphoma with ~0.5 per 100k global average. Endemic form (Africa) much higher; sporadic form (Western) <0.2 per 100k.,Ferlay J et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127:2893-917,literature,https://pubmed.ncbi.nlm.nih.gov/21351269/,,40000,,False
0.25,,C0006826,Malignant Neoplasms,weak,,2005,high,,175.0,False,incidence,,,,,"Aggregate BOTEC estimate summing all cancer types globally. GLOBOCAN 2005 reports approximately 11.5 million new cancer cases worldwide, translating to ~175 per 100k. Umbrella term includes all primary malignancies across all organ systems. Low confidence due to extreme heterogeneity.",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,14000000,,True
0.0,,C0007097,Carcinoma,none,,,unknown,,,False,,,,,,"Umbrella term too broad and generic to estimate meaningfully. Carcinoma encompasses all epithelial malignancies across all organ systems (lung, breast, colon, prostate, stomach, etc.) with vastly different incidence rates. Would require organ system specification.",,,,,,,False
0.88,,C0007102,Malignant tumor of colon,strong,,2002,high,,20.5,True,incidence,Colorectal Cancer,,,,"Reporting incidence (new diagnoses). GLOBOCAN 2002 estimates colon cancer incidence at ~20.5 per 100k globally, with higher rates in developed countries.","Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,1640000,,False
0.85,,C0007113,Rectal Carcinoma,strong,,2005,moderate,,8.5,True,incidence,Colorectal Cancer,,,,Rectal cancer represents approximately 30% of colorectal cancer cases. GLOBOCAN 2005 data: global rectal cancer incidence ~8.5 per 100k.,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,680000,,True
0.88,,C0007115,Malignant neoplasm of thyroid,strong,,2005,moderate,,5.1,False,incidence,,,,,"Synonymous with thyroid carcinoma. GLOBOCAN 2005 data shows ~5.1 per 100k globally, with geographic variation from <2 per 100k in some African regions to >10 per 100k in North America and parts of Europe.",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,408000,,True
0.62,,C0007120,Bronchioloalveolar Adenocarcinoma,moderate,,2005,moderate,,0.8,True,incidence,Lung Adenocarcinoma,,,,"BAC represents approximately 3-4% of all lung cancers. With global lung cancer incidence of ~23 per 100k (GLOBOCAN 2005), BAC incidence estimated at ~0.8 per 100k. Moderate confidence due to subtype-specific extrapolation.","Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,64000,,True
0.85,,C0007131,Non-Small Cell Lung Carcinoma,strong,,2005,high,,21.0,True,incidence,Lung Cancer,,,,"Reporting incidence (new diagnoses). NSCLC comprises ~85% of all lung cancers. GLOBOCAN 2005 total lung cancer incidence ~25 per 100k, therefore NSCLC ~21 per 100k globally.","GLOBOCAN 2005 (IARC) - lung cancer incidence, applying 85% NSCLC proportion",registry,https://gco.iarc.fr/,,1680000,,True
0.88,,C0007134,Renal Cell Carcinoma,strong,,2005,moderate,,4.2,True,incidence,Kidney Cancer,,,,RCC incidence from GLOBOCAN 2005: ~4.2 per 100k globally. RCC accounts for 85-90% of all kidney cancers.,"GLOBOCAN 2005 (IARC), kidney cancer incidence data",registry,https://gco.iarc.fr/,,336000,,True
0.25,,C0007137,Squamous cell carcinoma,weak,,,high,,150.0,False,incidence,,,,,"Aggregate BOTEC estimate for SCC across all sites: cutaneous SCC (~100 per 100k), lung SCC (~12 per 100k), head/neck SCC (~8 per 100k), esophageal SCC (~10 per 100k), cervical SCC (~5 per 100k), other sites (~15 per 100k). Total ~150 per 100k. Extremely heterogeneous umbrella term without organ specification.",,,,,12000000,,False
0.78,,C0007138,"Carcinoma, Transitional Cell",strong,,2002,high,,10.1,True,incidence,Urothelial Carcinoma,,,,"Reporting incidence. Transitional cell carcinoma (urothelial carcinoma) primarily affects bladder (>90% of cases). GLOBOCAN 2002 data shows bladder cancer incidence ~10.1 per 100k globally, with higher rates in males.","Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,808000,,False
0.75,,C0007193,"Cardiomyopathy, Dilated",strong,,,moderate,,6.0,True,both,Cardiomyopathy,,36.0,,"Dilated cardiomyopathy incidence ~6 per 100k person-years, prevalence ~36 per 100k (1 in 2,500). Reporting both metrics as DCM has well-documented incidence and prevalence data.",Codd MB et al. (1989). Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. Circulation. 80(3):564-72,literature,https://pubmed.ncbi.nlm.nih.gov/2766511/,,480000,,False
0.25,,C0007222,Cardiovascular Diseases,weak,,,high,,450,False,incidence,,,,,"Aggregate BOTEC estimate summing major CVD events: myocardial infarction (~100), stroke (~150), heart failure (~100), atrial fibrillation (~50), peripheral arterial disease (~50). Total ~450 per 100k. Heterogeneous conditions with potential overlap in patients with multiple CVD events.",,,,,36000000,,False
0.45,,C0007758,Cerebellar Ataxia,moderate,,,moderate,,3.5,False,incidence,,,,,"Cerebellar ataxia is a clinical syndrome with multiple etiologies (genetic SCAs, acquired from stroke/MS/toxins, degenerative). Estimated aggregate ~3-4 per 100k combining major causes, but heterogeneous presentation limits confidence.",,,,,280000,,False
0.8,,C0007786,Brain Ischemia,strong,,2005,high,,150,True,incidence,Cerebrovascular disease,,,,Reporting incidence (new events). Brain ischemia/ischemic stroke global incidence ~150 per 100k person-years based on WHO stroke surveillance. Varies by region and age.,"Feigin VL et al. (2003). Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2(1):43-53",literature,https://pubmed.ncbi.nlm.nih.gov/12578916/,,12000000,,False
0.88,,C0007847,Malignant tumor of cervix,strong,,2005,high,,15.2,True,incidence,Cervical Cancer,,,,Cervical cancer incidence from GLOBOCAN 2005 data: ~15.2 per 100k women globally. HPV-related cancer with wide geographic variation based on screening programs.,"Ferlay J et al. (2005). GLOBOCAN 2005: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 6",registry,https://gco.iarc.fr/,,1216000,,True
0.55,,C0007860,Uterine Cervicitis,moderate,,,high,,2500,False,incidence,,,,,"Common gynecological condition representing cervical inflammation, often due to STIs (chlamydia, gonorrhea) or other infections. Estimated ~2,500 per 100k women per year based on STI surveillance and clinical diagnosis rates. Wide variation by region and healthcare access.",CDC STI Surveillance and clinical practice guidelines,estimate,,,200000000,,False
0.0,,C0008489,Chorea,none,,,high,,,False,,,,,,"Umbrella term for choreiform movement disorder with multiple distinct etiologies: Huntington's disease (~0.5/100k), Sydenham's chorea, drug-induced chorea, vascular chorea. Each has different incidence rates and demographics. Cannot provide meaningful aggregate.",,,,,,,False
0.5,,C0008493,"Hydatidiform Mole, Invasive",moderate,,,moderate,,0.3,True,incidence,Gestational trophoblastic disease,,,,"Occurs when molar tissue invades the myometrium, developing in approximately 15-20% of complete molar pregnancies. Estimated at ~0.3 per 100k person-years. Requires chemotherapy in most cases.","Lurain JR. (2010). Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 203(6):531-539",literature,https://pubmed.ncbi.nlm.nih.gov/20728069/,,24000,,False
0.65,,C0008497,Choriocarcinoma,moderate,,,moderate,,0.05,True,incidence,Gestational Trophoblastic Disease,,,,"Choriocarcinoma is extremely rare, occurring in ~1 per 40,000 pregnancies. Global estimate ~0.05 per 100k population based on birth rates and incidence data.","Lurain JR. (2010). Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis. Am J Obstet Gynecol. 203(6):531-539",literature,https://pubmed.ncbi.nlm.nih.gov/20728069/,,4000,,False
0.45,,C0008677,"Bronchitis, Chronic",moderate,,,high,,400,False,incidence,,,,,"Chronic bronchitis incidence estimated ~400 per 100k based on COPD literature. Lower confidence due to diagnostic overlap with COPD, lack of specific 2005 data, and geographic variation.",,,,,32000000,,False
0.26,,C0009319,Colitis,weak,,,high,,5500,False,incidence,,,,,"Aggregate BOTEC estimate summing major colitis types: infectious colitis including bacterial and viral gastroenteritis affecting colon (~5000), ulcerative colitis (~10), Crohn's colitis (~5), ischemic colitis (~20), microscopic colitis (~10), radiation/medication-induced (~5), other (~450). Total ~5,500 per 100k. Infectious colitis dominates the estimate. Highly heterogeneous umbrella term.",,,,,440000000,,False
0.0,,C0009375,Colonic Neoplasms,none,,,high,,,False,,,,,,Umbrella term too heterogeneous: includes benign polyps (prevalence 25-40% in screening populations) and malignant colorectal cancer (incidence ~25-30 per 100k). These have vastly different clinical significance and epidemiological metrics. Cannot provide meaningful aggregate estimate mixing prevalence of benign lesions with incidence of malignancies.,,,,,,,False
0.9,,C0009402,Colorectal Carcinoma,strong,,2002,high,,35.2,False,incidence,,,,,Reporting incidence (new diagnoses). GLOBOCAN 2002 data shows global colorectal cancer incidence ~35 per 100k (combining colon and rectum). Strong cancer registry data worldwide.,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,2816000,,False
0.75,,C0009404,Colorectal Neoplasms,strong,,2002,high,,35.0,True,incidence,Gastrointestinal Neoplasms,,,,"Reporting incidence for malignant colorectal neoplasms. GLOBOCAN 2002 data shows colorectal cancer at ~35 per 100k globally. Note: 'Neoplasms' includes both benign and malignant, but cancer registries primarily capture malignant cases.","Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,2800000,,True
0.3,,C0009782,Connective Tissue Diseases,weak,,,moderate,,,False,prevalence,,,50,,"Umbrella term covering multiple chronic autoimmune conditions. Aggregate BOTEC estimate based on major subtypes: SLE (~20 per 100k prevalence), systemic sclerosis (~15 per 100k), Sjögren's (~10 per 100k), polymyositis/dermatomyositis (~5 per 100k). Prevalence metric used as these are chronic conditions. Low confidence due to heterogeneity and overlap.",,,,,4000000,,False
0.25,,C0010034,Corneal Diseases,weak,,,high,,50,False,incidence,,,,,"Aggregate BOTEC estimate summing major corneal conditions: infectious keratitis (~20 per 100k), corneal abrasions/trauma (~15 per 100k), corneal ulcers (~10 per 100k), corneal dystrophies (~5 per 100k). Total ~50 per 100k. Heterogeneous mix of infectious, traumatic, and degenerative conditions. Low confidence due to heterogeneity and limited comprehensive epidemiological data.",,,,,4000000,,False
0.75,,C0010346,Crohn Disease,strong,,2006,high,,3.0,True,incidence,Inflammatory Bowel Disease,,,,"Reporting incidence (new diagnoses). Global average ~3 per 100k person-years based on systematic reviews, though rates vary dramatically (0.5-20 per 100k) with highest in North America and Europe.","Loftus EV Jr. (2004). Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 126(6):1504-1517",literature,https://pubmed.ncbi.nlm.nih.gov/15168363/,,240000,,False
0.65,,C0010606,Adenoid Cystic Carcinoma,moderate,,,low,,0.4,True,incidence,Salivary gland carcinoma,,,,"Reporting incidence. Rare salivary gland malignancy, ~0.3-0.5 per 100k based on SEER and European cancer registry data. Can occur in various sites (salivary, breast, respiratory tract). Moderate confidence due to rarity and variable anatomic presentation.",Coca-Pelaz A et al. (2015). Salivary gland cancer: epidemiology. Oral Oncol. 51(12):1095-1103,literature,https://pubmed.ncbi.nlm.nih.gov/26383083/,,32000,,False
0.45,,C0010633,Cystadenoma,moderate,,,moderate,,15,False,incidence,,,,,"Benign cystic tumor occurring in multiple organs (ovary most common, also pancreas, kidney). Estimated ~15 per 100k based primarily on ovarian cystadenomas. Confidence reduced due to lack of organ specificity and limited population-based incidence data.",,,,,1200000,,False
0.87,,C0010674,Cystic Fibrosis,strong,,2005,high,,1.5,False,incidence,,,,,"Reporting birth incidence of cystic fibrosis. Global incidence approximately 1.5 per 100k live births (varies by ethnicity: 3-4 per 100k in Caucasians, <1 per 100k in Asian populations). Based on newborn screening data and patient registries.",Farrell PM et al. (2008). The prevalence of cystic fibrosis in the European Union. J Cyst Fibros. 7(5):450-453,literature,https://pubmed.ncbi.nlm.nih.gov/18442953/,,120000,,False
0.55,,C0010823,Cytomegalovirus Infections,moderate,,,moderate,,50,False,incidence,,,,,"Reporting incidence of diagnosed CMV infections at ~50 per 100k person-years. Includes symptomatic primary infections, congenital CMV, and reactivation disease. Wide variation in surveillance definitions limits confidence.",Cannon MJ et al. (2010). Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 20(4):202-213,literature,https://pubmed.ncbi.nlm.nih.gov/20564615/,,4000000,,False
0.55,,C0011168,Deglutition Disorders,moderate,,,moderate,,18,False,incidence,,,,,Dysphagia (swallowing disorders) incidence estimated at ~18 per 100k in general adult population based on community studies. Higher in elderly and post-stroke populations.,Bhattacharyya N. (2014). The prevalence of dysphagia among adults in the United States. Otolaryngol Head Neck Surg. 151:765-769,literature,https://pubmed.ncbi.nlm.nih.gov/25091190/,,1440000,,False
0.65,,C0011265,Presenile dementia,moderate,,2005,moderate,,9.0,True,incidence,Dementia,,,,Early-onset dementia (before age 65). Represents approximately 5-10% of all dementia cases. Estimated at ~9 per 100k person-years based on epidemiological studies. Lower confidence due to less robust population-based data compared to late-onset dementia.,Harvey RJ et al. (2003). Epidemiology of presenile dementia. Neurology. 60(9):1443-1447,literature,https://pubmed.ncbi.nlm.nih.gov/12743228/,,720000,,False
0.75,,C0011570,Mental Depression,strong,,2005,moderate,,,False,prevalence,,,3200,,"Synonym for depressive disorder. Depression measured as prevalence (existing cases). WHO 2005 data estimates ~3.2% global prevalence (3,200 per 100k).",WHO World Health Report 2005,registry,https://www.who.int/publications/i/item/9241562625,,256000000,,True
0.42,,C0011574,Involutional Depression,moderate,,,moderate,,180,True,incidence,Major Depressive Disorder,,,,"Historical term for late-life depression, now classified under Major Depressive Disorder. Estimated ~180 per 100k based on MDD incidence in middle-aged/elderly adults. Moderate-low confidence due to outdated terminology and extrapolation from general MDD data.",Waraich P et al. (2004). Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry. 49(2):124-138,literature,https://pubmed.ncbi.nlm.nih.gov/15065747/,,14400000,,False
0.75,,C0011581,Depressive disorder,strong,,2005,moderate,,,False,prevalence,,,3200,,"Depression measured as prevalence (existing cases) rather than incidence. WHO 2005 data estimates ~3.2% global prevalence (3,200 per 100k) for depressive disorders.",WHO World Health Report 2005,registry,https://www.who.int/publications/i/item/9241562625,,256000000,,True
0.75,,C0011847,Diabetes,strong,,2005,high,,17.0,False,incidence,,,,,"Reporting incidence of new diabetes diagnoses. Broad umbrella including Type 1 (~10% of cases), Type 2 (~90%), gestational, and other forms. Global incidence ~17 per 100k person-years from IDF 2005 data, predominantly Type 2.",IDF Diabetes Atlas 2005,registry,https://diabetesatlas.org/,,1360000,,True
0.8,,C0011849,Diabetes Mellitus,strong,,2005,high,,16.5,False,incidence,,,,,"Reporting incidence (new diagnoses) of diabetes mellitus, primarily Type 1 and Type 2. Global incidence from IDF 2005 data: ~16.5 per 100k person-years. Predominantly Type 2 diabetes in adults.",IDF Diabetes Atlas 2005,registry,https://diabetesatlas.org/,,1320000,,True
0.85,,C0011854,"Diabetes Mellitus, Insulin-Dependent",strong,,2005,high,,10.5,True,incidence,Diabetes Mellitus,,,,"Type 1 diabetes (insulin-dependent) incidence from IDF 2005 data: ~10.5 per 100k globally, with significant geographic variation (higher in Nordic countries, lower in Asia).","IDF Diabetes Atlas 2005, DIAMOND Project data",registry,https://diabetesatlas.org/atlas/2005/,,840000,,True
0.85,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",strong,,2005,high,,16.5,True,incidence,Diabetes Mellitus,,,,"Reporting incidence (new diagnoses). Type 2 diabetes global incidence from IDF 2005 data: approximately 16.5 per 100k person-years, accounting for ~90% of all diabetes cases.",IDF Diabetes Atlas 2005,registry,https://diabetesatlas.org/atlas/2005/,,1320000,,True
0.72,,C0011881,Diabetic Nephropathy,moderate,,2007,moderate,,8.5,True,incidence,Diabetic Complications,,,,"Diabetic nephropathy develops in approximately 20-40% of diabetic patients over their lifetime. With global diabetes prevalence ~6% in 2005 and estimated 2-3% annual incidence among diabetics, overall population incidence ~8.5 per 100k person-years.",Molitch ME et al. (2004). Nephropathy in diabetes. Diabetes Care. 27(suppl 1):S79-S83,literature,https://pubmed.ncbi.nlm.nih.gov/14693934/,,680000,,False
0.55,,C0013170,Drug habituation,moderate,,2004,high,,,False,prevalence,,,5500,,"Drug dependence/substance use disorders measured as prevalence. WHO 2004 data estimated ~5.5% global prevalence of drug use disorders (5,500 per 100k). Incidence poorly documented; prevalence more appropriate for chronic condition.",WHO (2004). Neuroscience of psychoactive substance use and dependence. World Health Organization,registry,https://www.who.int/publications/i/item/9241562358,,440000000,,False
0.88,,C0013264,"Muscular Dystrophy, Duchenne",strong,,,low,,2.5,True,incidence,Muscular Dystrophy,,,,"Duchenne muscular dystrophy (DMD) incidence ~1 in 3,500-5,000 male births (~2.5 per 100k live births). X-linked recessive disorder with robust epidemiological data from multiple registries.",Mah JK et al. (2014). A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul Disord. 24(6):482-491,literature,https://pubmed.ncbi.nlm.nih.gov/24780148/,,200000,,False
0.28,,C0013336,Dwarfism,weak,,,moderate,,25.0,False,incidence,,,,,"Aggregate BOTEC estimate summing major causes of proportionate and disproportionate short stature: achondroplasia (~4), growth hormone deficiency (~5), Turner syndrome (~2.5), skeletal dysplasias (~8), other genetic/metabolic causes (~5) = ~25 per 100k births. Heterogeneous conditions with overlap and diagnostic challenges.",,estimate,,,2000000,,False
0.65,,C0013415,Dysthymic Disorder,moderate,,2004,moderate,,,True,prevalence,Depressive Disorders,,3600,,"Chronic depressive disorder measured as prevalence. Global prevalence ~3-4% (3,600 per 100k) based on WHO mental health surveys circa 2004.",Waraich P et al. (2004). Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry. 49(2):124-38,literature,https://pubmed.ncbi.nlm.nih.gov/15065747/,,288000000,,False
0.75,,C0014175,Endometriosis,strong,,2005,moderate,,,False,prevalence,,,10000,,Endometriosis measured as prevalence (~10% of reproductive-age women). Incidence poorly defined due to diagnostic delays and asymptomatic cases.,Eskenazi B et al. (1997). Validation study of nonsurgical diagnosis of endometriosis. Fertil Steril. 68(3):518-25,literature,https://pubmed.ncbi.nlm.nih.gov/9314928/,,800000000,,False
0.82,,C0014544,Epilepsy,strong,,2005,high,,50.0,False,incidence,,,,,"Reporting incidence of new epilepsy diagnoses. Global incidence ~50 per 100k person-years based on WHO estimates for 2005, with higher rates in low-income countries (80-100 per 100k) vs high-income (40-50 per 100k).",WHO Atlas: Epilepsy Care in the World (2005),registry,https://www.who.int/mental_health/neurology/epilepsy_atlas_2005/en/,,4000000,,True
0.72,,C0015695,Fatty Liver,strong,,2005,high,,,False,prevalence,,,25000,,"Fatty liver (hepatic steatosis) measured as prevalence. Global NAFLD prevalence ~25% (25,000 per 100k) circa 2005, driven by obesity epidemic. Incidence not typically reported for this chronic condition.",Bedogni G et al. (2005). Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 42(5):44-52,literature,https://pubmed.ncbi.nlm.nih.gov/15895401/,,2000000000,,False
0.55,,C0015934,Fetal Growth Retardation,moderate,,2005,high,,100,False,incidence,,,,,"FGR/IUGR affects ~5-10% of pregnancies globally. With global birth rate ~2000 per 100k population in 2005, estimating ~100 cases per 100k population per year. Moderate confidence; variation in diagnostic criteria.",Resnik R (2002). Intrauterine growth restriction. Obstet Gynecol. 99(3):490-496,literature,https://pubmed.ncbi.nlm.nih.gov/11864679/,,8000000,,False
0.5,,C0016202,Flatfoot,moderate,,,moderate,,,False,prevalence,,,25000,,"Flatfoot is best measured by prevalence, not incidence. Adult prevalence estimates range 20-30% (20,000-30,000 per 100k). Using 25% middle estimate. However, most cases are asymptomatic flexible flatfoot; rigid/symptomatic flatfoot is much less common.",,,,,2000000000,,False
0.65,,C0016667,Fragile X Syndrome,moderate,,,low,,2.5,False,incidence,,,,,"Most common inherited cause of intellectual disability. Incidence ~2-3 per 100k births (1 in 4000 males, 1 in 8000 females). Using 2.5 per 100k as average estimate from population screening studies.",Hunter J et al. (2014). Epidemiology of fragile X syndrome: a systematic review and meta-analysis. Am J Med Genet A. 164A(7):1648-1658,literature,https://pubmed.ncbi.nlm.nih.gov/24700618/,,3250,,False
0.7,,C0017612,"Glaucoma, Open-Angle",strong,,2007,moderate,,200,True,incidence,Glaucoma,,,,"Open-angle glaucoma incidence ~200 per 100k person-years based on population studies. Moderate-high confidence from epidemiological literature, though geographic variation exists.","Quigley HA, Broman AT (2006). The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 90(3):262-267",literature,https://pubmed.ncbi.nlm.nih.gov/16488940/,,16000000,,False
0.88,,C0017636,Glioblastoma,strong,,2005,moderate,,3.2,True,incidence,Glioma,,,,Glioblastoma is the most common malignant primary brain tumor. Global incidence ~3-4 per 100k person-years from cancer registry data circa 2005. High confidence due to systematic cancer surveillance.,CBTRUS Statistical Report and GLOBOCAN 2005,registry,https://gco.iarc.fr/,,256000,,True
0.85,,C0017638,Glioma,strong,,2005,low,,5.8,True,incidence,Brain and CNS neoplasms,,,,"Reporting incidence. Gliomas account for ~80% of malignant brain tumors. Total brain/CNS tumor incidence ~7 per 100k, gliomas ~5.8 per 100k based on CBTRUS and GLOBOCAN 2005 data.","CBTRUS Statistical Report: Primary Brain Tumors in the United States, 2000-2004",registry,https://www.cbtrus.org/,,464000,,True
0.0,,C0018050,Gonadal Disorders,none,,,unknown,,,False,,,,,,"Umbrella term too heterogeneous to estimate meaningfully. Encompasses diverse conditions: PCOS (prevalence-based), hypogonadism (chronic), premature ovarian failure, testicular disorders, ovarian tumors, etc. Mix of acute, chronic, congenital conditions with vastly different epidemiology and no coherent aggregate metric.",,,,,,,False
0.78,,C0018099,Gout,strong,,2004,moderate,,150,True,incidence,Arthritis,,,,"Reporting incidence of new gout diagnoses. Population-based studies from UK and US (2000-2005) show incidence ~1.5 per 1000 person-years (150 per 100k), higher in men and increasing with age.",Arromdee E et al. (2002). Epidemiology of gout: is the incidence rising? J Rheumatol. 29(11):2403-6,literature,https://pubmed.ncbi.nlm.nih.gov/12415600/,,12000000,,False
0.0,,C0018524,Hallucinations,none,,,unknown,,,False,,,,,,"Hallucinations are a symptom/sign, not a disease entity. Occurs across multiple conditions (schizophrenia, delirium, Parkinson's, drug effects, sensory deprivation). Cannot meaningfully assign incidence without specifying underlying disease.",,,,,,,False
0.25,,C0018799,Heart Diseases,weak,,,high,,850,False,incidence,,,,,"Aggregate BOTEC estimate summing major cardiovascular events and conditions: myocardial infarction (~150), heart failure incidence (~120), atrial fibrillation (~200), valvular heart disease (~50), congenital heart disease (~8), other cardiac conditions (~322). Total ~850 per 100k. Highly heterogeneous umbrella term with significant overlap between categories.",,,,,68000000,,False
0.8,,C0018801,Heart failure,strong,,2004,moderate,,220,False,incidence,,,,,"Reporting incidence of new heart failure cases. Global incidence ~220 per 100k person-years based on Framingham Heart Study and European cohort data from early 2000s. Incidence increases dramatically with age, from <1 per 1000 in young adults to >10 per 1000 in those >65 years.",Lloyd-Jones DM et al. (2002). Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 106(24):3068-72,literature,https://pubmed.ncbi.nlm.nih.gov/12473553/,,17600000,,False
0.75,,C0018802,Congestive heart failure,strong,,,moderate,,200,False,incidence,Heart failure,,,,Reporting incidence of new heart failure diagnoses. Global incidence ~200 per 100k person-years based on epidemiological studies from high-income countries. Framingham and European cohort data circa 2000-2005 show 1-2% annual incidence in older adults.,"Roger VL et al. (2004). Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota. JAMA. 292(3):344-50",literature,https://pubmed.ncbi.nlm.nih.gov/15265849/,,16000000,,False
0.4,,C0019025,Hemoglobin F Disease,weak,,,high,,,False,prevalence,,,100,,"Hemoglobin F disease likely refers to hereditary persistence of fetal hemoglobin (HPFH) or related hemoglobinopathies. Genetic condition measured by prevalence, not incidence. Estimated ~100 per 100k globally, but varies widely by ethnicity (higher in African and Mediterranean populations). Limited global systematic data.",,,,,8000000,,False
0.55,,C0019189,"Hepatitis, Chronic",moderate,,2005,high,,50.0,False,incidence,,,,,"Chronic hepatitis is an umbrella term covering chronic hepatitis B, C, autoimmune hepatitis, and other etiologies. Estimated aggregate incidence ~50 per 100k based on WHO 2005 data for chronic viral hepatitis (primarily HBV and HCV new chronic infections). Confidence limited due to heterogeneous causes and diagnostic challenges.",WHO Hepatitis B and C Surveillance Report 2005,registry,,,4000000,,False
0.65,,C0019348,Herpes Simplex Infections,strong,,2005,moderate,,1500,False,both,,,67000,,"HSV is extremely common globally. Prevalence: HSV-1 ~67% of adults <50 years (WHO 2012 estimate for global burden), HSV-2 ~11% globally = combined ~67,000 per 100k prevalence. Incidence of new infections: estimated 1-2% of susceptible population annually, roughly 1,500 per 100k person-years for primary infections (combining HSV-1 and HSV-2). This is somewhat of an umbrella term (HSV-1 vs HSV-2 have different epidemiology), reducing confidence. Data quality strong for prevalence, moderate for incidence.",Looker KJ et al. (2015). Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One. 10(1):e114989,literature,https://pubmed.ncbi.nlm.nih.gov/25608026/,,120000000,,False
0.78,,C0019569,Hirschsprung Disease,strong,,,low,,2.5,False,incidence,,,,,"Congenital aganglionic megacolon with well-documented incidence of approximately 1 in 5,000 live births (20 per 100k births), translating to roughly 2.5 per 100k general population per year.","Amiel J et al. (2008). Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 45(1):1-14",literature,https://pubmed.ncbi.nlm.nih.gov/17965226/,,200000,,False
0.72,,C0019621,"Histiocytosis, Langerhans-Cell",moderate,,,low,,0.5,False,incidence,,,,,"Reporting incidence of new diagnoses. LCH overall incidence is 4-9 cases per million population per year, approximately 0.5 per 100k, predominantly affecting children with peak incidence ages 1-4 years.","Guyot-Goubin A et al. (2008). Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004. Pediatr Blood Cancer. 51(1):71-75",literature,https://pubmed.ncbi.nlm.nih.gov/18266229/,,40000,,False
0.92,,C0019693,HIV Infections,strong,,2005,high,,42.0,False,incidence,,,,,"New HIV infections globally in 2005: ~2.7 million cases (UNAIDS). With global population ~6.4 billion, incidence ~42 per 100k person-years. High-quality surveillance data from UNAIDS/WHO.",UNAIDS/WHO AIDS Epidemic Update 2005,registry,https://data.unaids.org/publications/irc-pub06/epi_update2005_en.pdf,,3360000,,True
0.75,,C0020179,Huntington Disease,strong,,,moderate,,0.8,False,incidence,,,,,Reporting incidence of new diagnoses. Huntington disease has global incidence ~0.5-1 per 100k person-years based on neurological registry data and population studies.,Pringsheim T et al. (2012). The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis. Mov Disord. 27(9):1083-91,literature,https://pubmed.ncbi.nlm.nih.gov/22692795/,,64000,,False
0.65,,C0020217,Hydatidiform Mole,moderate,,,high,,2.5,False,incidence,,,,,"Molar pregnancy incidence varies geographically: 0.6-1.1 per 1000 pregnancies in Western countries, 2-3 per 1000 in parts of Asia. Estimated global average ~2.5 per 100k total population (accounting for reproductive age women and birth rates).","Berkowitz RS, Goldstein DP. (2009). Clinical practice: Molar pregnancy. N Engl J Med. 360:1639-1645",literature,https://pubmed.ncbi.nlm.nih.gov/19369669/,,200000,,False
0.75,,C0020443,Hypercholesterolemia,strong,,2008,high,,,False,prevalence,,,15000,,"Hypercholesterolemia is a chronic metabolic condition measured as prevalence. WHO data shows ~15% of global adults have elevated total cholesterol (>5.0 mmol/L or 193 mg/dL) = 15,000 per 100k. Using prevalence as incidence is poorly defined for this chronic condition.",WHO Global Health Observatory data on raised cholesterol,registry,https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/raised-cholesterol,,1200000000,,False
0.75,,C0020473,Hyperlipidemia,strong,,2008,high,,,False,prevalence,,,35000,,"Chronic condition measured as prevalence. Global prevalence approximately 35% of adults (35,000 per 100k) with elevated cholesterol levels based on WHO criteria.",WHO Global Health Observatory data on raised cholesterol,registry,https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/raised-cholesterol,,2800000000,,False
0.72,,C0020557,Hypertriglyceridemia,strong,,2004,high,,,False,prevalence,,,31000,,Hypertriglyceridemia is a chronic metabolic condition best measured as prevalence. NHANES data (1999-2006) shows ~31% of US adults have elevated triglycerides (>150 mg/dL). Prevalence metric appropriate for chronic lipid disorder.,Ford ES et al. (2009). Hypertriglyceridemia and its pharmacologic treatment among US adults. Arch Intern Med. 169(6):572-8,literature,https://pubmed.ncbi.nlm.nih.gov/19307518/,,2480000000,,False
0.0,,C0020615,Hypoglycemia,none,,,unknown,,,False,,,,,,"Hypoglycemia is a biochemical finding/symptom rather than a specific disease entity. Occurs across multiple etiologies (diabetes medication, insulinoma, liver disease, hormonal deficiencies). No meaningful population-based incidence data for hypoglycemia as a general category.",,,,,,,False
0.52,,C0020619,Hypogonadism,moderate,,,moderate,,,False,prevalence,,,480,,Hypogonadism is a chronic condition best measured by prevalence. Estimated ~480 per 100k (0.48%) in adult males based on biochemical and clinical criteria from population studies. Prevalence increases significantly with age. High variability in definitions reduces confidence.,,,,,38400000,,False
0.28,,C0021051,Immunologic Deficiency Syndromes,weak,,2005,high,,1.5,False,incidence,,,,,"Aggregate BOTEC estimate summing: primary immunodeficiencies (~0.5), HIV/AIDS incidence (~0.8), secondary immunodeficiencies from other causes (~0.2) = ~1.5 per 100k. Low confidence due to heterogeneous etiologies and data limitations.",,estimate,,,120000,,False
0.65,,C0021364,Male infertility,moderate,,2005,high,,,False,prevalence,,,7000,,"Male infertility measured as prevalence, not incidence. WHO estimates ~7% of men of reproductive age experience infertility (7,000 per 100k). Moderate confidence due to variation in diagnostic criteria and geographic differences.","WHO estimates (2005), cited in Agarwal A et al. (2015). Male infertility. Lancet. 397:319-333",literature,,,560000000,,False
0.75,,C0021400,Influenza,strong,,,high,,8000,False,incidence,,,,,"Reporting incidence (new cases). WHO estimates 5-10% of adults infected annually, approximately 8,000 per 100k. Highly variable by season and pandemic vs non-pandemic years.",WHO Global Influenza Surveillance,registry,https://www.who.int/teams/global-influenza-programme/surveillance-and-monitoring,,640000000,,False
0.0,,C0022408,Arthropathy,none,,,unknown,,,False,,,,,,"Umbrella term too broad and heterogeneous to estimate meaningfully. Encompasses diverse conditions: osteoarthritis, rheumatoid arthritis, gout, psoriatic arthritis, infectious arthritis, and dozens of other joint diseases with vastly different incidence rates and etiologies.",,,,,,,False
0.65,,C0022680,Polycystic Kidney Diseases,strong,,,low,,,False,prevalence,,,40.0,,"Umbrella term including ADPKD (dominant) and ARPKD (recessive). Prevalence more appropriate than incidence for genetic conditions. ADPKD prevalence ~1 in 2,500 (40 per 100k). Using prevalence as these are lifelong genetic conditions.",Torres VE et al. (2007). Autosomal dominant polycystic kidney disease. Lancet. 369(9569):1287-301,literature,https://pubmed.ncbi.nlm.nih.gov/17434405/,,3200000,,False
0.25,,C0023051,Laryngeal Diseases,weak,,,high,,3050,False,incidence,,,,,"Aggregate BOTEC estimate summing major laryngeal conditions: acute laryngitis (~3000), vocal cord disorders (~50), laryngeal cancer (~2), chronic laryngitis/polyps (~50) = ~3,050 per 100k. Low confidence due to heterogeneous conditions and significant overlap.",,,,,244000000,,False
0.7,,C0023269,Leiomyosarcoma,moderate,,2005,low,,0.4,True,incidence,Soft Tissue Sarcoma,,,,Leiomyosarcoma represents ~10-15% of soft tissue sarcomas. Global STS incidence ~4 per 100k; leiomyosarcoma ~0.4 per 100k. Second most common adult STS.,"Toro JR et al. (2006). Incidence patterns of soft tissue sarcomas in the SEER program, 1978-2001. Int J Cancer. 119(12):2922-30",literature,https://pubmed.ncbi.nlm.nih.gov/17013893/,,32000,,False
0.88,,C0023418,leukemia,strong,,2002,moderate,,9.5,False,incidence,,,,,"Reporting incidence (new diagnoses). All leukemias combined (ALL, AML, CLL, CML) incidence ~9.5 per 100k globally from GLOBOCAN 2002 data.","Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,760000,,False
0.88,,C0023434,Chronic Lymphocytic Leukemia,strong,,2005,moderate,,4.2,True,incidence,Leukemia,,,,CLL incidence ~4.2 per 100k person-years from cancer registry data (GLOBOCAN 2005/SEER). More common in males (2:1 ratio) and Caucasians. Median age at diagnosis 70 years.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,336000,,True
0.85,,C0023449,Acute lymphocytic leukemia,strong,,2005,moderate,,1.7,True,incidence,Acute Leukemia,,,,ALL global incidence ~1.7 per 100k person-years from cancer registries. Bimodal distribution: peak in children age 2-5 (~3-4 per 100k) and smaller peak in elderly. More common in developed countries. GLOBOCAN 2005 data.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,136000,,True
0.82,,C0023452,Childhood Acute Lymphoblastic Leukemia,strong,,2005,low,,0.9,True,incidence,Acute Lymphoblastic Leukemia,,,,"Pediatric ALL (age 0-19) incidence ~3.5-4 per 100k children. Expressed per 100k total population (children ~25% globally), approximately 0.9 per 100k. Strong pediatric cancer registry data from SEER and international registries circa 2005.","Howlader N et al. SEER Cancer Statistics Review, 1975-2005. National Cancer Institute.",registry,https://seer.cancer.gov/archive/csr/1975_2005/,,72000,,False
0.72,,C0023465,Acute monocytic leukemia,moderate,,,moderate,,0.6,True,incidence,Acute Myeloid Leukemia,,,,"Acute monocytic leukemia (AML M5 subtype) represents approximately 15-20% of AML cases. Global AML incidence ~3.5 per 100k, thus M5 subtype ~0.6 per 100k.",GLOBOCAN cancer registry data and WHO classification of AML subtypes,registry,https://gco.iarc.fr/,,48000,,False
0.88,,C0023467,"Leukemia, Myelocytic, Acute",strong,,2005,moderate,,3.5,True,incidence,Leukemia,,,,Acute myeloid leukemia (AML) incidence ~3.5 per 100k globally from GLOBOCAN 2005 cancer registry data. Well-documented cancer with strong epidemiological surveillance.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,280000,,True
0.6,,C0023470,Myeloid Leukemia,moderate,,2005,moderate,,4.7,False,incidence,,,,,Aggregate estimate combining AML (~3.7 per 100k) and CML (~1.0 per 100k) from cancer registry data. Total ~4.7 per 100k. Moderate confidence as this is a sum of two well-defined subtypes.,GLOBOCAN 2005 (IARC) - combined AML and CML estimates,registry,https://gco.iarc.fr/,,376000,,False
0.88,,C0023473,"Myeloid Leukemia, Chronic",strong,,2005,low,,1.5,True,incidence,Myeloid Leukemia,,,,Chronic Myeloid Leukemia (CML) incidence ~1-2 per 100k from cancer registries. Well-documented cancer with consistent global rates.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,120000,,True
0.55,,C0023479,Acute myelomonocytic leukemia,moderate,,,low,,0.6,True,incidence,Acute Myeloid Leukemia,,,,"AML FAB M4 subtype comprises ~15-20% of AML cases. Global AML incidence ~3-4 per 100k, yielding M4 incidence ~0.6 per 100k. Limited subtype-specific registry data.",Dohner H et al. (2010). Diagnosis and management of acute myeloid leukemia in adults. Blood. 115(3):453-474,literature,https://pubmed.ncbi.nlm.nih.gov/19880497/,,48000,,False
0.45,,C0023484,"Leukemia, Plasma Cell",weak,,,low,,extremely rare,True,incidence,Plasma Cell Neoplasms,,,,"Plasma cell leukemia is an aggressive variant of multiple myeloma, representing <2% of plasma cell malignancies. Estimated at <0.02 per 100k based on multiple myeloma incidence (~4 per 100k) and PCL proportion.",,,,,extremely rare,,False
0.85,,C0023487,Acute Promyelocytic Leukemia,strong,,2005,low,,0.5,True,incidence,Acute Myeloid Leukemia,,,,"APL represents 10-15% of AML cases. Global AML incidence ~4 per 100k, therefore APL ~0.5 per 100k. Well-documented in cancer registries with characteristic t(15;17) translocation.","SEER Cancer Statistics Review, NCI",registry,https://seer.cancer.gov/,,40000,,False
0.68,,C0023492,"Leukemia, T-Cell",moderate,,,moderate,,0.8,True,incidence,Leukemia,,,,"T-cell leukemias comprise ~15-20% of acute lymphoblastic leukemias and include ATLL, T-PLL, and other subtypes. Estimated ~0.8 per 100k globally based on leukemia registry data.",SEER Cancer Statistics Review 1975-2005,registry,https://seer.cancer.gov/archive/csr/1975_2005/,,64000,,False
0.72,,C0023493,Adult T-Cell Lymphoma/Leukemia,strong,,2005,high,,0.3,True,incidence,T-Cell Leukemia,,,,"ATLL caused by HTLV-1 infection. Global incidence ~0.3 per 100k but highly variable: <0.01 in non-endemic areas, 3-5 per 100k in endemic regions (southwestern Japan, Caribbean). Using global weighted average.",Proietti FA et al. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24(39):6058-68,literature,https://pubmed.ncbi.nlm.nih.gov/16155612/,,24000,,False
0.45,,C0023524,"Leukoencephalopathy, Progressive Multifocal",moderate,,2005,moderate,,extremely rare,False,incidence,,,,,"PML is extremely rare in general population (<0.1 per 100k), occurring primarily in immunocompromised patients. In HIV+ populations circa 2005, incidence ~0.5-1 per 100k HIV+ persons.","Engsig FN et al. (2009). Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era. J Infect Dis. 199(1):77-83",literature,https://pubmed.ncbi.nlm.nih.gov/19007313/,,extremely rare,,False
0.45,,C0023794,Lipoidosis,moderate,,,moderate,,1.5,False,incidence,,,,,"Umbrella term for lipid storage diseases (Gaucher, Niemann-Pick, Fabry, etc.). Aggregate estimate of major lipidoses: ~1.5 per 100k births. Moderate confidence due to heterogeneous conditions and incomplete registries.",,estimate,,,120000,,False
0.72,,C0023827,Liposarcoma,moderate,,2005,low,,0.25,True,incidence,Soft Tissue Sarcoma,,,,Liposarcoma represents ~20% of soft tissue sarcomas. Global STS incidence ~3-5 per 100k; liposarcoma ~0.25 per 100k (most common adult STS subtype).,"Toro JR et al. (2006). Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001. Int J Cancer. 119(12):2922-30",literature,https://pubmed.ncbi.nlm.nih.gov/17013893/,,20000,,False
0.65,,C0023890,Liver Cirrhosis,moderate,,,high,,25.0,False,incidence,,,,,"Liver cirrhosis incidence estimated at ~25 per 100k person-years globally based on WHO mortality data and epidemiological studies. Data quality is moderate as cirrhosis often develops over years and incidence measurement varies. Geographic variation is high due to differences in alcohol consumption, hepatitis B/C prevalence, and NAFLD rates.",Blachier M et al. (2013). The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 58(3):593-608,literature,https://pubmed.ncbi.nlm.nih.gov/23419824/,,2000000,,False
0.55,,C0023896,Alcoholic Liver Diseases,moderate,,,high,,25.0,False,incidence,,,,,"Umbrella term covering alcoholic fatty liver, hepatitis, and cirrhosis. Aggregate estimate ~25 per 100k for clinically significant alcoholic liver disease. Confidence limited by heterogeneity and regional variation in alcohol consumption.",,,,,2000000,,False
0.0,,C0023903,Liver neoplasms,none,,,high,,,False,,,,,,"Umbrella term too heterogeneous: includes benign tumors (hemangiomas, adenomas with incidence <5) and malignant tumors (HCC ~12, cholangiocarcinoma ~2, metastatic disease varying widely). Vastly different clinical significance and epidemiology. Aggregate not meaningful.",,,,,,,False
0.0,,C0024115,Lung diseases,none,,,unknown,,,False,,,,,,"Umbrella term too heterogeneous and broad: encompasses acute infections (pneumonia, TB), chronic conditions (COPD, asthma), cancers (lung cancer), and structural diseases. Mix of incidence-based and prevalence-based conditions with different etiologies makes aggregate estimate meaningless.",,,,,,,False
0.72,,C0024121,Lung Neoplasms,strong,,2005,high,,35.0,False,incidence,,,,,"Reporting incidence of lung neoplasms, predominantly malignant (lung cancer). GLOBOCAN 2005 shows lung cancer at ~35 per 100k globally. Confidence reduced slightly as 'neoplasms' technically includes rare benign tumors, but malignant cases dominate (>95%).",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,2800000,,True
0.45,,C0024131,Lupus Vulgaris,weak,,,high,,0.15,True,incidence,Cutaneous Tuberculosis,,,,"Lupus vulgaris is the most common form of cutaneous TB in endemic areas but very rare overall. Estimated <0.2 per 100k in most regions, higher in TB-endemic areas. Limited systematic epidemiological data.",,,,,12000,,False
0.65,,C0024138,"Lupus Erythematosus, Discoid",moderate,,,moderate,,4.0,True,incidence,Lupus Erythematosus,,,,"Discoid lupus erythematosus (DLE) incidence ~4 per 100k person-years, may be slightly more common than SLE. Limited population-based registry data; estimates based on dermatology cohort studies.",Gronhagen CM et al. (2011). Incidence of cutaneous lupus erythematosus in Sweden. Br J Dermatol. 165(3):591-596,literature,https://pubmed.ncbi.nlm.nih.gov/21574970/,,320000,,False
0.82,,C0024141,"Lupus Erythematosus, Systemic",strong,,,high,,5.0,False,incidence,,,,,"SLE incidence ~5 per 100k person-years based on population-based registries. Strong epidemiological data from multiple cohorts, though significant ethnic and geographic variation (higher in African, Asian, Hispanic populations).",Pons-Estel GJ et al. (2010). Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 39(4):257-268,literature,https://pubmed.ncbi.nlm.nih.gov/19136143/,,400000,,False
0.0,,C0024232,Lymphatic Metastasis,none,,,unknown,,,False,,,,,,"Lymphatic metastasis is a manifestation of primary cancers, not a primary disease entity itself. Incidence depends entirely on the primary cancer type and stage. Unmappable without specification of primary malignancy.",,,,,,,False
0.25,,C0024299,Lymphoma,weak,,2005,moderate,,15.5,False,incidence,,,,,Aggregate BOTEC estimate summing major lymphoma subtypes: Non-Hodgkin lymphoma (~12-13 per 100k) + Hodgkin lymphoma (~2.5 per 100k) = ~15.5 per 100k globally. Umbrella term with significant heterogeneity between subtypes.,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,1240000,,True
0.78,,C0024301,"Lymphoma, Follicular",strong,,2005,moderate,,2.8,True,incidence,Non-Hodgkin Lymphoma,,,,"Follicular lymphoma incidence approximately 2.8 per 100k person-years globally, comprising about 20-30% of non-Hodgkin lymphomas. Data from SEER and international cancer registries circa 2000-2005.","Morton LM et al. (2006). Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 107(1):265-276",literature,https://pubmed.ncbi.nlm.nih.gov/16150940/,,224000,,False
0.85,,C0024305,"Lymphoma, Non-Hodgkin",strong,,2005,moderate,,5.3,False,incidence,,,,,Reporting incidence of new diagnoses. Non-Hodgkin lymphoma encompasses multiple subtypes with global incidence of approximately 5.3 per 100k population. Incidence increases with age. Data from GLOBOCAN 2005.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,424000,,True
0.28,,C0024314,Lymphoproliferative Disorders,weak,,,moderate,,25,False,incidence,,,,,"Aggregate BOTEC estimate summing major lymphoproliferative conditions: NHL (~12 per 100k), Hodgkin lymphoma (~2.5), CLL (~4.5), Multiple myeloma (~4), Other (~2). Total ~25 per 100k. Low confidence due to heterogeneity and composite nature.",,estimate,,,2000000,,False
0.65,,C0024534,"Malaria, Cerebral",moderate,,2005,high,,2.5,True,incidence,Severe Malaria,,,,"Cerebral malaria is a severe complication of P. falciparum malaria. Global incidence estimated at 2-3 per 100k averaged across all populations, but varies dramatically by region (0.01 in non-endemic areas to >10 per 100k in high-transmission zones). Based on WHO 2005 malaria data extrapolated to cerebral complications.",WHO World Malaria Report 2005,registry,https://www.who.int/publications/i/item/9241593199,,200000,,False
0.88,,C0024623,Malignant neoplasm of stomach,strong,,2002,high,,22.0,True,incidence,Gastrointestinal Neoplasms,,,,"Reporting incidence (new cancer diagnoses). GLOBOCAN 2002 data shows gastric cancer incidence ~22 per 100k globally, with high geographic variation (high in East Asia, lower in Western countries).","Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,1760000,,True
0.68,,C0024713,Manic Disorder,moderate,,2004,low,,15,True,both,Bipolar Disorder,,800,,"Manic disorder (bipolar disorder with manic episodes) has similar epidemiology to bipolar depression. Incidence ~15 per 100k person-years, lifetime prevalence ~0.8%. Moderate confidence from population-based psychiatric surveys.",Merikangas KR et al. (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 64(5):543-552,literature,https://pubmed.ncbi.nlm.nih.gov/17485606/,,1200000,,False
0.75,,C0025149,Medulloblastoma,strong,,2004,low,,0.6,True,incidence,Central Nervous System Tumor,,,,Reporting incidence of new cases. Medulloblastoma global incidence ~0.6 per 100k all ages (higher in children at ~6 per 100k pediatric population). Most common malignant pediatric brain tumor from CBTRUS data.,"CBTRUS Statistical Report 2004-2005, Central Brain Tumor Registry of the United States",registry,https://www.cbtrus.org/,,48000,,False
0.85,,C0025202,melanoma,strong,,2002,high,,2.8,False,incidence,,,,,"Reporting incidence (new cancer diagnoses). GLOBOCAN 2002 global melanoma incidence ~2.8 per 100k, highly variable by region (>10 per 100k in Australia/NZ, <0.5 in Asia).","Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,224000,,False
0.65,,C0025362,Mental Retardation,moderate,,,moderate,,,False,prevalence,,,1500,,Outdated term for intellectual disability. Prevalence-based metric appropriate for this developmental/lifelong condition. Global prevalence ~1-2% (1500 per 100k) based on WHO estimates. Moderate confidence due to acceptable prevalence data but no specific 2005 source and variation in diagnostic criteria.,WHO estimates on developmental disabilities,estimate,,,120000000,,False
0.0,,C0026205,Miosis disorder,none,,,unknown,,,False,,,,,,"Miosis is a clinical sign (pupillary constriction) rather than a disease entity. Can result from multiple causes (opioids, neurological conditions, eye disorders). Not tracked epidemiologically as an independent condition.",,,,,,,False
0.65,,C0026277,Mixed Salivary Gland Tumor,moderate,,,low,,1.0,True,incidence,Salivary Gland Neoplasm,,,,"Pleomorphic adenoma (mixed tumor) is the most common salivary gland tumor, comprising approximately 60-70% of all salivary gland neoplasms. With total salivary gland tumor incidence of 1-2 per 100k, mixed tumor incidence is approximately 1 per 100k.","Speight PM, Barrett AW (2002). Salivary gland tumours. Oral Dis. 8(5):229-240",literature,https://pubmed.ncbi.nlm.nih.gov/12363107/,,80000,,False
0.75,,C0026691,Mucocutaneous Lymph Node Syndrome,strong,,2004,high,,8.5,False,incidence,,,,,"Kawasaki disease incidence varies dramatically by geography (Japan ~250/100k children, Western countries ~10-20/100k). Global weighted average ~8.5 per 100k all-age population based on pediatric incidence data from 2000s.",Nakamura Y et al. (2008). Epidemiologic features of Kawasaki disease in Japan. Pediatrics. 122(6):e1167-72,literature,https://pubmed.ncbi.nlm.nih.gov/19047216/,,680000,,False
0.85,,C0026764,Multiple Myeloma,strong,,2005,moderate,,4.5,True,incidence,Plasma Cell Neoplasms,,,,Reporting incidence of new multiple myeloma diagnoses. GLOBOCAN 2005 estimates approximately 4.5 per 100k person-years globally. Well-defined hematological malignancy with reliable registry data. Higher incidence in developed countries and older populations.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,360000,,True
0.0,,C0026848,Myopathy,none,,,unknown,,,False,,,,,,"Umbrella term covering numerous distinct muscle diseases (inflammatory, metabolic, toxic, genetic, congenital, endocrine myopathies) with vastly different incidence rates and etiologies. Too heterogeneous to estimate meaningfully without disease-specific specification.",,,,,,,False
0.75,,C0026896,Myasthenia Gravis,strong,,,moderate,,1.0,False,incidence,,,,,Autoimmune neuromuscular disorder with incidence ~1.0 per 100k person-years globally. Based on population-based epidemiological studies showing 0.5-2.0 per 100k depending on region.,Phillips LH 2nd et al. (2004). The epidemiology of myasthenia gravis. Ann N Y Acad Sci. 998:407-412,literature,https://pubmed.ncbi.nlm.nih.gov/15067620/,,80000,,False
0.65,,C0026948,Mycosis Fungoides,moderate,,,moderate,,0.4,True,incidence,Cutaneous T-cell Lymphoma,,,,"Rare cutaneous T-cell lymphoma with global incidence ~0.4 per 100k person-years. Data from cancer registries, though rare cancers have less robust surveillance.",Bradford PT et al. (2009). Cutaneous lymphoma incidence patterns in the United States. Arch Dermatol. 145(12):1421-7,literature,https://pubmed.ncbi.nlm.nih.gov/20026852/,,32000,,False
0.7,,C0026987,Myelofibrosis,moderate,,2005,low,,0.8,False,incidence,,,,,"Reporting incidence of myelofibrosis (including primary and secondary). Global incidence ~0.5-1.5 per 100k person-years, using midpoint estimate of 0.8.","Rollison DE et al. (2008). Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004. Br J Haematol. 142(3):395-404",literature,https://pubmed.ncbi.nlm.nih.gov/18616696/,,64000,,False
0.65,,C0027013,Myeloid Metaplasia,moderate,,,low,,0.8,False,incidence,,,,,"Reporting incidence. Myeloid metaplasia is an older term essentially synonymous with myelofibrosis, referring to extramedullary hematopoiesis. Using same estimate as myelofibrosis (~0.8 per 100k), though this term is less commonly used in modern literature.","Rollison DE et al. (2008). Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004. Br J Haematol. 142(3):395-404",literature,https://pubmed.ncbi.nlm.nih.gov/18616696/,,64000,,False
0.25,,C0027022,Myeloproliferative Disease,weak,,,moderate,,5.5,False,incidence,,,,,"Aggregate BOTEC estimate summing major myeloproliferative neoplasms: polycythemia vera (~1.5), essential thrombocythemia (~1.5), primary myelofibrosis (~0.5), chronic myeloid leukemia (~1-2). Total ~5.5 per 100k. Low confidence due to umbrella term heterogeneity.",,estimate,,,440000,,False
0.82,,C0027051,Myocardial Infarction,strong,,2005,high,,220,True,incidence,Ischemic Heart Disease,,,,"Acute MI incidence ~220 per 100k globally from WHO cardiovascular disease surveillance circa 2005, with high geographic variation (higher in developed nations).",WHO Global Burden of Disease 2005 Study,registry,https://www.who.int/healthinfo/global_burden_disease/,,17600000,,True
0.0,,C0027612,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",none,,,unknown,,,False,,,,,,"Umbrella term too broad and heterogeneous to estimate meaningfully. Encompasses thousands of distinct conditions across all organ systems including genetic syndromes, congenital malformations, metabolic disorders, and neonatal infections with vastly different incidence rates.",,,,,,,False
0.0,,C0027627,Neoplasm Metastasis,none,,,unknown,,,False,,,,,,"Unmappable: Metastasis is a process/complication of cancer, not a primary disease entity. Incidence depends entirely on the primary cancer type, staging, and treatment. Cannot provide meaningful aggregate estimate.",,,,,,,False
0.0,,C0027651,Neoplasms,none,,,unknown,,,False,,,,,,Umbrella term too broad and generic to estimate meaningfully. Encompasses all benign and malignant tumors across all organ systems with vastly different incidence rates and clinical significance.,,,,,,,False
0.0,,C0027765,nervous system disorder,none,,,unknown,,,False,,,,,,"Unmappable umbrella term encompassing all neurological conditions (stroke, epilepsy, Parkinson's, MS, migraines, neuropathy, etc.). Too heterogeneous and broad to provide meaningful aggregate estimate.",,,,,,,False
0.87,,C0027819,Neuroblastoma,strong,,2005,low,,0.9,False,incidence,,,,,Neuroblastoma primarily affects children (90% diagnosed before age 5). Overall population incidence ~0.9 per 100k. Data from SEER and international cancer registries.,"Ries LAG et al. SEER Cancer Statistics Review, 1975-2005",registry,https://seer.cancer.gov/archive/csr/1975_2005/,,72000,,True
0.72,,C0027831,Neurofibromatosis 1,strong,,,low,,0.67,True,incidence,Neurofibromatosis,,,,"Reporting incidence based on birth prevalence of 1 in 3,000 live births. With global birth rate ~2,000 per 100k per year (2005), population incidence is ~0.67 per 100k person-years. Well-documented genetic disorder.",Lammert M et al. (2005). Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol. 141(1):71-74,literature,https://pubmed.ncbi.nlm.nih.gov/15655144/,,53600,,False
0.82,,C0028754,Obesity,strong,,2005,high,,,False,prevalence,,,9800,,"Obesity measured as prevalence, not incidence. WHO 2005 data shows 9.8% of global adults obese (9,800 per 100k).",Kelly T et al. (2008). Global burden of obesity in 2005 and projections to 2030. Int J Obes. 32:1431-1437,literature,https://pubmed.ncbi.nlm.nih.gov/18607383/,,784000000,,True
0.0,,C0029182,orbit (eye disorders),none,,,unknown,,,False,,,,,,"Umbrella term covering all orbital disorders including orbital tumors, thyroid eye disease, orbital infections, trauma, congenital abnormalities, and inflammatory conditions. Too heterogeneous to estimate meaningfully without specification of specific orbital condition.",,,,,,,False
0.65,,C0029408,Degenerative polyarthritis,moderate,,2005,moderate,,240,True,incidence,Osteoarthritis,,,,Degenerative polyarthritis refers to osteoarthritis affecting multiple joints. Symptomatic OA incidence ~240 per 100k based on primary care and registry data (2000-2010). Lower confidence due to variable diagnostic criteria and reporting of polyarticular vs monoarticular disease.,"Oliveria SA et al. (1995). Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum. 38(8):1134-41",literature,https://pubmed.ncbi.nlm.nih.gov/7639811/,,19200000,,False
0.22,,C0029422,Osteochondrodysplasias,weak,,,low,,2.5,False,incidence,,,,,"Aggregate BOTEC estimate summing major skeletal dysplasias: achondroplasia (~0.4 per 100k births), osteogenesis imperfecta (~0.5), multiple epiphyseal dysplasia (~0.3), other rare types (~1.3) = ~2.5 per 100k births. Highly heterogeneous group of >400 genetic conditions.",,,,,200000,,False
0.75,,C0029463,Osteosarcoma,strong,,,low,,0.35,False,incidence,,,,,Reporting incidence at ~0.35 per 100k person-years. Most common primary bone malignancy with incidence of 3-4 per million globally based on SEER and international cancer registry data including GLOBOCAN.,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,28000,,False
0.88,,C0029925,Ovarian Carcinoma,strong,,2005,moderate,,6.3,False,incidence,,,,,Ovarian cancer global incidence from GLOBOCAN 2005: ~6.3 per 100k women (age-standardized rate). Well-documented cancer with strong registry data from multiple countries.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,504000,,True
0.65,,C0030297,Pancreatic Neoplasm,strong,,2005,moderate,,7.5,False,incidence,,,,,Umbrella term covering benign and malignant pancreatic tumors. Reporting primarily malignant pancreatic cancer incidence at ~7.5 per 100k from GLOBOCAN 2005 data. Benign neoplasms are less well documented. Confidence reduced due to heterogeneity of term.,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,600000,,True
0.72,,C0030319,Panic Disorder,strong,,2005,moderate,,280,True,both,Anxiety Disorders,,2700,,Reporting incidence of ~280 per 100k person-years for new onset panic disorder. Lifetime prevalence ~2.7% (2700 per 100k) based on epidemiological surveys from early 2000s.,"Kessler RC et al. (2006). The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 63(4):415-424",literature,https://pubmed.ncbi.nlm.nih.gov/16585471/,,22400000,,False
0.0,,C0030354,Papilloma,none,,,high,,,False,,,,,,"Umbrella term covering 25+ distinct papilloma types (breast, bladder, laryngeal, skin, etc.) with vastly different incidence rates ranging from <1 to >100 per 100k. Cannot meaningfully aggregate.",,,,,,,False
0.0,,C0030552,Paresis,none,,,unknown,,,False,,,,,,"Symptom descriptor (partial weakness/paralysis) rather than disease entity. Can result from stroke, spinal cord injury, MS, neuropathies, brain lesions, etc. Too broad and non-specific to assign disease incidence without underlying cause specification.",,,,,,,False
0.78,,C0030567,Parkinson Disease,strong,,2005,moderate,,13.4,False,incidence,,,,,"Parkinson disease incidence ~13.4 per 100k person-years globally (age-adjusted). Incidence increases dramatically with age: <1 per 100k under age 50, rising to >100 per 100k over age 80. Based on systematic review data circa 2005.",de Lau LM et al. (2006). Epidemiology of Parkinson's disease. Lancet Neurol. 5(6):525-535,literature,https://pubmed.ncbi.nlm.nih.gov/16713924/,,1072000,,False
0.65,,C0031069,Familial Mediterranean Fever,moderate,,,high,,2.0,False,incidence,,,,,"Reporting incidence of new diagnoses. Global average ~2 per 100k, but varies dramatically from <0.1 in Northern Europe to 100-200 per 100k in high-risk Mediterranean populations (Sephardic Jews, Armenians, Turks).",Ozen S et al. (2009). Familial Mediterranean fever. Nat Rev Rheumatol. 5:10-16,literature,https://pubmed.ncbi.nlm.nih.gov/19098926/,,160000,,False
0.72,,C0031090,Periodontal Diseases,strong,,2005,moderate,,,False,prevalence,,,50000,,"Umbrella term for gingivitis, periodontitis, and related conditions. Reporting prevalence as chronic condition (~50% global adult prevalence for moderate-to-severe periodontal disease based on WHO Global Oral Health Data Bank circa 2005).",Petersen PE et al. (2005). The global burden of periodontal disease: towards integration with chronic disease prevention and control. Periodontol 2000. 60(1):15-39,literature,https://pubmed.ncbi.nlm.nih.gov/22909104/,,4000000000,,False
0.55,,C0031094,Periodontal Pocket,moderate,,,moderate,,,True,prevalence,Periodontal Diseases,,35000,,Periodontal pockets are a clinical manifestation of periodontitis rather than a distinct disease. Reporting prevalence (~35% of adults globally have periodontal pockets ≥4mm based on NHANES and global surveys). Confidence moderate due to being a clinical finding rather than disease entity.,Eke PI et al. (2012). Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 91(10):914-920,literature,https://pubmed.ncbi.nlm.nih.gov/22935673/,,2800000000,,False
0.25,,C0032002,Pituitary Diseases,weak,,,moderate,,5.0,False,incidence,,,,,"Aggregate BOTEC estimate summing major pituitary conditions: pituitary adenomas (~4 per 100k), hypopituitarism (~0.5), acromegaly (~0.3), other rare conditions (~0.2) = ~5 per 100k. Heterogeneous group with varying pathophysiology.",,,,,400000,,False
0.78,,C0032285,Pneumonia,strong,,2004,high,,1200,False,incidence,,,,,Community-acquired pneumonia incidence approximately 1200 per 100k person-years globally based on WHO estimates circa 2005. Varies significantly by age (higher in children <5 and adults >65) and region.,Rudan I et al. (2008). Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 86(5):408-416,literature,https://pubmed.ncbi.nlm.nih.gov/18545744/,,96000000,,False
0.75,,C0032580,Adenomatous Polyposis Coli,strong,,,low,,1.2,True,incidence,Polyposis Syndrome,,,,"Familial Adenomatous Polyposis (FAP) incidence ~1 in 8,000-10,000 births (1.2 per 100k). Well-documented genetic condition with clear diagnostic criteria.",Jasperson KW et al. (2010). Hereditary and familial colon cancer. Gastroenterology. 138(6):2044-2058,literature,https://pubmed.ncbi.nlm.nih.gov/20420945/,,96000,,False
0.0,,C0032927,Precancerous Conditions,none,,,unknown,,,False,,,,,,"Umbrella term covering heterogeneous conditions across multiple organs (cervical dysplasia, colorectal polyps, Barrett's esophagus, DCIS, etc.) with vastly different detection rates and clinical significance. Too broad to estimate meaningfully.",,,,,,,False
0.88,,C0033578,Prostatic Neoplasms,strong,,2005,high,,25.3,False,incidence,,,,,"Prostate cancer incidence from GLOBOCAN 2005: approximately 679,000 new cases globally in 2002, translating to ~25 per 100k men (age-standardized rate ~30 per 100k).",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,680000,,True
0.42,,C0033770,Prune Belly Syndrome,moderate,,,low,,extremely rare,False,incidence,,,,,"Rare congenital condition (absent abdominal muscles, urinary tract abnormalities). Incidence ~3 per 100,000 live births based on birth defect registries. Predominantly affects males (95%).",Routh JC et al. (2010). Epidemiological trends in pediatric urologic practice: the prune belly syndrome experience. J Urol. 184(4):1702-6,literature,https://pubmed.ncbi.nlm.nih.gov/20728144/,,extremely rare,,False
0.52,,C0033999,Pterygium,moderate,,,high,,8.0,False,incidence,,,,,Pterygium (fibrovascular conjunctival growth onto cornea) incidence ~8 per 100k globally. Strongly UV-dependent with 10-fold+ variation by latitude. Limited systematic incidence studies; estimate based on prevalence data and typical progression rates.,,,,,640000,,False
0.72,,C0034067,Pulmonary Emphysema,moderate,,2007,high,,,True,prevalence,Chronic Obstructive Pulmonary Disease (COPD),,1800,,"Emphysema is a chronic structural lung disease (part of COPD spectrum) measured by prevalence. Global COPD prevalence ~10% of adults over 40, emphysema comprises roughly 40-50% of COPD cases. Estimated ~1800 per 100k total population.",Halbert RJ et al. (2006). Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 28(3):523-532,literature,https://pubmed.ncbi.nlm.nih.gov/16611654/,,144000000,,False
0.75,,C0035334,Retinitis Pigmentosa,strong,,2006,low,,1.2,False,both,,,25,,Inherited retinal dystrophy with prevalence ~1 in 4000 (25 per 100k) and incidence ~1-1.5 per 100k births. Both metrics documented. Prevalence more commonly cited for this progressive genetic condition.,Hamel C. (2006). Retinitis pigmentosa. Orphanet J Rare Dis. 1:40,literature,https://pubmed.ncbi.nlm.nih.gov/17032466/,,96000,,False
0.78,,C0035335,Retinoblastoma,strong,,2005,moderate,,0.4,False,incidence,Eye Neoplasms,,,,Reporting incidence (new diagnoses). Rare pediatric eye cancer with global incidence ~3-4 per million children or ~0.4 per 100k total population. Data from cancer registries and IARC.,"Kivela T (1999). The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 83(7):767-73",literature,https://pubmed.ncbi.nlm.nih.gov/10381661/,,32000,,False
0.75,,C0035372,Rett Syndrome,strong,,2005,low,,5.0,False,incidence,,,,,"Rett syndrome incidence ~1 per 10,000-15,000 female births, approximately 5 per 100k total births. Well-documented X-linked dominant disorder caused by MECP2 mutations.",Laurvick CL et al. (2006). Rett syndrome in Australia: a review of the epidemiology. J Pediatr. 148(3):347-352,literature,https://pubmed.ncbi.nlm.nih.gov/16615965/,,40000,,False
0.75,,C0036220,Kaposi Sarcoma,strong,,2005,high,,2.5,False,incidence,,,,,"KS incidence strongly linked to HIV/AIDS prevalence. Global incidence ~2.5 per 100k in 2005, with dramatic variation: <0.1 in developed countries, >20 per 100k in sub-Saharan Africa during peak HIV epidemic.","Parkin DM et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,200000,,True
0.82,,C0036341,Schizophrenia,strong,,2005,low,,15.2,False,both,,,400,,Well-defined psychiatric disorder with robust epidemiological data. Incidence approximately 15.2 per 100k person-years globally; lifetime prevalence approximately 0.4% (400 per 100k). Both metrics commonly reported; incidence shows peak onset in early adulthood.,"McGrath J et al. (2008). Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 30:67-76",literature,https://pubmed.ncbi.nlm.nih.gov/18480098/,,1216000,,False
0.55,,C0036346,"Schizophrenia, Childhood",moderate,,,low,,0.04,True,incidence,Schizophrenia,,,,Childhood-onset schizophrenia (onset before age 13) is extremely rare: ~0.04 per 100k children per year based on pediatric psychiatric literature. Much rarer than adult-onset schizophrenia.,"Remschmidt H et al. (2007). Schizophrenia in children and adolescents. Cambridge University Press, citing epidemiological studies",literature,,,3200,,False
0.78,,C0036631,Seminoma,strong,,2005,moderate,,2.5,True,incidence,Testicular Germ Cell Tumors,,,,"Reporting incidence (new diagnoses). Seminoma accounts for ~50% of testicular cancer cases. With testicular cancer incidence at ~5-6 per 100k men globally (~2.5-3 per 100k total population), seminoma is ~2.5 per 100k.",McGlynn KA et al. (2005). Trends in the incidence of testicular germ cell tumors in the United States. Cancer. 97(1):63-70,literature,https://pubmed.ncbi.nlm.nih.gov/12491506/,,200000,,False
0.68,,C0036646,Age-related cataract,strong,,2004,moderate,,,True,prevalence,Cataract,,8500,,"Age-related cataract measured as prevalence (chronic condition). WHO 2004-2005 data indicates cataract affects ~8-9% of global population over age 40, representing the largest cause of blindness globally. Prevalence more appropriate than incidence for this progressive condition.","Pascolini D, Mariotti SP. (2012). Global estimates of visual impairment: 2010. Br J Ophthalmol. 96(5):614-618",literature,https://pubmed.ncbi.nlm.nih.gov/22133988/,,680000000,,False
0.62,,C0036690,Septicemia,moderate,,,high,,75,True,incidence,Sepsis,,,,Septicemia (bloodstream infection) is a specific subtype of sepsis. Incidence estimated ~75 per 100k based on blood culture-confirmed bacteremia rates from hospital registries.,,,,,6000000,,False
0.35,,C0036920,Sezary Syndrome,weak,,,unknown,,extremely rare,True,incidence,Cutaneous T-Cell Lymphoma,,,,Rare leukemic variant of cutaneous T-cell lymphoma. Estimated <0.1 per 100k based on SEER and registry data. Represents ~5% of CTCL cases.,Bradford PT et al. (2009). Cutaneous lymphoma incidence patterns in the United States. Arch Dermatol. 145(8):870-6,literature,https://pubmed.ncbi.nlm.nih.gov/19687417/,,extremely rare,,False
0.0,,C0037579,Soft Tissue Neoplasms,none,,,high,,,False,,,,,,"Umbrella term too heterogeneous: includes benign soft tissue tumors (lipomas, hemangiomas - extremely common) and malignant sarcomas (rare, ~5 per 100k). Vastly different clinical significance and epidemiology make aggregate estimate meaningless.",,,,,,,False
0.0,,C0038354,Stomach Diseases,none,,,high,,,False,,,,,,"Umbrella term covering vastly different conditions (gastritis, peptic ulcers, gastric cancer, gastroparesis, etc.) with different incidence rates, severities, and clinical significance. Too heterogeneous to estimate meaningfully.",,,,,,,False
0.0,,C0038356,Stomach Neoplasms,none,,,high,,,False,,,,,,"Umbrella term too heterogeneous to estimate meaningfully: includes gastric adenocarcinoma (most common, ~10-15 per 100k), gastric lymphoma (<1 per 100k), GISTs (~1-2 per 100k), benign polyps, and other rare tumors with vastly different incidence rates and clinical significance.",,,,,,,False
0.65,,C0038436,Post-Traumatic Stress Disorder,moderate,,2005,high,,,False,prevalence,,,350,,PTSD primarily measured as prevalence (~3.5% or 350 per 100k adults). Incidence poorly documented as onset varies widely after trauma exposure. Using prevalence data from epidemiological studies.,Kessler RC et al. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders. Arch Gen Psychiatry. 62(6):593-602,literature,https://pubmed.ncbi.nlm.nih.gov/15939837/,,28000000,,False
0.85,,C0038454,Cerebrovascular accident,strong,,2005,high,,200.0,False,incidence,,,,,"Reporting incidence (new strokes per year). WHO STEPS Stroke 2005 data shows global stroke incidence ~200 per 100k person-years, with significant geographic variation.",Strong K et al. (2007). Preventing stroke: saving lives around the world. Lancet Neurol. 6(2):182-187,literature,https://pubmed.ncbi.nlm.nih.gov/17239805/,,16000000,,True
0.75,,C0038644,Sudden infant death syndrome,strong,,2005,high,,7.5,False,incidence,,,,,"SIDS incidence ~0.55 per 1000 live births globally in 2005 (post Back-to-Sleep era). With ~133M births/year globally, approximately 73,000 SIDS deaths/year. Reported per 100k infants (0-1 year population ~133M, or ~1.7% of 8B = 136M) = ~54 per 100k infants. Converted to general population incidence: ~7.5 per 100k person-years. High geographic variation (0.2-0.8 per 1000 births).",Hauck FR et al. (2008). International trends in sudden infant death syndrome: stabilization of rates requires further action. Pediatrics. 122(3):660-666,literature,https://pubmed.ncbi.nlm.nih.gov/18762537/,,6000,,True
0.82,,C0039483,Giant Cell Arteritis,strong,,2004,high,,10.0,True,incidence,Vasculitis,,,,"GCA incidence varies by age and geography. Population-adjusted global average ~10 per 100k, with peak incidence 15-25 per 100k in populations >50 years. Strong registry data from Northern Europe and North America.",Salvarani C et al. (2004). Epidemiology of giant cell arteritis. Clin Exp Rheumatol. 22(6 Suppl 36):S23-7,literature,https://pubmed.ncbi.nlm.nih.gov/15675131/,,800000,,False
0.55,,C0039585,Androgen-Insensitivity Syndrome,moderate,,,low,,,False,prevalence,,,2.0,,"Genetic condition present from birth, so prevalence is more appropriate than incidence. Complete AIS prevalence ~1-2 per 100k; partial AIS may be slightly higher. Limited population-based studies; confidence moderate due to underdiagnosis.",Hughes IA et al. (2006). Consensus statement on management of intersex disorders. Arch Dis Child. 91(7):554-563,literature,https://pubmed.ncbi.nlm.nih.gov/16624884/,,160000,,False
0.65,,C0039730,Thalassemia,moderate,,,high,,,False,prevalence,,,25,,"Umbrella term for alpha and beta thalassemia. Reporting prevalence of symptomatic disease (thalassemia major/intermedia) at ~25 per 100k globally. Well-studied genetic hemoglobinopathy with established epidemiology, though incidence varies dramatically by region (much higher in Mediterranean, Southeast Asia, Middle East). Carrier prevalence is much higher (~1500-3000 per 100k).",WHO guidelines on thalassemia and hemoglobinopathies,literature,,,2000000,,False
0.0,,C0040136,Thyroid Neoplasm,none,,,high,,,False,,,,,,Umbrella term too heterogeneous: includes benign thyroid adenomas (prevalence ~5-10% of adults by autopsy/ultrasound) and malignant thyroid cancers (incidence ~10 per 100k). Vastly different clinical significance and epidemiological patterns. Not meaningful to aggregate.,,,,,,,False
0.75,,C0041696,Unipolar Depression,strong,,2004,moderate,,370,True,both,Depressive Disorders,,3300,,"Unipolar depression (major depression without bipolar features) has global incidence ~370 per 100k person-years for new episodes, with prevalence ~3.3% (3300 per 100k). WHO 2004-2005 GBD data.",WHO Global Burden of Disease Study 2004,registry,https://www.who.int/healthinfo/global_burden_disease/,,29600000,,True
0.0,,C0042373,Vascular Diseases,none,,,high,,,False,,,,,,"Umbrella term far too broad to estimate meaningfully. Encompasses coronary artery disease, stroke, peripheral artery disease, aneurysms, vasculitis, venous thrombosis - each with distinct epidemiology and clinical significance. Aggregate estimate would not be useful.",,,,,,,False
0.28,,C0042384,Vasculitis,weak,,,high,,40,False,incidence,,,,,"Aggregate BOTEC estimate summing major vasculitides: Giant cell arteritis (~10), Takayasu arteritis (~2), Polyarteritis nodosa (~2), Microscopic polyangiitis (~3), Granulomatosis with polyangiitis (~5), Eosinophilic granulomatosis (~2), Henoch-Schönlein purpura (~10), Behçet's (~3), other (~3) = ~40 per 100k. Heterogeneous group with overlap and variable diagnostic criteria.",,estimate,,,3200000,,False
0.45,,C0042514,"Tachycardia, Ventricular",moderate,,,moderate,,2.5,True,incidence,Cardiac Arrhythmias,,,,Reporting incidence of sustained ventricular tachycardia at approximately 2-3 per 100k person-years in general population. Incidence varies significantly based on underlying heart disease prevalence. Limited population-based registry data available.,,,,,200000,,False
0.45,,C0043119,Werner Syndrome,weak,,,high,,extremely rare,False,incidence,Progeroid Syndrome,,,,"Werner syndrome is an extremely rare autosomal recessive progeroid disorder. Prevalence estimated at 1-9 per million, translating to incidence <0.01 per 100k. Higher prevalence in Japan (~1 in 50,000) due to founder effect.","Oshima J et al. (2017). Werner syndrome: Clinical features, pathogenesis and potential therapeutic interventions. Ageing Res Rev. 33:105-114",literature,https://pubmed.ncbi.nlm.nih.gov/27374323/,,extremely rare,,False
0.45,,C0043346,Xeroderma Pigmentosum,weak,,,high,,extremely rare,False,incidence,,,,,"Extremely rare autosomal recessive disorder. Birth incidence ~0.4 per 100k in US/Europe (1 in 250,000), higher in Japan (1 in 40,000). Limited systematic epidemiological data.","Kleijer WJ et al. (2008). Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. DNA Repair. 7(5):744-750",literature,https://pubmed.ncbi.nlm.nih.gov/18329345/,,extremely rare,,False
0.65,,C0079218,"Fibromatosis, Aggressive",moderate,,,low,,0.3,True,incidence,Fibromatosis,,,,Desmoid tumors (aggressive fibromatosis) have documented incidence of 2-4 per million per year (0.2-0.4 per 100k). Using midpoint estimate of 0.3 per 100k based on population-based registry data.,"Reitamo JJ et al. (1982). The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol. 77(6):665-673",literature,https://pubmed.ncbi.nlm.nih.gov/7091046/,,24000,,False
0.65,,C0079298,Epidermolysis Bullosa Simplex,moderate,,,low,,0.3,True,incidence,Epidermolysis Bullosa,,,,EBS is the most common form of epidermolysis bullosa with estimated incidence of ~0.3 per 100k births. Based on epidemiological studies and rare disease registries.,Fine JD et al. (2008). The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol. 58(6):931-950,literature,https://pubmed.ncbi.nlm.nih.gov/18374450/,,24000,,False
0.68,,C0079588,"Ichthyosis, X-Linked",moderate,,,low,,0.3,True,incidence,Ichthyosis,,,,"X-linked ichthyosis affects approximately 1 in 2,000-6,000 males (birth prevalence). Converting to incidence per 100k person-years with global birth rate: ~0.3 per 100k. Moderate confidence based on established genetic prevalence data.",Orphanet and genetic disease registries,registry,,,24000,,False
0.28,,C0079731,B-Cell Lymphomas,weak,,2005,moderate,,12.0,False,incidence,,,,,"Aggregate BOTEC estimate summing major B-cell lymphoma subtypes: DLBCL (~4.2), follicular lymphoma (~2.5), marginal zone (~1.5), CLL (~3.0), other B-cell lymphomas (~0.8) = ~12 per 100k. Low confidence due to heterogeneity and potential overlap.",,estimate,,,960000,,True
0.45,,C0079740,High Grade Lymphoma (neoplasm),moderate,,,moderate,,8.5,True,incidence,Lymphoma,,,,"High-grade/aggressive lymphomas comprise ~60-65% of NHL cases. Estimated ~8.5 per 100k based on NHL incidence (~13 per 100k) × proportion high-grade. Includes DLBCL, Burkitt, other aggressive subtypes.",,estimate,,,680000,,False
0.82,,C0079744,Diffuse Large B-Cell Lymphoma,strong,,2005,moderate,,4.2,True,incidence,Non-Hodgkin Lymphoma,,,,DLBCL is the most common NHL subtype (~30-40% of NHL cases). Global NHL incidence 2005 ~10-12 per 100k; DLBCL accounts for ~4.2 per 100k based on GLOBOCAN and registry data.,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,336000,,True
0.72,,C0079772,T-Cell Lymphoma,strong,,2005,moderate,,1.5,True,incidence,Non-Hodgkin Lymphoma,,,,"Reporting incidence. T-cell lymphomas comprise ~10-15% of Non-Hodgkin lymphomas. Global NHL incidence ~10 per 100k, T-cell subtypes ~1.5 per 100k based on SEER and international registry data.",Vose J et al. (2008). International peripheral T-cell and natural killer/T-cell lymphoma study. J Clin Oncol. 26(25):4124-4130,literature,https://pubmed.ncbi.nlm.nih.gov/18626005/,,120000,,False
0.28,,C0085078,Lysosomal Storage Diseases,weak,,,moderate,,1.5,False,incidence,,,,,"Aggregate BOTEC summing 50+ rare genetic disorders including Gaucher (0.5), Fabry (0.2), Pompe (0.2), MPS disorders (0.3), others (0.3). Total ~1.5 per 100k. Low confidence due to heterogeneity of conditions.",,estimate,,,120000,,False
0.75,,C0085110,Severe Combined Immunodeficiency,strong,,2010,low,,1.7,False,incidence,,,,,"Reporting incidence per 100k births. SCID incidence ~1 in 58,000 live births (~1.7 per 100k births) based on newborn screening data.",Kwan A et al. (2014). Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 312(7):729-738,literature,https://pubmed.ncbi.nlm.nih.gov/25138334/,,136000,,False
0.75,,C0085215,"Ovarian Failure, Premature",moderate,,,moderate,,,False,prevalence,,,1000,,"Primary Ovarian Insufficiency (POI) is a chronic condition best measured by prevalence rather than incidence. Affects approximately 1% of women under 40 (1,000 per 100k women). Data from epidemiological studies, though not 2005-specific.",Coulam CB et al. (1986). Incidence of premature ovarian failure. Obstet Gynecol. 67(4):604-606,literature,https://pubmed.ncbi.nlm.nih.gov/3960433/,,80000000,,False
0.35,,C0085576,Iron-Refractory Iron Deficiency Anemia,weak,,,unknown,,extremely rare,True,incidence,Iron Deficiency Anemia,,,,Reporting incidence of this rare genetic disorder caused by TMPRSS6 mutations. Extremely rare condition with <0.01 per 100k births based on case report literature. Limited systematic epidemiological data available.,De Falco L et al. (2013). Iron refractory iron deficiency anemia. Haematologica. 98(6):845-853,literature,https://pubmed.ncbi.nlm.nih.gov/23729726/,,extremely rare,,False
0.8,,C0085669,Acute leukemia,strong,,2005,moderate,,5.5,False,incidence,Leukemia,,,,Combined acute lymphoblastic leukemia (ALL ~1.8 per 100k) and acute myeloid leukemia (AML ~3.7 per 100k) from GLOBOCAN 2005 data. Total ~5.5 per 100k globally.,Ferlay J et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127(12):2893-2917,registry,https://pubmed.ncbi.nlm.nih.gov/21351269/,,440000,,True
0.55,,C0085682,Hypophosphatemia,moderate,,,moderate,,,False,prevalence,,,2500,,"Hypophosphatemia is a laboratory finding/metabolic state rather than a discrete disease. Reporting prevalence (~2-3% of general population, ~2500 per 100k) as incidence is poorly defined for this biochemical abnormality. Much higher in hospitalized patients (30-80%).",,,,,200000000,,False
0.72,,C0087012,"Ataxia, Spinocerebellar",strong,,,moderate,,0.8,True,both,Cerebellar Ataxia,,3.0,,"Spinocerebellar ataxias (SCAs) are hereditary progressive ataxias with prevalence ~3 per 100k. Incidence of new clinical diagnoses ~0.8 per 100k person-years, accounting for typical age of onset (20-40 years) and disease progression.",Ruano L et al. (2014). The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology. 42(3):174-83,literature,https://pubmed.ncbi.nlm.nih.gov/24603320/,,64000,,False
0.65,,C0149678,Epstein-Barr Virus Infections,moderate,,,moderate,,500,False,incidence,,,,,"Reporting incidence of symptomatic EBV infection (infectious mononucleosis). Global incidence ~500 per 100k person-years, highest in adolescents/young adults. Most infections are asymptomatic.",Ebell MH. (2004). Epstein-Barr virus infectious mononucleosis. Am Fam Physician. 70(7):1279-1287,literature,https://pubmed.ncbi.nlm.nih.gov/15508538/,,40000000,,False
0.82,,C0149782,Squamous cell carcinoma of lung,strong,,2005,high,,5.5,True,incidence,Lung cancer,,,,Squamous cell carcinoma comprises ~25-30% of lung cancers. Global lung cancer incidence ~20 per 100k (GLOBOCAN 2005); squamous cell subtype ~5.5 per 100k.,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,440000,,True
0.45,,C0149939,Obstructive nephropathy,moderate,,,moderate,,4.5,False,incidence,,,,,"Obstructive nephropathy encompasses various etiologies (stones, tumors, BPH, congenital). Estimated ~4-5 per 100k for acute presentations requiring intervention based on urology literature, but lacks systematic population-based tracking.",,,,,360000,,False
0.0,,C0151650,Renal fibrosis,none,,,unknown,,,False,,,,,,"Renal fibrosis is a pathological process/endpoint rather than a distinct disease entity. It represents the common final pathway of various kidney diseases (CKD, diabetic nephropathy, glomerulonephritis). Cannot meaningfully assign independent incidence/prevalence as it's a histological feature, not a diagnostic category.",,,,,,,False
0.72,,C0151744,Myocardial Ischemia,moderate,,2005,high,,280,False,both,,,4500,,Broader term encompassing acute MI (~130 per 100k) and chronic ischemic heart disease (~150 per 100k). Total incidence ~280 per 100k based on WHO/MONICA data circa 2005. Geographic variation due to risk factors.,WHO MONICA Project and Global Burden of Disease 2005,registry,https://www.who.int/healthinfo/global_burden_disease/,,22400000,,False
0.35,,C0153676,Secondary malignant neoplasm of lung,weak,,,moderate,,25,False,incidence,Metastatic Neoplasm,,,,"Lung is the most common site for metastases from breast, colon, kidney, and other cancers. Estimated ~25 per 100k based on autopsy studies showing 30-55% of cancer patients develop lung metastases, but no systematic registry data. Low confidence due to heterogeneous primary sources and lack of population-based incidence studies.",,,,,2000000,,False
0.55,,C0153690,Secondary malignant neoplasm of bone,moderate,,,moderate,,85,False,incidence,,,,,"Bone metastases occur in ~70% of breast/prostate cancer patients and 30-40% of lung cancer patients. Estimating ~85 per 100k based on primary cancer incidence and metastasis rates, though incidence varies by primary cancer burden.",Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20 Pt 2):6243s-6249s,literature,https://pubmed.ncbi.nlm.nih.gov/17062708/,,6800000,,False
0.65,,C0158266,Intervertebral Disc Degeneration,moderate,,,moderate,,,False,prevalence,,,8500,,"Chronic degenerative condition measured as prevalence. Symptomatic disc degeneration affects approximately 8.5% of adults globally based on population studies, though radiographic evidence is much higher. Using prevalence as incidence poorly defined for gradual degeneration.",Hartvigsen J et al. (2018). What low back pain is and why we need to pay attention. Lancet. 391(10137):2356-2367,literature,https://pubmed.ncbi.nlm.nih.gov/29573870/,,680000000,,False
0.62,,C0162429,Malnutrition,moderate,,2005,high,,,False,prevalence,,,15000,,"Malnutrition is better measured by prevalence than incidence. WHO 2005 data shows approximately 15% of global population (15,000 per 100k) affected by various forms of malnutrition including undernutrition and micronutrient deficiencies. Broad umbrella term with significant geographic variation.","WHO Global Database on Child Growth and Malnutrition, 2005",registry,https://www.who.int/nutrition/databases/en/,,1200000000,,True
0.0,,C0178874,Tumor Progression,none,,,unknown,,,False,,,,,,"Tumor progression is a pathological process describing how tumors advance and become more aggressive, not a disease entity. Cannot be assigned an incidence rate. This is a biological concept, not a diagnosis.",,,,,,,False
0.35,,C0205698,Undifferentiated carcinoma,weak,,,high,,1.5,True,incidence,Carcinoma,,,,"Undifferentiated carcinoma (poorly differentiated/anaplastic) occurs in various organs - thyroid, nasopharyngeal, bladder, etc. Estimated ~1.5 per 100k aggregate across sites, but lack of organ specificity limits confidence. No single comprehensive source.",,,,,120000,,False
0.65,,C0206245,"Amyloid Neuropathies, Familial",moderate,,,high,,0.1,True,incidence,Hereditary Amyloidosis,,,,"Familial amyloid polyneuropathy (FAP, TTR-related) incidence ~0.1 per 100k globally, higher in endemic areas (Portugal, Sweden, Japan). Rare but well-characterized genetic condition.",Planté-Bordeneuve V et al. (2011). Familial amyloid polyneuropathy. Lancet Neurol. 10(12):1086-1097,literature,https://pubmed.ncbi.nlm.nih.gov/22094129/,,8000,,False
0.62,,C0206630,Endometrial Stromal Sarcoma,moderate,,,low,,0.15,True,incidence,Uterine Sarcoma,,,,Rare uterine malignancy representing ~10-15% of uterine sarcomas. Estimated ~0.1-0.2 per 100k women globally based on SEER and cancer registry data.,D'Angelo E et al. (2011). Endometrial stromal sarcomas. Semin Diagn Pathol. 28(4):342-349,literature,https://pubmed.ncbi.nlm.nih.gov/22195412/,,12000,,False
0.58,,C0206650,Fibroadenoma,moderate,,,moderate,,120,False,incidence,,,,,"Most common benign breast tumor, particularly in women 20-40 years old. Estimated ~120 per 100k based on clinical presentation data. Prevalence higher than incidence suggests, but incidence data from clinical registries. Confidence moderate due to underreporting (many asymptomatic).",,,,,9600000,,False
0.62,,C0206659,Embryonal Carcinoma,moderate,,,moderate,,0.4,True,incidence,Non-seminomatous Germ Cell Tumors,,,,"Reporting incidence. Embryonal carcinoma comprises ~40% of testicular germ cell tumors. With testicular cancer at ~6 per 100k men (3 per 100k total population), embryonal carcinoma estimated at ~0.4 per 100k.",Horwich A et al. (2006). Testicular germ cell cancer. Lancet. 367(9512):754-765,literature,https://pubmed.ncbi.nlm.nih.gov/16517276/,,32000,,False
0.68,,C0206677,Adenomatous Polyps,moderate,,,moderate,,,True,prevalence,Colorectal Polyps,,25000,,"Reporting prevalence (existing cases), not incidence. Adenomatous polyps are benign precursor lesions found in ~25-30% of adults over age 50 (25,000 per 100k). Prevalence is the appropriate metric for this chronic, often asymptomatic condition.",Lieberman DA et al. (2000). Prevalence of polyps greater than 9 mm in a consortium of diverse geographic areas. Clin Gastroenterol Hepatol. 3(8):798-805,literature,https://pubmed.ncbi.nlm.nih.gov/16234009/,,2000000000,,False
0.78,,C0206682,Follicular thyroid carcinoma,strong,,2005,moderate,,1.5,True,incidence,Thyroid Neoplasm,,,,"Follicular thyroid carcinoma comprises ~10-15% of thyroid cancers. Global thyroid cancer incidence ~10-12 per 100k (GLOBOCAN 2005), so FTC ~1.5 per 100k. Second most common thyroid malignancy after papillary type.","Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,120000,,True
0.75,,C0206698,Cholangiocarcinoma,strong,,2005,high,,2.0,False,incidence,,,,,Total cholangiocarcinoma (intrahepatic + extrahepatic) incidence ~2.0 per 100k globally circa 2005. Encompasses all bile duct malignancies. Significantly higher in Southeast Asia (Thailand ~85 per 100k) due to liver fluke infection.,Khan SA et al. (2005). Cholangiocarcinoma. Lancet. 366(9493):1303-1314,literature,https://pubmed.ncbi.nlm.nih.gov/16214602/,,160000,,False
0.75,,C0206704,"Carcinoma, Large Cell",strong,,2005,moderate,,2.5,True,incidence,Lung Cancer,,,,"Large cell carcinoma represents ~10-15% of lung cancers. Global lung cancer incidence ~20 per 100k (2005), thus large cell subtype ~2.5 per 100k.",GLOBOCAN 2005 (IARC) - lung cancer histological subtypes,registry,https://gco.iarc.fr/,,200000,,True
0.75,,C0206708,Cervical Intraepithelial Neoplasia,strong,,2005,high,,400,False,incidence,,,,,"CIN (all grades: CIN 1, 2, 3) detection rate from cervical screening programs globally. Estimated ~400 per 100k women screened per year based on WHO/HPV screening data circa 2005. Includes all grades of dysplasia. High geographic variation based on HPV prevalence and screening coverage.",Schiffman M et al. (2007). Human papillomavirus and cervical cancer. Lancet. 370:890-907,literature,https://pubmed.ncbi.nlm.nih.gov/17826171/,,32000000,,False
0.7,,C0206734,Hemangioblastoma,moderate,,,low,,0.18,True,incidence,Central Nervous System Neoplasm,,,,Hemangioblastoma is a rare benign vascular tumor primarily of the cerebellum and spinal cord. Incidence approximately 0.15-0.2 per 100k person-years based on CNS tumor registries. Associated with von Hippel-Lindau disease in 20-30% of cases.,CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors,registry,https://www.cbtrus.org/,,14400,,False
0.82,,C0220597,Adult Hodgkin Lymphoma,strong,,2005,moderate,,2.4,True,incidence,Hodgkin Lymphoma,,,,Reporting incidence of new diagnoses. Adult Hodgkin lymphoma has global incidence of approximately 2.4 per 100k population. Bimodal age distribution with peaks in young adults and elderly. Data from GLOBOCAN 2005.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,192000,,True
0.78,,C0220644,Childhood Hodgkin Lymphoma,strong,,2005,moderate,,0.3,True,incidence,Hodgkin Lymphoma,,,,Reporting incidence of new diagnoses. Childhood Hodgkin lymphoma (ages 0-14) has incidence of approximately 0.3 per 100k total population (or 1.5 per 100k children). Data from GLOBOCAN and pediatric cancer registries.,Ferlay J et al. (2007). Estimates of cancer incidence and mortality in Europe in 2006. Ann Oncol. 18(3):581-592,literature,https://pubmed.ncbi.nlm.nih.gov/17287242/,,24000,,True
0.3,,C0220685,Achondrogenesis type 2,weak,,,unknown,,extremely rare,True,incidence,Skeletal dysplasia,,,,Lethal skeletal dysplasia caused by COL2A1 mutations. Extremely rare at <0.01 per 100k births based on case report frequency. Most cases are stillborn or die in neonatal period.,,,,,extremely rare,,False
0.55,,C0221273,Juvenile polyp,moderate,,,moderate,,50,False,both,,,1500,,"Juvenile polyps are benign hamartomatous polyps occurring in 1-2% of children (prevalence ~1500 per 100k). Incidence of clinical detection approximately 50 per 100k person-years based on pediatric gastroenterology studies. Most solitary and sporadic, distinct from juvenile polyposis syndrome.",Hyer W et al. (2004). Juvenile polyposis syndrome. J Med Genet. 41(1):1-11,literature,https://pubmed.ncbi.nlm.nih.gov/14729819/,,4000000,,False
0.45,,C0234535,Clonic Seizures,weak,,,moderate,,8,True,incidence,Seizure disorders,,,,Purely clonic seizures are relatively uncommon subtype of epilepsy. Estimated ~8 per 100k based on epilepsy incidence (~50-70 per 100k) with clonic seizures representing ~10-15% of seizure types. Limited specific epidemiological data for this seizure classification.,,,,,640000,,False
0.82,,C0235782,Gallbladder Carcinoma,strong,,2005,high,,2.5,True,incidence,Biliary Tract Cancer,,,,Gallbladder cancer incidence ~2-3 per 100k globally based on GLOBOCAN data. Shows high geographic variation (much higher in South America and South Asia).,Randi G et al. (2009). Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 118(7):1591-1602,literature,https://pubmed.ncbi.nlm.nih.gov/16397865/,,200000,,True
0.78,,C0235833,Congenital diaphragmatic hernia,strong,,,low,,23.0,False,incidence,,,,,"Reporting incidence at birth. CDH occurs in approximately 2.3 per 10,000 live births (23 per 100k) based on congenital anomaly registries. Well-documented birth defect with consistent global data.",McGivern MR et al. (2015). Epidemiology of congenital diaphragmatic hernia in Europe: a register-based study. Arch Dis Child Fetal Neonatal Ed. 100(2):F137-44,registry,https://pubmed.ncbi.nlm.nih.gov/25411443/,,1840000,,False
0.35,,C0238052,"Xanthomatosis, Cerebrotendinous",weak,,,low,,extremely rare,True,incidence,Lipid Storage Diseases,,,,Cerebrotendinous xanthomatosis (CTX) is an extremely rare autosomal recessive disorder caused by CYP27A1 mutations. Estimated at <0.1 per 100k births based on case registries and prevalence estimates of 1-9 per million population.,,,,,extremely rare,,False
0.78,,C0238461,Anaplastic thyroid carcinoma,strong,,2005,low,,0.15,True,incidence,Thyroid Carcinoma,,,,"Anaplastic thyroid carcinoma represents 1-2% of all thyroid cancers. With thyroid cancer incidence ~6-8 per 100k globally in 2005, anaplastic subtype incidence ~0.15 per 100k person-years from cancer registry data.",Kebebew E et al. (2005). Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer. 103(7):1330-1335,literature,https://pubmed.ncbi.nlm.nih.gov/15739211/,,12000,,True
0.82,,C0238463,Papillary Thyroid Carcinoma,strong,,2005,moderate,,5.2,True,incidence,Thyroid Cancer,,,,"Papillary thyroid carcinoma accounts for ~80% of thyroid cancers. Total thyroid cancer incidence ~6.5 per 100k globally in 2005, yielding ~5.2 per 100k for papillary subtype. Data from GLOBOCAN 2005.",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,416000,,True
0.0,,C0239211,Oedema auricular,none,,,unknown,,,False,,,,,,"Auricular edema is a clinical finding/symptom rather than a distinct disease entity. Can result from multiple etiologies including trauma, infection, allergic reaction, or inflammatory conditions. No meaningful incidence data as it's not tracked as a primary diagnosis.",,,,,,,False
0.88,,C0242379,Malignant neoplasm of lung,strong,,2005,high,,35.0,True,incidence,Lung Neoplasms,,,,Lung cancer incidence from GLOBOCAN 2005: ~35 per 100k globally. Primarily refers to primary lung cancer in epidemiological reporting. Higher in males (~50 per 100k) than females (~20 per 100k).,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,2800000,,True
0.72,,C0243026,Sepsis,strong,,2017,high,,189,False,incidence,,,,,"Reporting incidence (new cases). Global estimate ~189 per 100k based on hospital surveillance data. Definition has evolved over time, affecting comparability.",Fleischmann C et al. (2016). Assessment of global incidence and mortality of hospital-treated sepsis. Am J Respir Crit Care Med. 193(3):259-272,literature,https://pubmed.ncbi.nlm.nih.gov/26414292/,,15120000,,False
0.45,,C0262584,"Carcinoma, Small Cell",moderate,,2005,high,,8.5,False,incidence,,,,,"Small cell carcinoma without organ specification is problematic. If interpreted as small cell lung cancer (most common form), incidence ~8.5 per 100k. However, lack of anatomical specificity reduces confidence significantly as small cell carcinomas can occur in multiple organs.","GLOBOCAN 2005 lung cancer data, SCLC comprises ~15% of lung cancers",registry,https://gco.iarc.fr/,,680000,,True
0.45,,C0264133,Acquired flat foot,moderate,,,moderate,,,True,prevalence,Foot deformities,,2400,,"Acquired flatfoot (posterior tibial tendon dysfunction) measured as prevalence, not incidence. Estimated ~2-3% adult prevalence (2,400 per 100k) based on orthopedic screening studies, but no systematic population-based registries.",,,,,192000000,,False
0.68,,C0264694,Chronic myocardial ischemia,moderate,,2005,high,,150,True,both,Myocardial Ischemia,,4200,,"Chronic ischemic heart disease incidence ~150 per 100k, prevalence ~4200 per 100k (WHO 2005 estimates). Both metrics relevant for chronic condition. Moderate confidence due to diagnostic variability and limited 2005-specific sources.",WHO Global Burden of Disease 2005,registry,https://www.who.int/healthinfo/global_burden_disease/,,12000000,,False
0.25,,C0266449,Congenital anomaly of brain,weak,,,high,,30.0,False,incidence,,,,,"Aggregate BOTEC estimate summing major congenital brain malformations per 100k births: neural tube defects (10), hydrocephalus (8), microcephaly (5), holoprosencephaly (1), other malformations (6) = ~30 per 100k births. Heterogeneous group with significant geographic variation.",,,,,39000,,False
0.45,,C0268164,"Primary hyperoxaluria, type I",moderate,,,moderate,,extremely rare,True,incidence,Primary hyperoxaluria,,,,Extremely rare autosomal recessive metabolic disorder. Estimated incidence <1 per million births (<0.1 per 100k) based on registry data from Europe. PH1 is the most common and severe form of primary hyperoxaluria.,Cochat P et al. (1995). Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant. 10(11):1746-53,literature,https://pubmed.ncbi.nlm.nih.gov/8559471/,,extremely rare,,False
0.65,,C0268381,Primary amyloidosis,moderate,,,low,,1.0,True,incidence,Amyloidosis,,,,AL (primary) amyloidosis incidence ~1.0 per 100k based on population-based studies. Rare plasma cell disorder with monoclonal light chain deposition.,"Kyle RA et al. (2003). Incidence of AL amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood. 101(7):2462-3",literature,https://pubmed.ncbi.nlm.nih.gov/12433690/,,80000,,False
0.65,,C0269102,Endometrioma,moderate,,,moderate,,,True,prevalence,Endometriosis,,700,,Endometrioma is a chronic condition measured by prevalence. Occurs in ~25% of endometriosis cases. Endometriosis affects ~10% of reproductive-age women; endometriomas estimated at ~700 per 100k total population (all ages/sexes).,Giudice LC et al. (2004). Endometriosis. Lancet. 364(9447):1789-1799,literature,https://pubmed.ncbi.nlm.nih.gov/15541453/,,56000000,,False
0.45,,C0271994,Hereditary persistence of fetal hemoglobin thalassemia,weak,,,high,,,True,prevalence,Thalassemia,,50,,"HPFH with thalassemia is a genetic hemoglobinopathy. Prevalence-based metric appropriate for lifelong genetic condition. Estimated ~50 per 100k globally, but varies significantly by ethnicity (higher in Mediterranean, African, and Asian populations). Limited comprehensive global epidemiological data.",,,,,4000000,,False
0.0,,C0275518,Acute infectious disease,none,,,unknown,,,False,,,,,,"Umbrella term too broad to estimate meaningfully - encompasses all acute bacterial, viral, fungal, and parasitic infections across all organ systems. Would require specification of pathogen type or organ system.",,,,,,,False
0.72,,C0278510,Childhood Medulloblastoma,strong,,2005,low,,0.5,True,incidence,Medulloblastoma,,,,"Reporting incidence of pediatric cases. Childhood medulloblastoma represents ~85% of all medulloblastomas, with incidence of ~6 per 100k in pediatric population (0-14 years), which equals ~0.5 per 100k when calculated against total population.","Rickert CH, Paulus W (2001). Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification. Childs Nerv Syst. 17:503-511",literature,https://pubmed.ncbi.nlm.nih.gov/11585301/,,40000,,False
0.55,,C0278607,Adult Leiomyosarcoma,moderate,,,low,,0.3,True,incidence,Soft Tissue Sarcoma,,,,Leiomyosarcoma represents ~10-15% of soft tissue sarcomas. Estimated adult incidence ~0.3 per 100k based on SEER and European cancer registry data.,"Toro JR et al. (2006). Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001. Int J Cancer. 119(12):2922-2930",literature,https://pubmed.ncbi.nlm.nih.gov/17013893/,,24000,,False
0.6,,C0278608,Adult Liposarcoma,moderate,,2005,low,,0.4,True,incidence,Soft Tissue Sarcoma,,,,"Most common soft tissue sarcoma in adults, representing ~20% of cases. Estimated incidence ~0.4 per 100k based on SEER registry data from early 2000s.","Toro JR et al. (2006). Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001. Int J Cancer. 119(12):2922-2930",literature,https://pubmed.ncbi.nlm.nih.gov/17013893/,,32000,,False
0.65,,C0278764,Adult Burkitt Lymphoma,moderate,,,high,,0.3,True,incidence,Burkitt Lymphoma,,,,Adult-onset Burkitt lymphoma represents ~20-30% of all Burkitt cases. Estimated ~0.3 per 100k adults in Western populations.,Molyneux EM et al. (2012). Burkitt's lymphoma. Lancet. 379(9822):1234-44,literature,https://pubmed.ncbi.nlm.nih.gov/22333947/,,24000,,False
0.55,,C0278876,Adult Medulloblastoma,moderate,,,unknown,,extremely rare,True,incidence,Medulloblastoma,,,,"Reporting incidence of adult cases. Adult medulloblastoma represents only ~10-15% of all medulloblastomas, with incidence <0.05 per 100k adults. Extremely rare with limited epidemiological data.",Brandes AA et al. (2003). Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET). Crit Rev Oncol Hematol. 66:223-246,literature,https://pubmed.ncbi.nlm.nih.gov/18406622/,,extremely rare,,False
0.68,,C0278879,Childhood Burkitt Lymphoma,moderate,,2005,high,,1.2,True,incidence,Burkitt Lymphoma,,,,Childhood form represents 70-80% of Burkitt cases. Endemic areas (equatorial Africa): 5-10 per 100k children. Sporadic (Western): 0.2-0.5 per 100k. Global average ~1.2 per 100k children.,Mbulaiteye SM et al. (2012). Burkitt lymphoma: beyond discoveries. Infect Agent Cancer. 7:3,literature,https://pubmed.ncbi.nlm.nih.gov/22289355/,,96000,,False
0.82,,C0279607,Adult Hepatocellular Carcinoma,strong,,2005,high,,11.5,True,incidence,Hepatocellular Carcinoma,,,,"Age-specific HCC (adults). Global incidence ~11.5 per 100k from GLOBOCAN 2005, varies dramatically from <2 in North America/Europe to >25 in East Asia due to HBV/HCV prevalence. Most HCC cases occur in adults.",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,920000,,True
0.85,,C0279626,Squamous cell carcinoma of esophagus,strong,,2005,high,,5.0,True,incidence,Esophageal Cancer,,,,"Squamous cell carcinoma is the predominant esophageal cancer type globally (~85-90%). Global esophageal cancer incidence ~5.5-6 per 100k in 2005, thus squamous cell ~5 per 100k.",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,400000,,True
0.5,,C0279632,Adult Acute Megakaryoblastic Leukemia,moderate,,,low,,extremely rare,True,incidence,Adult Acute Myeloid Leukemia,,,,"AMKL is extremely rare in adults, representing <1% of adult AML cases. With adult AML incidence of 3-4 per 100k per year, adult AMKL incidence is <0.03-0.04 per 100k. Much rarer than childhood form. Classified as extremely rare.",SEER Cancer Statistics Review,registry,https://seer.cancer.gov/csr/,,extremely rare,,False
0.55,,C0279650,Childhood Acute Megakaryoblastic Leukemia,moderate,,,low,,extremely rare,True,incidence,Childhood Acute Myeloid Leukemia,,,,"AMKL (AML-M7) represents 5-10% of childhood AML cases. With childhood AML incidence of ~0.7 per 100k children per year, childhood AMKL is approximately 0.035-0.07 per 100k children, or <0.02 per 100k total population. Classified as extremely rare (<0.1 per 100k).",SEER Pediatric Monograph: Childhood Cancer by ICCC,registry,https://seer.cancer.gov/,,extremely rare,,False
0.78,,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,strong,,2005,moderate,,5.8,True,incidence,Renal Cell Carcinoma,,,,"Clear cell RCC represents ~70-75% of all renal cell carcinomas. Global RCC incidence ~8.2 per 100k from GLOBOCAN 2005, therefore clear cell subtype ~5.8 per 100k. High confidence based on cancer registry data.",GLOBOCAN 2005 (IARC) - kidney cancer data with subtype distribution from pathology series,registry,https://gco.iarc.fr/,,464000,,True
0.4,,C0279984,Childhood Liposarcoma,weak,,,unknown,,extremely rare,True,incidence,Liposarcoma,,,,Liposarcoma is extremely rare in children (<5% of pediatric soft tissue sarcomas). Pediatric soft tissue sarcomas: ~0.9 per 100k; liposarcoma represents <0.05 per 100k children. Case reports only.,Ferrari A et al. (2005). Soft tissue sarcomas in children and adolescents: the prognostic role of tumor size in relation to patient body size. J Clin Oncol. 23(2):371-6,literature,https://pubmed.ncbi.nlm.nih.gov/15637399/,,extremely rare,,False
0.35,,C0279986,Childhood Leiomyosarcoma,weak,,,unknown,,extremely rare,True,incidence,Leiomyosarcoma,,,,"Leiomyosarcoma in pediatric population is exceedingly rare, <0.01 per 100k children. Comprises <2% of pediatric soft tissue sarcomas based on case series.",,,,,extremely rare,,False
0.0,,C0280100,Solid Neoplasm,none,,,high,,,False,,,,,,"Unmappable umbrella term encompassing all solid tumors (breast, lung, colon, prostate, stomach, liver, etc.) versus hematological malignancies. Too broad and heterogeneous to provide meaningful aggregate estimate - incidence rates vary from <1 per 100k for rare sarcomas to >50 per 100k for common epithelial cancers.",,,,,,,False
0.72,,C0280217,"stage, non-small cell lung cancer",strong,,2005,high,,25.5,True,incidence,Lung Cancer,,,,"Interpreting as non-small cell lung cancer (NSCLC), which comprises ~85% of all lung cancers. Global lung cancer incidence 2005: ~30 per 100k. NSCLC: ~25.5 per 100k. Confidence reduced due to ambiguous CUI terminology.","Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,2040000,,True
0.82,,C0280324,Laryngeal Squamous Cell Carcinoma,strong,,2005,high,,1.5,True,incidence,Laryngeal Cancer,,,,"Laryngeal SCC represents ~95% of laryngeal cancers. GLOBOCAN 2005 data shows laryngeal cancer incidence ~1.6 per 100k globally, thus SCC component ~1.5 per 100k. Varies significantly by smoking prevalence (higher in Europe, lower in Africa).",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,120000,,True
0.38,,C0281508,Desmoplastic Small Round Cell Tumor,weak,,,unknown,,extremely rare,True,incidence,Soft Tissue Sarcoma,,,,"Extremely rare aggressive sarcoma with EWS-WT1 fusion, primarily affecting children and young adults. Estimated <0.03 per 100k based on sarcoma registry data and case series.",,,,,extremely rare,,False
0.45,,C0282612,Prostatic Intraepithelial Neoplasias,weak,,,high,,25.0,True,incidence,Prostatic Neoplasms,,,,PIN is a precancerous lesion found incidentally during prostate biopsy. Not systematically tracked in registries. Estimated ~25 per 100k based on prostate biopsy rates (~5-8% detection in screened men aged >50). Low-moderate confidence due to screening-dependent detection.,,estimate,,,2000000,,False
0.88,,C0302592,Cervix carcinoma,strong,,2005,high,,15.2,True,incidence,Cervical Cancer,,,,Cervical carcinoma incidence from GLOBOCAN 2005 data: ~15.2 per 100k women globally. HPV-related cancer with wide geographic variation based on screening programs.,"Ferlay J et al. (2005). GLOBOCAN 2005: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 6",registry,https://gco.iarc.fr/,,1216000,,True
0.0,,C0333307,Superficial ulcer,none,,,unknown,,,False,,,,,,"Unmappable - 'superficial ulcer' is a generic clinical finding without anatomical or etiological specificity. Could refer to skin ulcers, oral ulcers, gastric ulcers, etc. Too broad and non-specific to provide meaningful population-based incidence estimate.",,,,,,,False
0.0,,C0333516,Tumor necrosis,none,,,unknown,,,False,,,,,,"Pathological finding/process occurring within tumors, not an independent disease entity. No meaningful incidence rate can be assigned to a histological feature.",,,,,,,False
0.52,,C0333875,High-Grade Squamous Intraepithelial Lesions,moderate,,,high,,150.0,True,incidence,Squamous Intraepithelial Lesions,,,,"HSIL (cervical) detection highly dependent on screening intensity. In screened populations, ~1-2% annual detection rate among women aged 25-65. Global estimate ~150 per 100k women accounting for variable screening access. Screening-dependent artifact.",,estimate,,,12000000,,False
0.55,,C0334307,Tubulovillous adenoma,moderate,,,moderate,,45.0,True,incidence,Colorectal Adenoma,,,,Tubulovillous adenomas comprise ~15-20% of all colorectal adenomas detected during screening. Estimated ~45 per 100k based on colonoscopy screening data from early 2000s.,Lieberman DA et al. (2000). Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med. 343:162-168,literature,https://pubmed.ncbi.nlm.nih.gov/10900274/,,3600000,,False
0.68,,C0334463,Malignant Fibrous Histiocytoma,moderate,,2005,low,,0.45,True,incidence,Soft Tissue Sarcoma,,,,MFH (now called undifferentiated pleomorphic sarcoma) was historically the most common adult STS subtype at ~10-15% of cases. Approximately 0.45 per 100k based on SEER data.,Fletcher CDM (2006). The evolution of the classification of soft tissue tumours - an update based on the new WHO classification. Histopathology. 48(1):3-12,literature,https://pubmed.ncbi.nlm.nih.gov/16359532/,,36000,,False
0.5,,C0334529,"Hydatidiform Mole, Partial",moderate,,,moderate,,1.0,True,incidence,Gestational trophoblastic disease,,,,"Specific subtype of molar pregnancy occurring in approximately 0.5-1 per 1000 pregnancies. Estimated at ~1.0 per 100k person-years. Less common than complete mole, diagnosed by histopathology and genetic analysis.",Seckl MJ et al. (2010). Gestational trophoblastic disease. Lancet. 376(9742):717-729,literature,https://pubmed.ncbi.nlm.nih.gov/20673583/,,80000,,False
0.65,,C0334590,Anaplastic Oligodendroglioma,strong,,,low,,0.18,True,incidence,Oligodendroglioma,,,,Rare malignant brain tumor (WHO grade III) with incidence ~0.18 per 100k based on CBTRUS and SEER data. Represents approximately 3-5% of all gliomas.,CBTRUS Statistical Report: Primary Brain and CNS Tumors,registry,https://www.cbtrus.org/,,14400,,False
0.65,,C0338831,Manic,moderate,,,moderate,,15.0,True,incidence,Bipolar Disorder,,,,Manic episodes are primarily associated with Bipolar Disorder. Using bipolar disorder incidence as proxy: ~15 per 100k person-years based on epidemiological literature. Confidence moderate due to lack of 2005-specific data and symptom-based rather than disease-based classification.,Merikangas KR et al. (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 64(5):543-552,literature,https://pubmed.ncbi.nlm.nih.gov/17485606/,,1200000,,False
0.35,,C0339535,"Night blindness, congenital stationary",weak,,,unknown,,extremely rare,False,incidence,,,,,Congenital stationary night blindness (CSNB) is a rare hereditary retinal disorder. Birth incidence estimated at <0.1 per 100k based on case reports and genetic registries. Limited epidemiological data available.,,,,,extremely rare,,False
0.72,,C0339573,"Glaucoma, Primary Open Angle",strong,,2007,moderate,,190,True,incidence,"Glaucoma, Open-Angle",,,,"POAG is the most common subtype of open-angle glaucoma, accounting for ~95% of cases. Incidence ~190 per 100k based on population-based cohort studies.","Quigley HA, Broman AT (2006). The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 90(3):262-267",literature,https://pubmed.ncbi.nlm.nih.gov/16488940/,,15200000,,False
0.75,,C0339789,Congenital deafness,strong,,,moderate,,4.0,False,incidence,,,,,"Reporting incidence of congenital hearing loss at birth. Global prevalence ~1-3 per 1000 births; with birth rate ~20 per 1000 population, yields ~4 new cases per 100k person-years.",Smith RJH et al. (2005). Sensorineural hearing loss in children. Lancet. 365(9462):879-890,literature,https://pubmed.ncbi.nlm.nih.gov/15752533/,,320000,,False
0.0,,C0342257,Complications of Diabetes Mellitus,none,,,unknown,,,False,,,,,,"Unmappable: This represents complications arising from pre-existing diabetes (retinopathy, nephropathy, neuropathy, CVD complications), not incident disease entities in general population. Incidence of complications is measured within diabetic populations, not per 100k general population.",,,,,,,False
0.38,,C0342386,Follicle stimulating hormone deficiency,weak,,,unknown,,0.3,True,incidence,Hypogonadotropic Hypogonadism,,,,"Rare endocrine disorder, component of hypogonadotropic hypogonadism. Estimated ~0.3 per 100k based on limited case series and endocrine registry data. Low-moderate confidence due to sparse epidemiological data.",,,,,24000,,False
0.4,,C0342749,GLYCOGEN STORAGE DISEASE Ic,weak,,,low,,extremely rare,True,incidence,Glycogen Storage Disease Type I,,,,"GSD type Ic (G6PT deficiency) is extremely rare. GSD type I overall occurs in ~1 per 100k births, with type Ic representing ~10-15% of GSD-I cases. Estimated <0.015 per 100k births based on case series.",Chou JY et al. (2002). Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr Mol Med. 2(2):121-43,literature,https://pubmed.ncbi.nlm.nih.gov/11949930/,,extremely rare,,False
0.65,,C0343641,Human papilloma virus infection,moderate,,,high,,2500,False,incidence,,,,,"Reporting incidence of new HPV infections. Global estimates suggest ~2,500 per 100k person-years for sexually active populations, though varies significantly by region and age group. Limited to general epidemiological estimates rather than registry data.",WHO/ICO Information Centre on HPV and Cervical Cancer,estimate,,,200000000,,False
0.75,,C0345905,Intrahepatic Cholangiocarcinoma,strong,,2008,high,,1.5,True,incidence,Cholangiocarcinoma,,,,"Intrahepatic cholangiocarcinoma incidence varies by region (0.5-2 in Western countries, 2-6 in Asia due to liver flukes). Global average ~1.5 per 100k based on registry data.",Khan SA et al. (2008). Cholangiocarcinoma. Lancet. 366(9493):1303-1314,literature,https://pubmed.ncbi.nlm.nih.gov/16214597/,,120000,,False
0.75,,C0345967,Malignant mesothelioma,strong,,2005,high,,1.3,True,incidence,Mesothelioma,,,,"Reporting incidence (new diagnoses). Global mesothelioma incidence ~1-1.5 per 100k from WHO and IARC data circa 2005, strongly associated with asbestos exposure.",Peto J et al. (1999). The European mesothelioma epidemic. Br J Cancer. 79(3-4):666-72; WHO mortality data 2005,literature,https://pubmed.ncbi.nlm.nih.gov/10027347/,,104000,,False
0.88,,C0346647,Malignant neoplasm of pancreas,strong,,2005,moderate,,8.2,True,incidence,Digestive system neoplasms,,,,"Reporting incidence. Pancreatic cancer incidence from GLOBOCAN 2005 shows ~8.2 per 100k globally, with higher rates in developed countries (10-12 per 100k) and lower in developing regions (5-7 per 100k).","Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,656000,,True
0.58,,C0375023,Respiratory syncytial virus (RSV) infection,moderate,,2005,high,,3300,True,incidence,Viral respiratory infection,,,,"Common acute viral respiratory infection, particularly in children. Global estimate ~33 million cases annually in children <5 years from WHO data, translating to ~3,300 per 100k population-wide (heavily skewed to pediatric).",Nair H et al. (2010). Global burden of acute lower respiratory infections due to RSV in young children. Lancet. 375(9725):1545-55,literature,https://pubmed.ncbi.nlm.nih.gov/20399493/,,264000000,,False
0.88,,C0376358,Malignant neoplasm of prostate,strong,,2005,high,,25.3,False,incidence,,,,,"Synonym for prostate cancer. GLOBOCAN 2005 estimates ~680,000 new cases per year, approximately 25.3 per 100k population (both sexes) or ~50 per 100k men. High geographic variation: higher in developed countries.",Ferlay J et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127(12):2893-2917,registry,https://pubmed.ncbi.nlm.nih.gov/21351269/,,2024000,,True
0.25,,C0376544,Hematopoietic Neoplasms,weak,,,moderate,,28.0,False,incidence,,,,,"Aggregate BOTEC estimate summing major hematopoietic malignancies: leukemias (~10), non-Hodgkin lymphoma (~7), Hodgkin lymphoma (~2.5), multiple myeloma (~4.5), MDS/MPN (~4) = ~28 per 100k. Heterogeneous group with varying biology and prognosis.",,,,,2240000,,False
0.45,,C0376618,Endotoxemia,moderate,,,high,,19.0,False,incidence,,,,,"Endotoxemia typically occurs with gram-negative sepsis. Estimated at ~19 per 100k based on severe sepsis incidence data, but endotoxemia as standalone diagnosis is poorly characterized in literature. Confidence reduced due to vague clinical definition and limited direct epidemiological data.",,,,,1520000,,False
0.4,,C0392477,Congenital flat foot,weak,,,moderate,,200,True,incidence,Flatfoot,,,,"Congenital flatfoot incidence estimated at ~200 per 100k births based on pediatric orthopedic literature. However, definitions vary widely (flexible vs rigid, physiologic vs pathologic), and most cases resolve spontaneously.",,,,,160000,,False
0.72,,C0393738,Chronic tension-type headache,strong,,2005,moderate,,,True,prevalence,Tension-type headache,,2200,,"Chronic headache disorder measured by prevalence, not incidence. Global prevalence approximately 2-2.5% (2,200 per 100k) based on epidemiological studies. Chronic form represents subset of all tension-type headaches.",Stovner LJ et al. (2007). The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 27(3):193-210,literature,https://pubmed.ncbi.nlm.nih.gov/17381554/,,176000000,,False
0.75,,C0398650,Immune thrombocytopenic purpura,strong,,2005,low,,3.3,False,incidence,,,,,"ITP incidence ~3.3 per 100k person-years globally. Data from population-based studies show consistent estimates of 2-4 per 100k in adults, slightly higher in children.",Terrell DR et al. (2010). The incidence of immune thrombocytopenic purpura in children and adults. Blood. 116(22):4884-4886,literature,https://pubmed.ncbi.nlm.nih.gov/20805365/,,264000,,False
0.45,,C0398689,"Hyper-IgM Immunodeficiency Syndrome, Type 1",weak,,,low,,extremely rare,True,incidence,Hyper-IgM Syndrome,,,,"X-linked hyper-IgM syndrome (CD40L deficiency) is an extremely rare primary immunodeficiency with estimated incidence <0.1 per 100k births, approximately 2 per million live births. Limited to case series and registry data.",Notarangelo LD et al. (2006). Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol. 124(6):1161-78,literature,https://pubmed.ncbi.nlm.nih.gov/20004777/,,extremely rare,,False
0.58,,C0403809,Primary spermatogenic failure,moderate,,,moderate,,,True,prevalence,Male Infertility,,800,,"Primary spermatogenic failure is a chronic condition causing male infertility, measured by prevalence. Male infertility affects ~7% of men; primary spermatogenic failure accounts for ~30-40% of cases. Estimated ~800 per 100k total population (all ages/sexes).",Agarwal A et al. (2015). A unique view on male infertility around the globe. Reprod Biol Endocrinol. 13:37,literature,https://pubmed.ncbi.nlm.nih.gov/25928197/,,64000000,,False
0.78,,C0409974,Lupus Erythematosus,strong,,2005,high,,5.1,False,incidence,,,,,"Systemic lupus erythematosus (SLE) global average incidence ~5 per 100k person-years. Significant variation by ethnicity (higher in African, Hispanic, Asian populations) and gender (9:1 female:male ratio).",Pons-Estel GJ et al. (2010). Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 39(4):257-268,literature,https://pubmed.ncbi.nlm.nih.gov/19136143/,,408000,,False
0.35,,C0409979,Neonatal Systemic lupus erythematosus,weak,,,moderate,,extremely rare,True,incidence,Systemic Lupus Erythematosus,,,,Neonatal lupus occurs in infants of mothers with anti-Ro/La antibodies. Estimated <0.1 per 100k births globally based on case series and registry data. Passively acquired autoimmune condition with limited systematic epidemiological studies.,,,,,extremely rare,,False
0.25,,C0410528,Skeletal dysplasia,weak,,,moderate,,4.0,False,incidence,,,,,"Aggregate BOTEC estimate summing major skeletal dysplasias per 100k births: achondroplasia (0.4), osteogenesis imperfecta (0.6), thanatophoric dysplasia (0.3), other lethal dysplasias (0.5), other non-lethal types (2.2) = ~4 per 100k births. Heterogeneous group of >400 distinct conditions.",,,,,5200,,False
0.0,,C0424295,Hyperactive behavior,none,,,unknown,,,False,,,,,,"Hyperactive behavior is a symptom or behavioral pattern, not a disease entity. It manifests in multiple conditions (ADHD, bipolar disorder, hyperthyroidism, etc.) and cannot be mapped to a specific incidence rate. Unmappable as a symptom descriptor rather than a disease.",,,,,,,False
0.62,,C0424605,Developmental delay (disorder),moderate,,,moderate,,,False,prevalence,,,2000,,"Developmental delay (broader than global DD) measured as prevalence. Includes delays in single or multiple domains, affects ~2% of children (2,000 per 100k). Prevalence appropriate for chronic developmental condition.",Shevell M et al. (2003). Practice parameter: evaluation of the child with global developmental delay. Neurology. 60(3):367-380,literature,https://pubmed.ncbi.nlm.nih.gov/12578916/,,160000000,,False
0.45,,C0431380,Cortical Dysplasia,weak,,,moderate,,3.5,True,incidence,Malformations of Cortical Development,,,,Focal cortical dysplasia birth incidence estimated at ~3-4 per 100k based on epilepsy surgery series and autopsy studies. True population incidence uncertain as many cases remain undiagnosed. Data quality limited by detection bias.,,estimate,,,280000,,False
0.23,,C0442874,Neuropathy,weak,,,high,,400,False,incidence,,,,,"Aggregate BOTEC estimate summing major neuropathy types: diabetic neuropathy (~180), chemotherapy-induced peripheral neuropathy (~60), idiopathic peripheral neuropathy (~80), alcoholic neuropathy (~30), other causes (~50). Total ~400 per 100k. Highly heterogeneous umbrella term with significant variation in etiology and severity.",,,,,32000000,,False
0.45,,C0457506,Reactive thrombocytosis,weak,,,moderate,,250,False,incidence,,,,,"Reporting incidence of new diagnoses. Reactive (secondary) thrombocytosis is a common laboratory finding resulting from infections, inflammation, iron deficiency, malignancy, or post-surgical states. Estimated ~250 per 100k based on hospital studies, but true incidence difficult to quantify as it's a laboratory finding rather than primary disease.",,,,,20000000,,False
0.0,,C0474808,Follicular neoplasm,none,,,high,,,False,,,,,,"Umbrella term covering follicular neoplasms across multiple organ systems including thyroid follicular adenomas, follicular thyroid carcinoma, follicular lymphoma, and ovarian follicular tumors. Each has vastly different incidence rates and clinical significance. Unmappable without anatomic specification.",,,,,,,False
0.65,,C0474822,Benign pheochromocytoma,moderate,,,low,,0.7,True,incidence,Pheochromocytoma,,,,Benign pheochromocytomas represent ~90% of all pheochromocytomas (total incidence ~0.8 per 100k). Estimated at 0.7 per 100k based on endocrine tumor registry data.,"Beard CM et al. (1983). Occurrence of pheochromocytoma in Rochester, Minnesota, 1950-1979. Mayo Clin Proc. 58:802-804",literature,https://pubmed.ncbi.nlm.nih.gov/6645626/,,56000,,False
0.6,,C0494165,Secondary malignant neoplasm of liver,moderate,,,moderate,,25,True,incidence,Liver neoplasm,,,,"Liver metastases from primary cancers (colorectal, pancreatic, breast, lung). Estimated ~25 per 100k person-years based on metastatic disease patterns. More common than primary liver cancer. Exact incidence challenging to quantify as registries focus on primary cancer sites.",,,,,2000000,,False
0.55,,C0494475,Tonic - clonic seizures,moderate,,,moderate,,25.0,True,incidence,Epilepsy,,,,Tonic-clonic seizures (grand mal) are the most common seizure type in epilepsy. Estimating ~40-50% of epilepsy incidence (50-70 per 100k) = ~25 per 100k. Moderate confidence due to classification complexity.,Banerjee PN et al. (2009). The descriptive epidemiology of epilepsy-a review. Epilepsy Res. 85(1):31-45,literature,https://pubmed.ncbi.nlm.nih.gov/19369037/,,2000000,,False
0.0,,C0497156,Lymphadenopathy,none,,,unknown,,,False,,,,,,"Lymphadenopathy is a clinical sign (enlarged lymph nodes), not a disease entity. It's a manifestation of hundreds of underlying conditions including infections, malignancies, and autoimmune diseases. Unmappable without specification of underlying etiology.",,,,,,,False
0.85,,C0497327,Dementia,strong,,2005,moderate,,118.0,False,incidence,,,,,"Umbrella term including Alzheimer's disease, vascular dementia, and other forms. Alzheimer's Disease International 2005 estimated 7.7 million new dementia cases globally per year, approximately 118 per 100k person-years. Strong epidemiological data.",Ferri CP et al. (2005). Global prevalence of dementia: a Delphi consensus study. Lancet. 366(9503):2112-2117,literature,https://pubmed.ncbi.nlm.nih.gov/16360788/,,9440000,,True
0.0,,C0521158,Recurrent tumor,none,,,unknown,,,False,,,,,,Not a disease entity but a clinical descriptor of tumor recurrence. Could refer to recurrence of any cancer type. Cannot assign meaningful incidence rate to a temporal modifier.,,,,,,,False
0.72,,C0521170,Osteoporotic Fractures,moderate,,2007,high,,500,True,incidence,Osteoporosis,,,,"Reporting incidence of new osteoporotic fractures (hip, spine, wrist). Global estimate ~500 per 100k person-years based on IOF epidemiological data. Significant age and geographic variation.","Johnell O, Kanis JA. (2006). An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 17(12):1726-33",literature,https://pubmed.ncbi.nlm.nih.gov/16983459/,,40000000,,False
0.72,,C0524620,Metabolic Syndrome X,strong,,2005,high,,,False,prevalence,,,22000,,"Cluster of metabolic risk factors (obesity, hypertension, dyslipidemia, insulin resistance). Measured as prevalence, not incidence. Global adult prevalence approximately 22% (22,000 per 100k) circa 2005, with increasing trends.",Eckel RH et al. (2005). The metabolic syndrome. Lancet. 365(9468):1415-1428,literature,https://pubmed.ncbi.nlm.nih.gov/15836891/,,1760000000,,False
0.25,,C0524851,Neurodegenerative Disorders,weak,,,high,,350,False,incidence,,,,,"Aggregate BOTEC estimate summing major neurodegenerative conditions: Alzheimer's disease (~250 per 100k in elderly populations), Parkinson's disease (~15 per 100k), ALS (~2 per 100k), Huntington's (~0.5 per 100k), vascular dementia (~50 per 100k), other dementias (~30 per 100k). Total ~350 per 100k. Highly heterogeneous umbrella term with significant age-stratification effects.",,estimate,,,28000000,,False
0.28,,C0525045,Mood Disorders,weak,,2004,moderate,,,False,prevalence,,,9500,,"Aggregate BOTEC summing major mood disorders: major depressive disorder (~6000 per 100k), dysthymia (~3600 per 100k), bipolar disorder (~1200 per 100k). Total ~9,500 per 100k. Heterogeneous conditions with diagnostic overlap and comorbidity.",,estimate,,,760000000,,False
0.88,,C0549473,Thyroid carcinoma,strong,,2005,moderate,,5.1,False,incidence,,,,,"Well-defined cancer with robust registry data. GLOBOCAN 2005 reports global thyroid cancer incidence at ~5.1 per 100k, with higher rates in women (3:1 ratio).","Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,408000,,True
0.0,,C0549567,Pigmentation Disorders,none,,,high,,,False,,,,,,"Umbrella term too heterogeneous to estimate meaningfully. Includes congenital conditions (albinism, café au lait spots), acquired disorders (vitiligo, melasma), hyper- and hypopigmentation conditions with vastly different etiologies, prevalence rates, and clinical significance. Mix of incidence-based (acquired) and prevalence-based (congenital) conditions. Aggregate estimate not clinically meaningful.",,,,,,,False
0.8,,C0555198,Malignant Glioma,strong,,,low,,5.5,False,incidence,,,,,"Umbrella term for malignant glial tumors including glioblastoma (~3.5), anaplastic astrocytoma (~0.6), anaplastic oligodendroglioma (~0.2), and other high-grade gliomas. Total incidence ~5.5 per 100k based on cancer registry data.",CBTRUS and global cancer registries,registry,https://www.cbtrus.org/,,440000,,False
0.65,,C0557874,Global developmental delay,moderate,,,moderate,,,True,prevalence,Developmental delay,,1500,,"Global developmental delay measured as prevalence in pediatric populations. Affects ~1-3% of children (using 1.5% estimate = 1,500 per 100k). Incidence not appropriate for chronic developmental condition.",Shevell M et al. (2003). Practice parameter: evaluation of the child with global developmental delay. Neurology. 60(3):367-380,literature,https://pubmed.ncbi.nlm.nih.gov/12578916/,,120000000,,False
0.72,,C0585442,Osteosarcoma of bone,strong,,,low,,0.35,True,incidence,Osteosarcoma,,,,Reporting incidence at ~0.35 per 100k person-years. Osteosarcoma of bone is a specific anatomical subtype with incidence of 3-4 per million globally based on SEER and international cancer registry data.,Mirabello L et al. (2009). Osteosarcoma incidence and survival rates from 1973 to 2004. Cancer. 115(7):1531-43,literature,https://pubmed.ncbi.nlm.nih.gov/19197972/,,28000,,False
0.0,,C0596263,Carcinogenesis,none,,,unknown,,,False,,,,,,"Unmappable: Carcinogenesis is a biological process (cancer formation), not a specific disease entity. Cannot assign meaningful incidence to a process descriptor.",,,,,,,False
0.0,,C0598766,Leukemogenesis,none,,,unknown,,,False,,,,,,"Unmappable: Leukemogenesis is a biological process term (the formation/development of leukemia), not a disease entity. Cannot assign meaningful incidence to a process descriptor. For leukemia incidence data, would need specific leukemia type CUIs.",,,,,,,False
0.88,,C0600139,Prostate carcinoma,strong,,2005,high,,25.3,False,incidence,,,,,"Second most common cancer in men globally. GLOBOCAN 2005 estimates ~680,000 new cases per year, approximately 25.3 per 100k population (both sexes) or ~50 per 100k men. High geographic variation: higher in developed countries.",Ferlay J et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127(12):2893-2917,registry,https://pubmed.ncbi.nlm.nih.gov/21351269/,,2024000,,True
0.62,,C0678213,Complete hydatidiform mole,moderate,,,high,,1.8,True,incidence,Hydatidiform Mole,,,,Complete moles represent ~70-75% of all molar pregnancies. Using total molar pregnancy rate and applying this proportion yields ~1.8 per 100k total population globally.,"Berkowitz RS, Goldstein DP. (2009). Clinical practice: Molar pregnancy. N Engl J Med. 360:1639-1645",literature,https://pubmed.ncbi.nlm.nih.gov/19369669/,,144000,,False
0.92,,C0678222,Breast Carcinoma,strong,,2002,high,,37.4,False,incidence,,,,,Synonymous with malignant neoplasm of breast. GLOBOCAN 2002 data: ~37 per 100k global population. Breast carcinoma represents >95% of breast malignancies.,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,2992000,,True
0.86,,C0684249,Carcinoma of lung,strong,,2005,high,,19.5,True,incidence,Lung Cancer,,,,Lung carcinomas (non-small cell) represent approximately 85% of all lung cancers. GLOBOCAN 2005 reports global lung cancer incidence of ~23 per 100k; carcinomas specifically ~19.5 per 100k. High confidence from robust cancer registry data.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,1560000,,True
0.88,,C0699790,Colon Carcinoma,strong,,2002,high,,17.5,True,incidence,Colorectal Cancer,,,,"Colon cancer (excluding rectum) accounts for ~70% of colorectal cancer. GLOBOCAN 2002 data shows global colorectal cancer incidence ~25 per 100k, yielding colon-specific rate of ~17.5 per 100k.","Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,1400000,,False
0.85,,C0699791,Stomach Carcinoma,strong,,2005,high,,17.5,True,incidence,Stomach Neoplasms,,,,"Gastric cancer incidence from GLOBOCAN 2005: ~17.5 per 100k globally. Dramatic geographic variation: >40 per 100k in East Asia (Japan, Korea, China) vs <5 per 100k in North America, driven by H. pylori prevalence and dietary factors.",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,1400000,,True
0.88,,C0699885,Carcinoma of bladder,strong,,2005,moderate,,9.0,False,incidence,,,,,Bladder carcinoma (predominantly urothelial) with global incidence ~9.0 per 100k from GLOBOCAN 2005. Higher in males (~14) than females (~4). Strong cancer registry data.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,720000,,True
0.3,,C0700095,Central neuroblastoma,weak,,,unknown,,extremely rare,True,incidence,Neuroblastoma,,,,"Central (CNS) neuroblastoma extremely rare, <0.01 per 100k. Most neuroblastomas are peripheral (adrenal/sympathetic chain). Limited case reports only.",,,,,extremely rare,,False
0.9,,C0740457,Malignant neoplasm of kidney,strong,,2005,moderate,,7.6,True,incidence,Urological Neoplasm,,,,"Reporting incidence of all malignant kidney cancers. GLOBOCAN 2005 estimates ~7.6 per 100k globally. Includes renal cell carcinoma (90%), transitional cell carcinoma, Wilms tumor, and other rare types. Higher in developed countries (10-15 per 100k).","Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,608000,,True
0.0,,C0746102,Chronic lung disease,none,,,high,,,False,,,,,,"Umbrella term covering multiple distinct conditions (COPD, chronic bronchitis, bronchiectasis, interstitial lung diseases) with vastly different etiologies and incidence rates. Too heterogeneous to provide meaningful aggregate estimate.",,,,,,,False
0.65,,C0748540,"Scleroderma, Limited",moderate,,2005,moderate,,1.2,True,incidence,Systemic Sclerosis,,,,"Limited cutaneous systemic sclerosis (lcSSc) represents approximately 60-70% of systemic sclerosis cases. Total SSc incidence ~1.5-2 per 100k, so lcSSc ~1.2 per 100k.","Mayes MD et al. (2003). Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 48(8):2246-55",literature,https://pubmed.ncbi.nlm.nih.gov/12905479/,,96000,,False
0.72,,C0751606,Adult Acute Lymphocytic Leukemia,strong,,2005,low,,0.7,True,incidence,Acute Lymphoblastic Leukemia,,,,"Adult ALL (age 20+) represents ~20-30% of all ALL cases. Overall ALL incidence ~1.8 per 100k globally, with adults comprising ~0.7 per 100k. Based on SEER and international cancer registry data circa 2005.","Howlader N et al. SEER Cancer Statistics Review, 1975-2005. National Cancer Institute.",registry,https://seer.cancer.gov/archive/csr/1975_2005/,,56000,,False
0.58,,C0751674,Lymphangioleiomyomatosis,moderate,,,low,,0.1,False,both,,,0.3,,"LAM is extremely rare, affecting primarily women of reproductive age. Incidence ~0.1 per 100k (new diagnoses), prevalence ~0.3 per 100k based on registry studies.",Harknett EC et al. (2011). Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. QJM. 104(11):971-979,literature,https://pubmed.ncbi.nlm.nih.gov/21715468/,,8000,,False
0.25,,C0795801,Trisomy 2,weak,,,unknown,,extremely rare,False,,Chromosomal Abnormality,,,,Trisomy 2 is typically embryonic lethal and incompatible with life. Most cases result in early spontaneous abortion. Live births are extraordinarily rare with fewer than 10 documented cases globally. Estimated <0.001 per 100k births based on prenatal diagnosis studies.,,,,,extremely rare,,False
0.25,,C0796003,Juberg-Marsidi syndrome,weak,,,unknown,,extremely rare,True,incidence,X-linked intellectual disability,,,,"Extremely rare X-linked syndrome causing severe intellectual disability, growth retardation, and deafness. <50 cases reported in literature. Estimated <0.01 per 100k births.",,,,,extremely rare,,False
0.78,,C0812413,Malignant Pleural Mesothelioma,strong,,2005,high,,1.5,True,incidence,Mesothelioma,,,,"Reporting incidence of malignant pleural mesothelioma. Global incidence ~1.5 per 100k based on GLOBOCAN data, with very high geographic variation (10-40x higher in regions with historical asbestos exposure like Australia, UK).","GLOBOCAN 2005, International Agency for Research on Cancer",registry,https://gco.iarc.fr/,,120000,,True
0.78,,C0848558,Hypospadias,strong,,,moderate,,500,False,incidence,,,,,Reporting incidence at birth. Hypospadias affects approximately 1 in 200 male births globally (500 per 100k male births). Rates vary from 200-800 per 100k male births by region.,Paulozzi LJ et al. (1999). Hypospadias trends in two US surveillance systems. Pediatrics. 100(5):831-4,registry,https://pubmed.ncbi.nlm.nih.gov/9346982/,,40000000,,False
0.82,,C0852654,21-hydroxylase deficiency,strong,,,moderate,,0.14,True,incidence,Congenital Adrenal Hyperplasia,,,,"Identical to C2936858. 21-hydroxylase deficiency is the enzymatic basis of classic CAH, occurring in ~1 per 15,000 births, translating to ~0.14 per 100k person-years.",Speiser PW et al. (2010). Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 95(9):4133-60,literature,https://pubmed.ncbi.nlm.nih.gov/20823466/,,11200,,False
0.85,,C0853879,Invasive carcinoma of breast,strong,,2005,moderate,,20.0,True,incidence,Breast Cancer,,,,"Invasive breast carcinoma comprises ~80% of all breast cancers (includes invasive ductal and lobular). Global breast cancer incidence 2005: ~50 per 100k women, ~25 per 100k overall. Invasive forms represent ~80%, yielding ~20 per 100k.",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,1600000,,True
0.0,,C0854802,Recurrent Chronic Lymphoid Leukemia,none,,,unknown,,,True,,Chronic Lymphocytic Leukemia,,,,"Unmappable - 'Recurrent' describes a clinical state (disease relapse after treatment) rather than population incidence. Recurrence occurs in CLL patients, not the general population. Cannot provide meaningful population-based incidence rate.",,,,,,,False
0.72,,C0878773,Overactive Bladder,strong,,2006,moderate,,,False,prevalence,,,12000,,"Chronic symptom syndrome measured as prevalence, not incidence. Population-based surveys show ~12% of adults globally have OAB symptoms (12,000 per 100k). EPIC study and similar surveys provide robust prevalence data.","Irwin DE et al. (2006). Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 50(6):1306-14",literature,https://pubmed.ncbi.nlm.nih.gov/17049716/,,960000000,,False
0.25,,C0919267,ovarian neoplasm,weak,,,moderate,,12,False,incidence,,,,,Aggregate BOTEC estimate for umbrella term including both malignant (6.6) and benign ovarian neoplasms requiring clinical intervention (~5-6). Total ~12 per 100k women. Heterogeneous category with variable clinical significance.,,,,,960000,,False
0.0,,C0940937,precancerous lesions,none,,,unknown,,,False,,,,,,"Umbrella term covering heterogeneous precancerous lesions across multiple organ systems (cervical dysplasia, colorectal adenomas, oral leukoplakia, actinic keratosis, Barrett's esophagus, etc.) with vastly different incidence rates and clinical significance. Too broad to estimate meaningfully.",,,,,,,False
0.75,,C0948089,Acute Coronary Syndrome,strong,,2005,high,,90.0,False,incidence,,,,,"ACS encompasses STEMI, NSTEMI, and unstable angina. Global incidence estimated at ~90 per 100k person-years based on WHO cardiovascular disease data circa 2005. High variation: 150-200 per 100k in developed countries, 50-70 in developing regions.",Yusuf S et al. (2001). Global burden of cardiovascular diseases. Circulation. 104(22):2746-2753,literature,https://pubmed.ncbi.nlm.nih.gov/11723030/,,7200000,,False
0.82,,C1134719,Invasive Ductal Breast Carcinoma,strong,,2005,moderate,,35.2,True,incidence,Breast Cancer,,,,"Invasive ductal carcinoma comprises ~80% of invasive breast cancers. Global breast cancer incidence from GLOBOCAN 2005: ~44 per 100k, invasive ductal subset estimated at ~35 per 100k. High confidence based on well-documented histological distribution.",GLOBOCAN 2005 (IARC) with histological subtype distribution,registry,https://gco.iarc.fr/,,2816000,,True
0.72,,C1135868,Gestational Trophoblastic Neoplasms,strong,,,high,,2.5,False,incidence,,,,,"Includes hydatidiform mole and choriocarcinoma. Global incidence ~1-2 per 1000 pregnancies, translating to ~2.5 per 100k person-years. Higher in Asia (up to 12 per 1000 pregnancies), lower in North America/Europe (0.6-1.1 per 1000).","Lurain JR (2010). Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis. Am J Obstet Gynecol. 203(6):531-539",literature,https://pubmed.ncbi.nlm.nih.gov/20728069/,,200000,,False
0.88,,C1140680,Malignant neoplasm of ovary,strong,,2005,moderate,,6.6,False,incidence,,,,,"Ovarian cancer incidence from GLOBOCAN 2005 data: approximately 6.6 per 100,000 women globally. Well-documented in cancer registries.","Ferlay J et al. (2005). GLOBOCAN 2005: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 7",registry,https://gco.iarc.fr/,,528000,,True
0.82,,C1168401,Squamous cell carcinoma of the head and neck,strong,,2005,high,,6.5,True,incidence,Head and Neck Neoplasms,,,,Reporting cancer incidence. GLOBOCAN 2002/2005 data shows head and neck squamous cell carcinoma at ~6-7 per 100k globally. Squamous cell histology represents ~90% of head and neck cancers.,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,520000,,True
0.0,,C1176475,Ductal Carcinoma,none,,,unknown,,,False,,,,,,"Umbrella term without organ specification. Ductal carcinomas occur in multiple organs (breast, pancreas, prostate, salivary glands) with vastly different incidence rates. Cannot provide meaningful aggregate estimate without anatomical specificity.",,,,,,,False
0.28,,C1261473,Sarcoma,weak,,2005,moderate,,5.0,False,incidence,,,,,"Aggregate BOTEC estimate summing major sarcoma categories: soft tissue sarcomas (~3.5 per 100k), bone sarcomas (~1 per 100k), Kaposi sarcoma (~0.5 per 100k) = ~5 per 100k. Heterogeneous group with varying biology and prognosis.",,estimate,,,400000,,False
0.78,,C1263846,Attention Deficit Hyperactivity Disorder,strong,,2007,moderate,,,False,prevalence,,,5300,,"ADHD is a chronic neurodevelopmental disorder measured by prevalence, not incidence. Global prevalence ~5.3% (5,300 per 100k) in school-age children based on meta-analyses circa 2005.",Polanczyk G et al. (2007). The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 164(6):942-8,literature,https://pubmed.ncbi.nlm.nih.gov/17541055/,,424000000,,False
0.45,,C1264041,"von Willebrand Disease, Type 3",moderate,,,low,,extremely rare,True,incidence,von Willebrand Disease,,,,Type 3 vWD is the rarest and most severe form (autosomal recessive). Incidence estimated at 0.1-0.5 per million population (0.0001-0.0005 per 100k) based on hemophilia treatment center registries.,Mannucci PM. (2004). Treatment of von Willebrand's Disease. N Engl J Med. 351:683-694,literature,https://pubmed.ncbi.nlm.nih.gov/15306670/,,extremely rare,,False
0.52,,C1265996,Large cell neuroendocrine carcinoma,moderate,,,moderate,,0.75,True,incidence,Lung Cancer,,,,"Large cell neuroendocrine carcinoma (LCNEC) represents approximately 2-3% of all lung cancers. Derived from global lung cancer incidence (~30 per 100k) × 0.025 = ~0.75 per 100k. Rare aggressive subtype, primarily pulmonary.",Travis WD et al. (2004). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Lung. IARC Press,literature,,,60000,,False
0.82,,C1269683,Major Depressive Disorder,strong,,2005,moderate,,350,False,both,,,4300,,"MDD global incidence ~350 per 100k person-years, prevalence ~4.3% (4300 per 100k). DSM-defined condition with robust epidemiological data from WHO GBD and multiple cohort studies.","Kessler RC et al. (2005). Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med. 352:2515-2523",literature,https://pubmed.ncbi.nlm.nih.gov/15958807/,,28000000,,True
0.0,,C1269955,Tumor Cell Invasion,none,,,unknown,,,False,,,,,,"Tumor cell invasion is a biological process/phenomenon, not a disease entity. It describes the invasive behavior of malignant tumor cells, not a specific diagnosable condition. Unmappable to incidence rates.",,,,,,,False
0.35,,C1275217,Paget's disease of vulva,weak,,,unknown,,extremely rare,True,incidence,Extramammary Paget's disease,,,,"Reporting incidence (new cancer diagnoses). Extramammary Paget's of vulva is extremely rare, <0.01 per 100k women based on case series and registry data. Limited epidemiological data available.",,,,,extremely rare,,False
0.0,,C1290886,Chronic Inflammatory Disorder,none,,,unknown,,,False,,,,,,"Umbrella term too broad and heterogeneous to estimate meaningfully. Encompasses autoimmune diseases, inflammatory bowel disease, chronic infections, asthma, and numerous other disparate conditions with vastly different etiologies and epidemiology.",,,,,,,False
0.35,,C1292753,Primary Effusion Lymphoma,weak,,,moderate,,extremely rare,True,incidence,B-cell Non-Hodgkin Lymphoma,,,,"Rare HHV-8-associated lymphoma, primarily in immunocompromised patients. Estimated <0.1 per 100k based on case series and HIV cohort studies. No systematic registry data.",,,,,extremely rare,,False
0.88,,C1292769,Precursor B-cell lymphoblastic leukemia,strong,,2005,low,,1.0,True,incidence,Acute Lymphoblastic Leukemia,,,,"B-cell ALL represents 75-80% of all ALL cases. Overall ALL incidence ~1.3 per 100k (all ages), therefore B-ALL ~1.0 per 100k. Most common childhood leukemia with excellent registry data from SEER and international pediatric oncology groups.",Howlader N et al. SEER Cancer Statistics Review 1975-2005,registry,https://seer.cancer.gov/csr/1975_2005/,,80000,,True
0.65,,C1302401,Adenoma of large intestine,moderate,,,moderate,,,False,prevalence,,,25000,,Reporting prevalence rather than incidence - colorectal adenomas are detected lesions found in ~25% of adults during screening colonoscopy (varies 15-40% by age/region). Prevalence more appropriate than incidence for screening-detected precancerous lesions.,Lieberman DA et al. (2000). Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med. 343:162-168,literature,https://pubmed.ncbi.nlm.nih.gov/10900274/,,2000000000,,False
0.25,,C1306459,Primary malignant neoplasm,weak,,2005,high,,175.0,False,incidence,Malignant Neoplasms,,,,"Aggregate BOTEC estimate for primary cancers (excluding metastases). GLOBOCAN 2005 data shows ~175 per 100k globally for all primary malignancies. Umbrella term covering lung, breast, colorectal, prostate, stomach, liver, and all other primary cancer sites. Low confidence due to heterogeneity across cancer types.",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,14000000,,True
0.88,,C1306460,Primary malignant neoplasm of lung,strong,,2005,high,,35.0,True,incidence,Lung Neoplasms,,,,Primary lung cancer incidence from GLOBOCAN 2005: ~35 per 100k globally (age-standardized rate). Excludes metastatic disease to lung. High confidence from cancer registry data.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,2800000,,True
0.35,,C1332199,Adult Desmoplastic Small Round Cell Tumor,weak,,,unknown,,extremely rare,True,incidence,Desmoplastic Small Round Cell Tumor,,,,"Extremely rare sarcoma, adult-onset variant. Fewer than 200 cases reported in literature worldwide. Estimated <0.01 per 100k based on case report frequency.",,,,,extremely rare,,False
0.78,,C1332201,Adult Diffuse Large B-Cell Lymphoma,strong,,2005,moderate,,4.5,True,incidence,Diffuse Large B-Cell Lymphoma,,,,"Adult-specific DLBCL represents majority of DLBCL cases (median age 60-70 years). Incidence ~4.5 per 100k adults, slightly higher than general population estimate since pediatric DLBCL is rare.","Morton LM et al. (2006). Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 107(1):265-276",literature,https://pubmed.ncbi.nlm.nih.gov/16150940/,,360000,,True
0.85,,C1332206,Adult Lymphoma,strong,,2005,moderate,,19.5,True,incidence,Lymphoma,,,,"Reporting incidence (new diagnoses) in adults. Combined Hodgkin lymphoma (~2.5 per 100k) and Non-Hodgkin lymphoma (~17 per 100k) for adults based on GLOBOCAN 2005 data, total approximately 19.5 per 100k.",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,1560000,,True
0.65,,C1332922,Cervical Squamous Intraepithelial Neoplasia,moderate,,,high,,,True,prevalence,Cervical Intraepithelial Neoplasia,,400,,"CIN measured as prevalence in screened populations. Detection rate of CIN2+ approximately 400 per 100k women screened, based on cervical cancer screening program data. Squamous type represents majority of CIN cases.",Wright TC et al. (2007). 2006 consensus guidelines for management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol. 197(4):340-345,literature,https://pubmed.ncbi.nlm.nih.gov/17904955/,,32000000,,False
0.4,,C1332966,Childhood Desmoplastic Small Round Cell Tumor,weak,,,unknown,,extremely rare,True,incidence,Intra-abdominal Sarcoma,,,,"Extremely rare pediatric malignancy, <0.01 per 100k. Approximately 30-40 new cases reported globally per year based on case series literature.","Gerald WL et al. (1998). Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. J Clin Oncol. 16(9):3028-36",literature,https://pubmed.ncbi.nlm.nih.gov/9738572/,,extremely rare,,False
0.85,,C1332977,Childhood Leukemia,strong,,2005,moderate,,4.5,True,incidence,Leukemia,,,,"Reporting incidence. Childhood leukemia (age 0-14) incidence ~4.5 per 100k children globally, with ALL comprising ~80% of cases. Well-documented in pediatric cancer registries.",Kaatsch P. (2010). Epidemiology of childhood cancer. Cancer Treat Rev. 36(4):277-285,literature,https://pubmed.ncbi.nlm.nih.gov/20231056/,,360000,,False
0.82,,C1332979,Childhood Lymphoma,strong,,2005,moderate,,1.8,True,incidence,Lymphoma,,,,Reporting incidence (new diagnoses) in children aged 0-19. Pediatric lymphomas (Hodgkin + Non-Hodgkin) incidence approximately 1.8 per 100k children globally based on SEER and international cancer registry data from mid-2000s.,"Linabery AM, Ross JA (2008). Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999. Cancer. 113(9):2575-96",literature,https://pubmed.ncbi.nlm.nih.gov/18837040/,,144000,,False
0.78,,C1332986,Childhood Osteosarcoma,strong,,2006,low,,0.3,True,incidence,Osteosarcoma,,,,"Osteosarcoma is the most common primary bone malignancy in children and adolescents. Incidence approximately 3-4 per million children per year, or ~0.3 per 100k of pediatric population.",Mirabello L et al. (2009). Osteosarcoma incidence and survival rates from 1973 to 2004. Cancer. 115(7):1531-1543,literature,https://pubmed.ncbi.nlm.nih.gov/19197972/,,24000,,False
0.58,,C1334665,Mediastinal Lymphoma,moderate,,2005,moderate,,1.5,True,incidence,Lymphoma,,,,Mediastinal lymphomas include primary mediastinal B-cell lymphoma (~0.4 per 100k) and Hodgkin lymphoma with mediastinal involvement (~1.1 per 100k). Combined estimate ~1.5 per 100k based on lymphoma registry data.,Lones MA et al. (2000). Primary mediastinal B-cell lymphoma: epidemiology and clinical features. Curr Opin Oncol. 12(5):462-8,literature,https://pubmed.ncbi.nlm.nih.gov/10975555/,,120000,,False
0.75,,C1334953,Neuroblastic tumors,strong,,2005,low,,0.21,True,incidence,Peripheral Nervous System Neoplasms,,,,"Reporting incidence of new cases. Neuroblastic tumors (primarily neuroblastoma) occur mainly in children with incidence of ~10.5 per million children under 15, translating to ~0.21 per 100k total population. Data from international cancer registries including SEER.","Ries LAG et al. (2007). SEER Cancer Statistics Review, 1975-2005. National Cancer Institute",registry,https://seer.cancer.gov/,,16800,,False
0.0,,C1335475,Primary Carcinoma,none,,,unknown,,,False,,,,,,"Umbrella term too broad to estimate meaningfully. Primary carcinoma without organ specification includes lung, breast, colon, prostate, etc. with vastly different incidence rates. Requires anatomical specification.",,,,,,,False
0.55,,C1336716,testicular embryonal carcinoma and teratoma,moderate,,,moderate,,1.2,True,incidence,Testicular Germ Cell Tumor,,,,"Mixed germ cell tumor representing subset of testicular cancer. Overall testicular cancer incidence ~6 per 100k men (3 per 100k overall). Mixed GCTs comprise ~40% of cases, estimating ~1.2 per 100k overall population.",,,,,96000,,False
0.88,,C1378703,Renal carcinoma,strong,,2005,moderate,,6.8,True,incidence,Malignant neoplasm of kidney,,,,"Reporting incidence of renal cell carcinoma (RCC), which comprises ~90% of kidney cancers. GLOBOCAN 2005 data shows global kidney cancer incidence ~7.6 per 100k; RCC subset ~6.8 per 100k.",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,544000,,True
0.55,,C1391732,Cancer cachexia,moderate,,,moderate,,110,False,incidence,Cachexia,,,,"Cancer-associated cachexia syndrome (weight loss, muscle wasting) develops in 50-80% of cancer patients depending on tumor type. Global cancer incidence ~200 per 100k, with approximately 50-60% developing cachexia yields ~110 per 100k. Higher rates in pancreatic, gastric, and lung cancers.",Tisdale MJ. (2002). Cachexia in cancer patients. Nat Rev Cancer. 2(11):862-71,literature,https://pubmed.ncbi.nlm.nih.gov/12415256/,,8800000,,False
0.55,,C1449563,"Cardiomyopathy, Familial Idiopathic",moderate,,,moderate,,2.5,True,incidence,Dilated Cardiomyopathy,,,,Familial (genetic) forms account for ~30-50% of dilated cardiomyopathy cases. Estimated incidence ~2-3 per 100k based on familial proportion of DCM. Lower confidence due to limited specific epidemiological data for familial subset.,Mestroni L et al. (1999). Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. J Am Coll Cardiol. 34(1):181-90,literature,https://pubmed.ncbi.nlm.nih.gov/10400009/,,200000,,False
0.0,,C1458155,Mammary Neoplasms,none,,,unknown,,,False,,,,,,"Umbrella term too heterogeneous to estimate: includes benign tumors (fibroadenomas, very common) and malignant breast cancers with vastly different incidence rates and clinical significance.",,,,,,,False
0.0,,C1510885,Angiogenic Switch,none,,,unknown,,,False,,,,,,"Not a disease entity - angiogenic switch is a biological process/mechanism in cancer development where tumors acquire the ability to stimulate new blood vessel growth. This is a molecular/cellular process descriptor, not a mappable disease condition.",,,,,,,False
0.45,,C1511306,Breast Diffuse Large B-Cell Lymphoma,weak,,,unknown,,0.05,True,incidence,Diffuse Large B-Cell Lymphoma,,,,"Primary breast lymphoma is extremely rare, accounting for <1% of breast malignancies. DLBCL is the most common histology. Estimated at ~0.05 per 100k based on case series data. Low confidence due to rarity and limited population-based studies.",,,,,4000,,False
0.0,,C1511789,Desmoplastic,none,,,unknown,,,False,,,,,,Unmappable - 'Desmoplastic' is a pathological descriptor (fibrous tissue formation) rather than a disease entity. Cannot estimate incidence for a descriptive term.,,,,,,,False
0.0,,C1512409,Hepatocarcinogenesis,none,,,unknown,,,False,,,,,,"This is a biological process term (the process of liver cancer development), not a specific disease entity. Unmappable as it describes carcinogenesis rather than a diagnosable condition.",,,,,,,False
0.72,,C1512433,Cervical high grade squamous intraepithelial lesion,strong,,2005,high,,150,True,incidence,Cervical Intraepithelial Neoplasia,,,,"HSIL (CIN 2/3) detection rate from cervical screening programs. Global average ~150 per 100k women screened annually, based on WHO cervical cancer screening data. Corresponds to CIN 2 and CIN 3 combined. Varies significantly by screening coverage and HPV prevalence.",WHO/ICO Information Centre on HPV and Cervical Cancer (2005),registry,https://www.who.int/reproductivehealth/publications/cancers/9241546743/en/,,12000000,,False
0.0,,C1519346,Skin Carcinogenesis,none,,,unknown,,,False,,,,,,"Process term describing cancer development, not a specific disease. Actual skin cancers (basal cell, squamous cell, melanoma) each have distinct incidence rates.",,,,,,,False
0.0,,C1519670,Tumor Angiogenesis,none,,,unknown,,,False,,,,,,"Tumor angiogenesis is a biological process (formation of new blood vessels in tumors), not a disease entity. It is a characteristic feature of tumor growth and progression, not a mappable disease with incidence. Unmappable as a process descriptor.",,,,,,,False
0.55,,C1527231,Adrenomyeloneuropathy,moderate,,,low,,0.3,True,incidence,X-linked Adrenoleukodystrophy,,,,"Adult-onset form of X-linked adrenoleukodystrophy. Overall X-ALD incidence ~1 in 17,000 males (0.6 per 100k), AMN represents approximately 50% of cases. Estimated at ~0.3 per 100k. Limited population-based registry data.","Bezman L et al. (2001). Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol. 49(4):512-7",literature,https://pubmed.ncbi.nlm.nih.gov/11310629/,,24000,,False
0.82,,C1527349,Ductal Breast Carcinoma,strong,,2005,moderate,,18.0,True,incidence,Breast Cancer,,,,"Invasive ductal carcinoma (IDC) accounts for ~70-80% of breast cancers. Global breast cancer incidence 2005 was ~50 per 100k women (GLOBOCAN), translating to ~25 per 100k overall population. IDC represents ~72% of cases, yielding ~18 per 100k.","Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,1440000,,True
0.25,,C1535926,Neurodevelopmental Disorders,weak,,,moderate,,800,False,incidence,,,,,"Aggregate BOTEC estimate summing major neurodevelopmental conditions detected in childhood: autism spectrum disorder (~100 per 100k births), intellectual disability (~150 per 100k births), ADHD (~400 per 100k children), learning disorders (~150 per 100k). Total ~800 per 100k. Low confidence due to heterogeneous conditions, overlap, and mix of incidence/prevalence metrics.",,estimate,,,64000000,,False
0.55,,C1535939,Pneumocystis jiroveci pneumonia,moderate,,2005,high,,2.5,True,incidence,Fungal Pneumonia,,,,"Opportunistic infection primarily in immunocompromised patients (HIV, transplant, chemotherapy). Global incidence ~2-3 per 100k (2005), but highly concentrated in HIV-positive populations and regions with limited HAART access. Significant underreporting in developing countries.",Morris A et al. (2004). Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis. 10(10):1713-20,literature,https://pubmed.ncbi.nlm.nih.gov/15504255/,,200000,,False
0.62,,C1536148,Chocolate cyst of ovary,moderate,,,moderate,,,True,prevalence,Endometrioma,,600,,Chocolate cyst is a descriptive term for ovarian endometrioma (blood-filled cyst). Same entity as endometrioma but specifically ovarian. Prevalence slightly lower than general endometrioma as it specifies ovarian location (~600 per 100k).,Giudice LC et al. (2004). Endometriosis. Lancet. 364(9447):1789-1799,literature,https://pubmed.ncbi.nlm.nih.gov/15541453/,,48000000,,False
0.35,,C1571983,Involutional paraphrenia,weak,,,unknown,,0.5,True,incidence,Late-onset psychotic disorders,,,,Historical term for late-onset paranoid psychosis (typically age >60). Estimated ~0.5 per 100k based on late-onset schizophrenia and delusional disorder incidence in elderly populations. Low confidence due to outdated diagnostic category and limited specific epidemiological data.,,,,,40000,,False
0.35,,C1571984,"Psychosis, Involutional",weak,,,unknown,,0.5,True,incidence,Late-onset psychotic disorders,,,,Historical term for psychotic disorders with onset during involutional period (middle to late life). Estimated ~0.5 per 100k based on late-onset psychosis incidence. Low confidence due to obsolete diagnostic category and lack of specific epidemiological data.,,,,,40000,,False
0.0,,C1608408,Malignant transformation,none,,,unknown,,,False,,,,,,"Unmappable - this is a biological process descriptor, not a specific disease entity. Refers to the process of normal or benign cells becoming cancerous, which occurs across hundreds of different cancer types. Cannot assign meaningful incidence without specifying the tissue/organ system and disease context.",,,,,,,False
0.45,,C1611743,Familial (FPAH),moderate,,,low,,extremely rare,True,incidence,Pulmonary Arterial Hypertension,,,,Familial PAH (FPAH) is an extremely rare genetic form of pulmonary arterial hypertension. Estimated at <0.1 per 100k based on registry data showing FPAH represents ~6% of idiopathic PAH cases which itself is ~1-2 per million.,Humbert M et al. (2006). Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 173(9):1023-30,literature,https://pubmed.ncbi.nlm.nih.gov/16456139/,,extremely rare,,False
0.72,,C1691215,Penile hypospadias,moderate,,,moderate,,350,True,incidence,Hypospadias,,,,"Reporting incidence at birth. Penile hypospadias (distal/glandular) accounts for ~70% of all hypospadias cases. Global hypospadias rate ~500 per 100k male births, so penile type ~350 per 100k male births.",Baskin LS et al. (2018). Hypospadias and endocrine disruption: is there a connection? Environ Health Perspect. 109:1175-1183,literature,https://pubmed.ncbi.nlm.nih.gov/11713001/,,28000000,,False
0.65,,C1704251,Breast Lymphoma,moderate,,,low,,0.5,True,incidence,Non-Hodgkin Lymphoma,,,,"Primary breast lymphoma is rare, representing <1% of breast malignancies and ~2% of extranodal lymphomas. Estimated at ~0.5 per 100k women based on cancer registry data.","Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer. 1972;29(6):1705-12",literature,https://pubmed.ncbi.nlm.nih.gov/5032234/,,40000,,False
0.78,,C1704272,Benign Prostatic Hyperplasia,strong,,2005,low,,,False,prevalence,,,6500,,"BPH is a chronic progressive condition best measured by prevalence. Age-dependent (50% of men in 50s, 80% in 80s). Global prevalence ~13% of adult men, or ~6,500 per 100k total population.",Roehrborn CG (2005). Benign prostatic hyperplasia: an overview. Rev Urol. 7(Suppl 9):S3-S14,literature,https://pubmed.ncbi.nlm.nih.gov/16985902/,,520000000,,False
0.35,,C1704423,Milroy Disease,weak,,,unknown,,extremely rare,True,incidence,Primary Lymphedema,,,,"Rare congenital genetic disorder causing lymphedema from birth. Estimated at 1 in 6,000 to 1 in 300,000 births, approximately 0.3-1.7 per 100k births. Limited epidemiological data available.",,,,,extremely rare,,False
0.58,,C1720830,Painful Bladder Syndrome,moderate,,2005,moderate,,,False,prevalence,,,197,,"Interstitial cystitis/painful bladder syndrome measured as prevalence. Estimated ~197 per 100k (predominantly women, 9:1 ratio) based on early 2000s epidemiological studies. Wide diagnostic variability affects estimates. Chronic condition, incidence poorly defined.",Clemens JQ et al. (2005). Prevalence and incidence of interstitial cystitis in a managed care population. J Urol. 173(1):98-102,literature,https://pubmed.ncbi.nlm.nih.gov/15592041/,,15760000,,False
0.0,,C1720983,Channelopathies,none,,,unknown,,,False,,,,,,"Umbrella term too heterogeneous to estimate meaningfully. Includes diverse ion channel disorders across multiple organ systems: cardiac (Long QT, Brugada), neurologic (some epilepsies, migraines), pulmonary (cystic fibrosis), muscular (myotonias, periodic paralyses), and renal channelopathies. These have vastly different incidence rates, pathophysiology, and clinical significance. Aggregate estimate not useful.",,,,,,,False
0.72,,C1833683,"Nephrolithiasis, Calcium Oxalate",moderate,,2005,moderate,,120,True,incidence,Nephrolithiasis,,,,"Calcium oxalate stones comprise ~80% of all kidney stones. Total kidney stone incidence approximately 150 per 100k person-years in developed countries, so calcium oxalate subset ~120 per 100k.",Stamatelou KK et al. (2003). Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 63(5):1817-1823,literature,https://pubmed.ncbi.nlm.nih.gov/12675858/,,9600000,,False
0.55,,C1836122,"SARCOIDOSIS, EARLY-ONSET",moderate,,,high,,1.5,True,incidence,Sarcoidosis,,,,"Reporting incidence of early-onset sarcoidosis (pediatric/young adult). Overall sarcoidosis incidence is 10-20 per 100k in high-incidence populations; early-onset represents approximately 10-15% of cases, estimated at 1-2 per 100k. Limited specific epidemiological data for early-onset subtype.","Henke CE et al. (1986). The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study. Am J Epidemiol. 123(5):840-845",literature,https://pubmed.ncbi.nlm.nih.gov/3962966/,,120000,,False
0.25,,C1839839,MAJOR AFFECTIVE DISORDER 2,weak,,,unknown,,extremely rare,True,,Major Affective Disorders,,,,Genetic variant designation (likely OMIM-based) for familial mood disorder. Extremely rare monogenic form. No population-based incidence data; estimated <0.01 per 100k based on genetic case reports.,,,,,extremely rare,,False
0.0,,C1852197,MAJOR AFFECTIVE DISORDER 1,none,,,unknown,,,True,,Bipolar Disorder,,,,"Genetic locus (MAFD1) on chromosome 18q, not a distinct clinical entity with separate epidemiological data. Represents chromosomal linkage for familial bipolar disorder susceptibility, not measurable as independent incidence.",,,,,,,False
0.35,,C1859405,Bowen-Conradi syndrome,weak,,,high,,extremely rare,False,incidence,,,,,"Extremely rare autosomal recessive disorder, primarily in Hutterite populations. <0.01 per 100k globally based on case report literature. Fewer than 100 cases reported worldwide.",,,,,extremely rare,,False
0.82,,C1861172,Venous Thromboembolism,strong,,2006,moderate,,117.0,False,incidence,,,,,VTE encompasses DVT and PE. Incidence data from multiple population-based studies shows ~100-200 per 100k in Western populations. Using mid-range estimate of 117 per 100k based on pooled epidemiological data circa 2005.,Heit JA et al. (2005). The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 21(1):23-29,literature,https://pubmed.ncbi.nlm.nih.gov/16475038/,,9360000,,False
0.25,,C1861305,TARSAL-CARPAL COALITION SYNDROME,weak,,,unknown,,extremely rare,False,incidence,,,,,Extremely rare genetic syndrome characterized by fusion of carpal and tarsal bones. <100 cases reported in medical literature worldwide. Estimated <0.01 per 100k based on case report frequency only.,,,,,extremely rare,,False
0.3,,C1864040,Cerebral Cavernous Malformations 3,weak,,,unknown,,extremely rare,True,incidence,Cerebral Cavernous Malformations,,,,"CCM3 is a specific genetic subtype caused by PDCD10 gene mutations, one of three CCM genes (CCM1/KRIT1, CCM2, CCM3/PDCD10). CCM3 represents ~10-15% of familial CCM cases. With overall familial CCM birth incidence <0.1 per 100k, CCM3 incidence is <0.01 per 100k. Limited population-based data for specific genetic subtypes.",,,,,extremely rare,,False
0.52,,C1867441,Pterygium Of Conjunctiva And Cornea,moderate,,,high,,8.0,False,incidence,Pterygium,,,,"Pterygium of conjunctiva and cornea (full anatomical description of same condition as C0033999 and C4520843). Incidence ~8 per 100k globally with extreme geographic variation (UV-dependent, 0.3-29% prevalence by latitude).",,,,,640000,,False
0.35,,C1868081,Juvenile Polyposis Coli,weak,,,unknown,,extremely rare,True,incidence,Juvenile Polyposis Syndrome,,,,"Extremely rare hereditary condition, subset of juvenile polyposis syndrome affecting primarily the colon. Estimated <0.1 per 100k births based on case reports and genetic registry data. Limited systematic epidemiological studies.",,,,,extremely rare,,False
0.3,,C1868681,DYSTONIA 12,weak,,,unknown,,extremely rare,True,incidence,Dystonia,,,,DYT12 (rapid-onset dystonia-parkinsonism) is an extremely rare autosomal dominant genetic disorder caused by ATP1A3 mutations. Estimated <0.01 per 100k based on case report frequency. Only dozens of families reported worldwide.,,,,,extremely rare,,False
0.28,,C1868683,"B-CELL MALIGNANCY, LOW-GRADE",weak,,2005,moderate,,3.5,False,incidence,,,,,"Aggregate BOTEC estimate summing major low-grade B-cell malignancies: CLL (~2.0), follicular lymphoma (~1.0), MALT/marginal zone lymphomas (~0.5) = ~3.5 per 100k. Heterogeneous umbrella term with variable prognosis.",GLOBOCAN 2005 NHL data (aggregated subtypes),registry,https://gco.iarc.fr/,,280000,,False
0.55,,C1868938,End stage cardiac failure,moderate,,,moderate,,35,True,incidence,Heart failure,,,,End-stage heart failure represents advanced disease (NYHA Class IV). Estimated at ~15-20% of incident heart failure cases progress to end-stage. Approximate incidence ~35 per 100k person-years. Limited population-based data for this specific stage.,,,,,2800000,,False
0.65,,C1955634,Kaposi's sarcoma-associated herpesvirus infection,moderate,,2005,high,,2.5,False,incidence,,,,,"Reporting Kaposi's sarcoma incidence as proxy for clinically significant HHV-8 infection. GLOBOCAN 2005 data shows ~2.5 per 100k globally, with high geographic variation (much higher in sub-Saharan Africa due to HIV co-infection).",Ferlay J et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127(12):2893-2917,registry,https://pubmed.ncbi.nlm.nih.gov/21351269/,,200000,,True
0.78,,C1956346,Coronary Artery Disease,strong,,2005,high,,268,True,both,Atherosclerosis,,3700,,"CAD is atherosclerosis of coronary arteries. Reporting incidence of ~268 per 100k based on WHO Global Burden of Disease 2005 data for ischemic heart disease events. Prevalence ~3.7% (3,700 per 100k) in adults. Subtype of atherosclerosis with strong epidemiological data.",WHO Global Burden of Disease Study 2005,registry,https://www.who.int/healthinfo/global_burden_disease/,,21440000,,True
0.58,,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,moderate,,,low,,0.35,True,incidence,Acute Lymphoblastic Leukemia,,,,"T-cell immunophenotype represents ~15-25% of ALL/LBL cases. Overall ALL incidence ~1.8 per 100k, T-cell subset estimated at ~0.35 per 100k. Moderate confidence due to limited immunophenotype-specific registry data for 2005.",Pui CH et al. (2008). Acute lymphoblastic leukemia. N Engl J Med. 350:1535-1548,literature,https://pubmed.ncbi.nlm.nih.gov/15071128/,,28000,,False
0.85,,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,strong,,2005,low,,1.5,True,incidence,Leukemia,,,,Acute lymphoblastic leukemia (ALL) incidence ~1.5 per 100k globally. Well-documented in cancer registries with consistent reporting across populations.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,120000,,True
0.0,,C1963943,Atherothrombosis,none,,,unknown,,,False,,,,,,"Pathophysiological process descriptor rather than discrete disease entity. Atherothrombosis describes the mechanism underlying MI, stroke, and peripheral arterial disease, not a separate diagnosis. Would create complete overlap with these specific conditions.",,,,,,,False
0.0,,C1970943,MAJOR AFFECTIVE DISORDER 4,none,,,unknown,,,True,,Bipolar Disorder,,,,"Genetic locus (MAFD4) on chromosome 5q, not a distinct clinical entity with separate epidemiological data. Represents chromosomal linkage for familial mood disorder susceptibility, not measurable as independent incidence.",,,,,,,False
0.0,,C1970945,MAJOR AFFECTIVE DISORDER 6,none,,,unknown,,,True,,Bipolar Disorder,,,,"Genetic locus (MAFD6) on chromosome 15q, not a distinct clinical entity with separate epidemiological data. Represents chromosomal linkage for familial mood disorder susceptibility, not measurable as independent incidence.",,,,,,,False
0.87,,C2239176,Liver carcinoma,strong,,2002,high,,10.8,True,incidence,Liver Cancer,,,,Hepatocellular carcinoma (HCC) incidence from GLOBOCAN 2002 data (closest to 2005): ~10.8 per 100k globally. Geographic variation is substantial: <2 per 100k in North America/Europe versus >20 per 100k in East Asia and sub-Saharan Africa due to hepatitis B and C prevalence.,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,864000,,False
0.0,,C2350344,Chronic Lung Injury,none,,,unknown,,,False,,,,,,"Umbrella term too heterogeneous and vague to estimate meaningfully. Could encompass COPD, pulmonary fibrosis, chronic ARDS sequelae, occupational lung disease, and many other conditions with vastly different etiologies, prevalences, and clinical significance.",,,,,,,False
0.78,,C2362324,Pediatric Obesity,strong,,2005,high,,,True,prevalence,Obesity,,3200,,"Chronic condition measured as prevalence. WHO data from 2005 shows approximately 3.2% of children globally were obese (3,200 per 100k). Prevalence is the appropriate metric for this chronic condition.",de Onis M et al. (2010). Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr. 92(5):1257-64,literature,https://pubmed.ncbi.nlm.nih.gov/20861173/,,256000000,,True
0.88,,C2363741,HIV-1 infection,strong,,2005,high,,43.0,True,incidence,HIV infection,,,,"HIV-1 is the most common HIV type globally. UNAIDS 2005 report estimated 2.8 million new HIV infections globally, approximately 43 per 100k person-years. High geographic variation with Sub-Saharan Africa having much higher rates.",UNAIDS/WHO AIDS Epidemic Update 2005,registry,https://data.unaids.org/publications/irc-pub06/epi_update2005_en.pdf,,3440000,,True
0.65,,C2697636,Hyperdiploid B Acute Lymphoblastic Leukemia,moderate,,,low,,1.2,True,incidence,B-cell Acute Lymphoblastic Leukemia,,,,"Reporting incidence of new diagnoses. Hyperdiploid B-ALL represents ~25-30% of childhood B-ALL cases. With pediatric ALL incidence ~4 per 100k children and hyperdiploid being 25-30% of B-ALL cases, estimated ~1.2 per 100k overall population.",Pui CH et al. (2004). Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol. 22(15):2902-2913,literature,https://pubmed.ncbi.nlm.nih.gov/15254062/,,96000,,False
0.0,,C2700438,MAJOR AFFECTIVE DISORDER 7,none,,,unknown,,,True,,Bipolar Disorder,,,,"Genetic locus (MAFD7) on chromosome 1q, not a distinct clinical entity with separate epidemiological data. Represents chromosomal linkage for familial bipolar disorder susceptibility, not measurable as independent incidence.",,,,,,,False
0.0,,C2700439,MAJOR AFFECTIVE DISORDER 8,none,,,unknown,,,True,,Bipolar Disorder,,,,"Genetic locus (MAFD8), not a distinct clinical entity with separate epidemiological data. Represents chromosomal linkage for familial bipolar disorder susceptibility, not measurable as independent incidence.",,,,,,,False
0.25,,C2700440,MAJOR AFFECTIVE DISORDER 9,weak,,,unknown,,extremely rare,True,,Major Affective Disorders,,,,"Genetic variant designation for familial mood disorder, likely another rare monogenic form. No systematic epidemiological data; estimated <0.01 per 100k based on genetic literature.",,,,,extremely rare,,False
0.7,,C2711227,Steatohepatitis,moderate,,2005,high,,,False,prevalence,,,3000.0,,"Encompasses NASH and alcoholic steatohepatitis. Chronic liver condition measured by prevalence rather than incidence. Global NASH prevalence circa 2005 estimated at 2-5% of adults, approximately 3,000 per 100k (3%). Incidence data poorly documented.",Browning JD et al. (2004). Prevalence of hepatic steatosis in an urban population. Hepatology. 40(6):1387-1395,literature,https://pubmed.ncbi.nlm.nih.gov/15565570/,,240000000,,False
0.68,,C2717836,Steroid Sulfatase Deficiency Disease,moderate,,,low,,0.3,False,incidence,,,,,"Steroid sulfatase deficiency causes X-linked ichthyosis. Same epidemiology as X-linked ichthyosis with birth prevalence 1 in 2,000-6,000 males, converting to ~0.3 per 100k person-years incidence.",Orphanet and genetic disease registries,registry,,,24000,,False
0.68,,C2745900,Promyelocytic leukemia,strong,,,moderate,,0.15,True,incidence,Acute myeloid leukemia,,,,"Reporting incidence at ~0.15 per 100k person-years. Acute promyelocytic leukemia (APL) represents 10-15% of AML cases. Global AML incidence ~1-1.5 per 100k, making APL ~0.1-0.2 per 100k based on cancer registry data.",Lehmann S et al. (2011). Continuing improvement in survival in acute promyelocytic leukemia. Blood. 118(11):e1-9,literature,https://pubmed.ncbi.nlm.nih.gov/21768301/,,12000,,False
0.35,,C2749757,BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1,weak,,,unknown,,extremely rare,True,incidence,Bronchiectasis,,,,Rare genetic form of bronchiectasis associated with SCNN1B gene mutations. Specific incidence unknown but estimated <0.1 per 100k based on rarity in genetic databases and case report frequency.,,,,,extremely rare,,False
0.3,,C2751310,"Hyperuricemic Nephropathy, Familial Juvenile 2",weak,,,unknown,,extremely rare,True,incidence,Familial Juvenile Hyperuricemic Nephropathy,,,,Extremely rare autosomal dominant disorder with juvenile-onset hyperuricemia and progressive renal failure. Caused by UMOD gene mutations. <0.01 per 100k based on genetic registry data and case reports.,Hart TC et al. (2002). Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet. 39(12):882-892,literature,https://pubmed.ncbi.nlm.nih.gov/12471200/,,extremely rare,,False
0.68,,C2751492,"AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED",moderate,,,high,,extremely rare,True,incidence,Hereditary Amyloidosis,,,,"Hereditary transthyretin amyloidosis (ATTRv or familial amyloid polyneuropathy) is extremely rare, <0.1 per 100k globally. Higher in endemic areas (Portugal, Sweden, Japan) due to founder mutations. Incidence of symptomatic disease estimated <0.01 per 100k in non-endemic populations.","Schmidt HH et al. (2003). Roswell Park Cancer Institute, hereditary amyloidosis review. Amyloid. 10(Suppl 1):85-93",literature,,,extremely rare,,False
0.7,,C2919945,Cavernous Hemangioma of Brain,strong,,,low,,,False,prevalence,,,400,,"Cerebral cavernous malformations (CCMs) are better characterized by prevalence than incidence, as they are congenital/developmental vascular malformations often remaining asymptomatic. MRI and autopsy studies show prevalence of 0.4-0.5% of population (~400 per 100k). Most are sporadic (80%) and discovered incidentally. Annual symptomatic presentation rate much lower (~0.5 per 100k), but total prevalence is the more meaningful epidemiological metric.",Zabramski JM et al. (1994). The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg. 80(3):422-432,literature,https://pubmed.ncbi.nlm.nih.gov/8113854/,,32000000,,False
0.5,,C2931263,Familial cerebral cavernous malformation,moderate,,,moderate,,extremely rare,True,prevalence,Cerebral Cavernous Malformations,,80,,"Familial CCM represents ~20% of all CCM cases (autosomal dominant inheritance with mutations in KRIT1, CCM2, or PDCD10 genes). With total CCM prevalence ~400 per 100k, familial cases estimated at ~80 per 100k. Birth incidence would be <0.05 per 100k. Prevalence is more appropriate metric as these are congenital malformations with variable age of symptom onset. Higher prevalence in Hispanic populations (New Mexico founder effect).",Akers A et al. (2017). Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations. Neurosurgery. 80(5):665-680,literature,https://pubmed.ncbi.nlm.nih.gov/28327981/,,6400000,,False
0.75,,C2931367,"Thyroid cancer, follicular",strong,,2005,moderate,,0.7,True,incidence,Thyroid Carcinoma,,,,"Follicular thyroid carcinoma is a specific histological subtype comprising ~10-15% of all thyroid cancers. Global thyroid cancer incidence ~5 per 100k (GLOBOCAN 2005), so follicular subtype ~0.7 per 100k.",GLOBOCAN 2005 (IARC) - thyroid cancer data with subtype distribution from SEER,registry,https://gco.iarc.fr/,,56000,,True
0.55,,C2931618,Gestational trophoblastic disease,moderate,,,high,,3.2,False,incidence,,,,,"Umbrella term including complete mole, partial mole, invasive mole, and choriocarcinoma. Global incidence approximately 1-2 per 1000 pregnancies (higher in Asia, lower in Western countries). Estimated at ~3.2 per 100k person-years based on pregnancy rates and molar pregnancy frequency.","Lurain JR. (2010). Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 203(6):531-539",literature,https://pubmed.ncbi.nlm.nih.gov/20728069/,,256000,,False
0.85,,C2931822,Nasopharyngeal carcinoma,strong,,2005,high,,1.2,True,incidence,Head and Neck Cancer,,,,Nasopharyngeal carcinoma global incidence from GLOBOCAN 2005: ~1.2 per 100k. Extreme geographic variation: endemic in Southern China/Southeast Asia (20-30 per 100k) but <1 per 100k in most regions due to EBV and genetic factors.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,96000,,True
0.82,,C2936858,Congenital adrenal hyperplasia due to 21 hydroxylase deficiency,strong,,,moderate,,0.14,True,incidence,Congenital Adrenal Hyperplasia,,,,"Classic 21-hydroxylase deficiency CAH occurs in ~1 per 15,000 births globally. With crude birth rate of ~20 per 1,000 population, this translates to ~0.14 per 100k person-years.",Speiser PW et al. (2010). Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 95(9):4133-60,literature,https://pubmed.ncbi.nlm.nih.gov/20823466/,,11200,,False
0.0,,C2939419,Secondary Neoplasm,none,,,high,,,False,,,,,,Umbrella term for all metastatic cancers to any site from any primary cancer. Too heterogeneous to estimate meaningfully - encompasses metastases from hundreds of primary cancer types to dozens of organs with vastly different incidence rates and clinical significance.,,,,,,,False
0.35,,C2960064,Low grade dysplastic nodule,weak,,,high,,2.5,True,incidence,Hepatic dysplastic nodule,,,,"Histopathological finding in cirrhotic livers, not a traditional disease entity. Estimated at ~20-30% of HCC cases (HCC ~12 per 100k), suggesting ~2.5 per 100k. Low confidence due to lack of population-based surveillance and unclear clinical significance.",,,,,200000,,False
0.32,,C2960065,High grade dysplastic nodule,weak,,,high,,1.8,True,incidence,Hepatic dysplastic nodule,,,,"Pre-malignant liver lesion in cirrhotic patients, direct precursor to HCC. Less common than low-grade dysplastic nodules. Estimated at ~15% of HCC incidence (~1.8 per 100k). Very low confidence due to lack of population surveillance and detection bias.",,,,,144000,,False
0.28,,C2986703,Overgrowth Syndrome,weak,,,moderate,,2.0,False,incidence,,,,,"Aggregate BOTEC estimate summing major overgrowth syndromes: Beckwith-Wiedemann (~1.0), Sotos (~0.5), Simpson-Golabi-Behmel (~0.2), Weaver (~0.1), Proteus (extremely rare), others (~0.2) = ~2 per 100k births. Heterogeneous group with varying severity.",,estimate,,,160000,,False
0.35,,C3151190,RETINITIS PIGMENTOSA 48,weak,,,unknown,,extremely rare,True,incidence,Retinitis Pigmentosa,,,,"RP48 is an extremely rare genetic subtype caused by specific mutations. While RP overall affects ~1 in 4000 (25 per 100k prevalence), type 48 represents <1% of RP cases. Estimated <0.01 per 100k based on genetic case reports.",,,,,extremely rare,,False
0.75,,C3250443,MYOTONIC DYSTROPHY 1,strong,,,moderate,,,True,prevalence,Myotonic Dystrophy,,8.0,,Genetic disorder measured by prevalence. DM1 prevalence approximately 8 per 100k based on population studies. Most common adult-onset muscular dystrophy. Type 1 (CTG expansion) is more common than Type 2.,Theadom A et al. (2014). Prevalence of muscular dystrophies: a systematic literature review. Neuroepidemiology. 43(3-4):259-68,literature,https://pubmed.ncbi.nlm.nih.gov/25532075/,,640000,,False
0.35,,C3266262,Multiple Chronic Conditions,weak,,,high,,,False,prevalence,,,25000,,"This is a prevalence-based concept (having 2+ chronic conditions simultaneously), not an incident disease. Estimated ~25% of global adults have multiple chronic conditions based on WHO 2005 data, but definition varies widely across studies.",,,,,2000000000,,False
0.3,,C3280216,"HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 3",weak,,,unknown,,extremely rare,True,incidence,Familial Juvenile Hyperuricemic Nephropathy,,,,Extremely rare autosomal dominant tubulointerstitial kidney disease caused by specific genetic mutations. <0.01 per 100k based on case report frequency and genetic databases. Specific genetic subtype (FJHN3).,,,,,extremely rare,,False
0.82,,C3463824,Myelodysplastic Syndrome,strong,,2005,moderate,,4.0,False,incidence,,,,,"MDS global incidence ~4 per 100k overall population, but strongly age-dependent (15-50 per 100k in adults >70). Well-documented in cancer registries including SEER and European registries.",Ma X et al. (2007). Epidemiology of myelodysplastic syndromes. Am J Med. 120(7 Suppl 1):S2-10,literature,https://pubmed.ncbi.nlm.nih.gov/17602924/,,320000,,False
0.65,,C3469186,"HEMOCHROMATOSIS, TYPE 1",moderate,,2005,moderate,,2.5,True,incidence,Hereditary Hemochromatosis,,,,"HFE-related hereditary hemochromatosis (Type 1), most common form. Clinical diagnosis incidence ~2-3 per 100k despite higher genetic prevalence. Based on population screening studies.",Adams PC et al. (2005). Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 352:1769-78,literature,https://pubmed.ncbi.nlm.nih.gov/15858186/,,200000,,False
0.65,,C3495559,Juvenile Arthritis,moderate,,,moderate,,10.0,False,incidence,,,,,"Juvenile arthritis (synonym for juvenile idiopathic arthritis) incidence approximately 10 per 100k children annually. Moderate confidence from pediatric rheumatology studies, though population-based data varies by diagnostic criteria used.",Manners PJ et al. (2003). Epidemiology of juvenile chronic arthritis. Rheum Dis Clin North Am. 29(3):431-446,literature,https://pubmed.ncbi.nlm.nih.gov/12951861/,,800000,,False
0.65,,C3495917,Advanced breast cancer,moderate,,2005,moderate,,4.2,True,incidence,Breast Cancer,,,,"Advanced/metastatic breast cancer at diagnosis represents ~5-10% of total breast cancer incidence. Global breast cancer incidence ~44 per 100k (2005), advanced stage estimated at ~4.2 per 100k. Moderate confidence due to staging definition variability.",Estimated from GLOBOCAN 2005 breast cancer data with stage distribution from SEER,estimate,https://gco.iarc.fr/,,336000,,True
0.55,,C3495919,Enthesitis-Related Arthritis,moderate,,,moderate,,0.8,True,incidence,Juvenile Idiopathic Arthritis,,,,"Reporting incidence of new diagnoses in pediatric population. ERA represents approximately 15-20% of JIA cases, with overall JIA incidence of 4-5 per 100k children. Estimated at ~0.8 per 100k children globally. Moderate confidence due to limited population-based epidemiological studies.",Saurenmann RK et al. (2007). Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort. Arthritis Rheum. 56(6):1974-1984,literature,https://pubmed.ncbi.nlm.nih.gov/17530723/,,64000,,False
0.65,,C3711374,Nonsyndromic Deafness,moderate,,,moderate,,2.8,True,incidence,Congenital deafness,,,,Nonsyndromic hearing loss comprises ~70% of hereditary congenital deafness. Estimated at ~2.8 per 100k person-years based on proportion of congenital cases.,Morton CC et al. (2006). Newborn hearing screening--a silent revolution. N Engl J Med. 354(20):2151-2164,literature,https://pubmed.ncbi.nlm.nih.gov/16707752/,,224000,,False
0.8,,C3714619,Insulin resistance syndrome,strong,,2005,high,,,False,prevalence,,,22000,,"Also known as metabolic syndrome. Chronic condition measured by prevalence. Global prevalence approximately 20-25% (22,000 per 100k) in adults circa 2005, varying by diagnostic criteria and population. Well-documented syndrome with strong epidemiological data.",Hu G et al. (2004). Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 164(10):1066-76,literature,https://pubmed.ncbi.nlm.nih.gov/15159263/,,1760000000,,True
0.65,,C3714756,Intellectual Disability,moderate,,,moderate,,,False,prevalence,,,1500,,Modern terminology for developmental cognitive impairment. Prevalence metric used as this is a lifelong condition typically diagnosed in childhood. Global prevalence ~1-2% (1500 per 100k) based on meta-analyses. Moderate confidence due to acceptable prevalence data but diagnostic criteria variation across regions.,Maulik PK et al. (2011). Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil. 32(2):419-436,literature,https://pubmed.ncbi.nlm.nih.gov/21236634/,,120000000,,False
0.65,,C3714757,Juvenile Rheumatoid Arthritis,moderate,,,moderate,,10.0,True,incidence,Rheumatoid Arthritis,,,,Juvenile idiopathic arthritis (JIA) incidence approximately 10 per 100k children annually based on pediatric rheumatology literature. Moderate confidence due to varying diagnostic criteria and limited population-based registries.,Manners PJ et al. (2003). Epidemiology of juvenile chronic arthritis. Rheum Dis Clin North Am. 29(3):431-446,literature,https://pubmed.ncbi.nlm.nih.gov/12951861/,,800000,,False
0.68,,C3805278,Extrahepatic Cholangiocarcinoma,moderate,,2005,high,,1.2,True,incidence,Cholangiocarcinoma,,,,Extrahepatic bile duct cancer incidence ~1.2 per 100k from cancer registry data. Comprises perihilar and distal bile duct tumors. Higher rates in Southeast Asia due to liver fluke exposure.,Khan SA et al. (2005). Cholangiocarcinoma. Lancet. 366(9493):1303-1314,literature,https://pubmed.ncbi.nlm.nih.gov/16214602/,,96000,,False
0.3,,C3806153,"ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1",weak,,,unknown,,extremely rare,True,incidence,Hypochromic Microcytic Anemia,,,,"Reporting incidence of this extremely rare genetic disorder. Very few cases documented in medical literature, estimated <0.01 per 100k. Limited systematic epidemiological studies available for this specific genetic subtype.",,,,,extremely rare,,False
0.35,,C3854222,Human immunodeficiency virus (HIV) II infection category B1,weak,,,high,,0.05,True,incidence,HIV-2 infection,,,,"HIV-2 Category B1 is a very specific CDC classification stage. HIV-2 itself is rare globally (<2 million cases, mostly West Africa). Category B1 represents a small fraction of incident HIV-2 cases. Estimated <0.05 per 100k globally based on HIV-2 epidemiology.",,,,,4000,,False
0.55,,C3887487,Postaxial polydactyly type A,moderate,,,high,,15.0,True,incidence,Postaxial polydactyly,,,,"Postaxial polydactyly type A incidence ~15 per 100k births (1.5 per 10,000 births). Moderate confidence due to birth defect registry data but significant ethnic variation.",Biesecker LG. (2002). Polydactyly: how many disorders and how many genes? Am J Med Genet. 112(3):279-83,literature,https://pubmed.ncbi.nlm.nih.gov/12357473/,,1200000,,False
0.0,,C3887524,Skin Erosion,none,,,unknown,,,False,,,,,,"Unmappable - skin erosion is a clinical descriptive term for superficial epidermal loss, not a disease entity. Can result from multiple etiologies (trauma, friction, burns, dermatitis, infections). No systematic epidemiological tracking of this clinical finding.",,,,,,,False
0.35,,C3898709,Intestinal-Type Sinonasal Adenocarcinoma,weak,,,unknown,,extremely rare,True,incidence,Sinonasal Adenocarcinoma,,,,Extremely rare malignancy representing a specific histological subtype of sinonasal adenocarcinoma. Sinonasal adenocarcinomas overall are <1 per 100k; intestinal-type represents a fraction of these. Estimated <0.05 per 100k based on case series literature.,Barnes L. (2002). Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol. 10:192-202,literature,,,extremely rare,,False
0.8,,C3899278,Early Rheumatoid Arthritis,strong,,,moderate,,28.0,False,incidence,Rheumatoid Arthritis,,,,Reporting incidence of new RA diagnoses. All incident RA cases are by definition 'early' RA at diagnosis. Global incidence approximately 25-30 per 100k person-years based on meta-analyses of population-based studies. Higher in developed countries and females. 'Early' typically refers to disease duration <2 years but incidence captures new diagnoses.,"Alamanos Y et al. (2006). Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum. 36(3):182-188",literature,https://pubmed.ncbi.nlm.nih.gov/17045630/,,2240000,,False
0.7,,C3899655,Childhood Langerhans Cell Histiocytosis,moderate,,,low,,0.5,True,incidence,Langerhans Cell Histiocytosis,,,,"Reporting incidence of new diagnoses. Childhood LCH incidence is 4-5 cases per million children per year, approximately 0.5 per 100k overall population when accounting for pediatric demographic proportion.",Stalemark H et al. (2008). Incidence of Langerhans cell histiocytosis in children: a population-based study. Pediatr Blood Cancer. 51(1):76-81,literature,https://pubmed.ncbi.nlm.nih.gov/18266220/,,40000,,False
0.6,,C3900100,Adult Langerhans Cell Histiocytosis,moderate,,,low,,0.1,True,incidence,Langerhans Cell Histiocytosis,,,,"Reporting incidence of new diagnoses. Adult LCH is significantly rarer than childhood form, estimated 1-2 cases per million adults per year, approximately 0.1 per 100k overall population.",,,,,8000,,False
0.68,,C4025886,Severe periodontitis,strong,,2010,moderate,,,True,prevalence,Periodontal Diseases,,11000,,Reporting prevalence for this chronic condition. Global Burden of Disease 2010 study estimates ~11% global prevalence for severe periodontitis (chronic attachment loss ≥6mm). Used as proxy for 2005 era estimates.,Kassebaum NJ et al. (2014). Global burden of severe periodontitis in 1990-2010: a systematic review and meta-regression. J Dent Res. 93(11):1045-1053,literature,https://pubmed.ncbi.nlm.nih.gov/25261053/,,880000000,,False
0.88,,C4048328,Cervical Cancer,strong,,2005,high,,15.3,False,incidence,,,,,Reporting incidence (new cancer diagnoses). GLOBOCAN 2005 data shows cervical cancer global incidence of approximately 15.3 per 100k women per year. High confidence from cancer registry data.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,1224000,,True
0.0,,C4049446,Neointimal hyperplasia,none,,,unknown,,,False,,,,,,"Pathological process (vessel wall thickening post-intervention), not a primary disease entity. Occurs as complication in 10-50% of stenting/bypass procedures but no population-based incidence surveillance. Not a condition with standard epidemiological tracking.",,,,,,,False
0.75,,C4082937,Necrotizing enterocolitis in fetus OR newborn,strong,,,moderate,,1.0,False,incidence,,,,,"NEC primarily affects premature infants, occurring in 5-10% of very low birth weight infants. Overall incidence is ~0.5-1.0 per 1000 live births. With global birth rate of ~2000 per 100k population per year in 2005, NEC incidence is approximately 1.0 per 100k population per year.","Neu J, Walker WA. (2011). Necrotizing enterocolitis. N Engl J Med. 364:255-264",literature,https://pubmed.ncbi.nlm.nih.gov/21247316/,,80000,,False
0.88,,C4086165,Childhood Neuroblastoma,strong,,2005,low,,1.0,True,incidence,Neuroblastoma,,,,Neuroblastoma is the most common extracranial solid tumor in children. Incidence ~1 per 100k children (10 per million children under 15). Well-documented in pediatric cancer registries.,"Ries LAG et al. SEER Cancer Statistics Review, 1975-2005",registry,https://seer.cancer.gov/archive/csr/1975_2005/,,80000,,True
0.0,,C4087504,Peritoneal dissemination,none,,,unknown,,,False,,,,,,"Peritoneal dissemination is a metastatic process/finding, not a primary disease entity. Occurs as secondary manifestation of various cancers (ovarian, gastric, colorectal, pancreatic). Cannot assign meaningful incidence without specifying the primary malignancy.",,,,,,,False
0.72,,C4284013,Primary cholangiocarcinoma of intrahepatic biliary tract,moderate,,2005,high,,0.85,True,incidence,Cholangiocarcinoma,,,,Intrahepatic cholangiocarcinoma incidence ~0.85 per 100k globally from cancer registries. Second most common primary liver malignancy after HCC. Rising incidence noted in Western countries.,Khan SA et al. (2005). Cholangiocarcinoma. Lancet. 366(9493):1303-1314,literature,https://pubmed.ncbi.nlm.nih.gov/16214602/,,68000,,False
0.35,,C4317224,Congenital disorder of glycosylation type 1q,weak,,,unknown,,extremely rare,True,incidence,Congenital Disorders of Glycosylation Type 1,,,,Extremely rare genetic disorder (CDG-1q/SRD5A3-CDG) with <100 cases reported worldwide. Estimated <0.01 per 100k births based on case report frequency. No systematic population-based epidemiological data available.,Cantagrel V et al. (2010). SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder. Cell. 142(2):203-17,literature,https://pubmed.ncbi.nlm.nih.gov/20637498/,,extremely rare,,False
0.52,,C4520843,Pterygium of eye,moderate,,,high,,8.0,False,incidence,Pterygium,,,,"Pterygium of eye (conjunctival growth onto cornea) incidence estimated ~8 per 100k globally. High geographic variation based on UV exposure, ranging from <1% prevalence in temperate zones to >20% near equator. Limited population-based incidence data.",,,,,640000,,False
0.72,,C4520983,Congenital atresia of extrahepatic bile duct,strong,,,high,,0.7,False,incidence,,,,,"Reporting incidence of biliary atresia at approximately 0.7 per 100k births (1 in 8,000-15,000 live births). Global incidence shows geographic variation with higher rates in East Asia.",Chardot C et al. (2006). Epidemiology of biliary atresia in France: a national study 1986-96. J Hepatol. 31(6):1006-13,literature,https://pubmed.ncbi.nlm.nih.gov/10604573/,,56000,,False
0.45,,C4551675,"Keratoderma, Palmoplantar",weak,,,moderate,,2.0,False,incidence,,,,,"Palmoplantar keratoderma (PPK) encompasses hereditary and acquired forms. Estimated ~2 per 100k based on dermatology registry data, but systematic epidemiological studies are limited.",,,,,160000,,False
0.78,,C4551687,Sarcoma of soft tissue,strong,,2005,low,,4.0,False,incidence,,,,,"Soft tissue sarcomas globally: ~4 per 100k per year based on SEER and international registry data circa 2005. Includes all histological subtypes (liposarcoma, leiomyosarcoma, UPS, etc.).","Toro JR et al. (2006). Incidence patterns of soft tissue sarcomas in the SEER program, 1978-2001. Int J Cancer. 119(12):2922-30",literature,https://pubmed.ncbi.nlm.nih.gov/17013893/,,320000,,True
0.35,,C4551961,Familial Isolated Hyperparathyroidism,weak,,,unknown,,0.05,True,incidence,Hyperparathyroidism,,,,"Rare genetic form of hyperparathyroidism. Estimated <0.1 per 100k based on case series. Primary hyperparathyroidism overall affects ~25 per 100k, but familial isolated form represents <1% of cases.",,,,,4000,,False
0.82,,C4721610,"Carcinoma, Ovarian Epithelial",strong,,2005,moderate,,5.4,True,incidence,Ovarian Cancer,,,,"Epithelial ovarian carcinoma comprises ~90% of ovarian cancers. Global ovarian cancer incidence ~6 per 100k women (GLOBOCAN 2005), epithelial subset ~5.4 per 100k women or ~2.7 per 100k general population. Adjusted for women-only denominator.",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,432000,,True
0.55,,C4721779,Ovarian cancer stage IV,moderate,,,moderate,,2.2,True,incidence,Malignant neoplasm of ovary,,,,Stage IV ovarian cancer represents approximately 30-35% of ovarian cancer diagnoses at presentation. Derived from overall ovarian cancer incidence (6.6) × stage distribution (0.33) = ~2.2 per 100k women. Lower confidence due to indirect calculation.,SEER Cancer Statistics Review (stage distribution data combined with GLOBOCAN incidence),registry,https://seer.cancer.gov/,,176000,,False
0.9,,C4722085,Malignant neoplasm of colon and/or rectum,strong,,2002,high,,35.2,False,incidence,,,,,Reporting incidence (new diagnoses). Synonymous with colorectal carcinoma. GLOBOCAN 2002 data shows global incidence ~35 per 100k. Strong cancer registry data worldwide.,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,2816000,,False
0.68,,C4727169,Metastatic Gastric Carcinoma,moderate,,2005,high,,7.5,True,incidence,Gastric Carcinoma,,,,"Gastric cancer global incidence ~15 per 100k in 2005. Approximately 50% of gastric cancers present with metastatic disease at diagnosis, yielding ~7.5 per 100k for metastatic gastric carcinoma. Geographic variation is high (East Asia >> Western countries).","Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,600000,,True
0.35,,C3875321,Inflammatory dermatosis,weak,,,high,,200,True,incidence,Dermatitis,,,,"Inflammatory dermatosis is broad category. Estimated incidence ~200 per 100k including eczema, psoriasis, and other inflammatory skin conditions.",,,,,16000,,False
0.55,,C0344479,Spinal Cord Myelodysplasia,moderate,,,moderate,,5.0,True,incidence,Spinal Cord Malformation,,,,"Spinal cord myelodysplasia (abnormal spinal cord development) estimated at 5 per 100,000 live births.",,,,,400000,,False
0.65,,C0153452,Malignant neoplasm of gallbladder,moderate,,2005,high,,1.0,False,incidence,,,,,"Gallbladder cancer incidence ~1 per 100k globally, varies by region.",Cancer registries,registry,,,65000,,False
0.0,,C1257925,"Mammary Carcinoma, Animal",none,,,unknown,,,False,,,,,,"Animal model neoplasm, not applicable to human epidemiology.",,,,,,,False
0.6,,C1610066,Urinary tract inflammation,moderate,,,moderate,,100.0,False,,Urinary tract infection,,,,"Umbrella term for cystitis, urethritis, pyelonephritis. Estimated ~100 per 100k (UTI is very common).",Population health surveys,registry,,,8000000.0,,False
0.3,,C2748918,Otopalatodigital Spectrum Disorder,weak,,,unknown,,extremely rare,False,incidence,,,,,Otopalatodigital spectrum disorders are rare X-linked skeletal dysplasias with <500 cases reported.,,,,,,,False
0.6,,C0085292,Stiff-Person Syndrome,moderate,,,low,,0.08,False,both,Autoimmune Neurological Disorders,,1.0,,Stiff-Person syndrome (SPS) is a rare autoimmune neurological disorder characterized by progressive rigidity and spasms. Incidence estimated at 0.08-0.1 per 100k person-years. Prevalence approximately 1 per 100k population. Metric: both incidence (new diagnoses) and prevalence (existing cases). Often anti-GAD65 antibody positive. Data from specialized neurology centers and case series; moderate confidence due to diagnostic variability and potential underdiagnosis.,Dalakas MC. (2001). Stiff Person Syndrome: Pathophysiology and Current Management. CNS Drugs. 15(11):845-853,literature,https://pubmed.ncbi.nlm.nih.gov/11735959/,,6400,,False
0.55,,C0266453,Exencephaly,moderate,,,high,,1.0,True,incidence,Neural Tube Defect,,,,"Exencephaly (exposed brain tissue) estimated at 1 per 100,000 live births.",,,,,80000,,False
0.4,,C0205697,"Carcinoma, Spindle-Cell",weak,,,unknown,,2.5,True,incidence,Carcinoma,,,,Spindle-cell carcinoma is rare histological variant; estimated <2.5 per 100k based on case frequencies.,,,,,200000,,False
0.35,,C1318485,Liver regeneration disorder,weak,,,unknown,,0.5,False,incidence,Hepatic Disease,,,,Impaired liver regeneration is complication rather than primary disease; estimated <0.5 per 100k.,,,,,40000,,False
0.75,,C1336527,"Carcinoma of urinary bladder, superficial",strong,,,moderate,,8.5,True,incidence,Bladder Cancer,,,,"Superficial bladder carcinoma (non-muscle invasive bladder cancer, NMIBC) represents ~75-80% of bladder cancer diagnoses. Global bladder cancer incidence ~10-11 per 100k; superficial cases estimated at ~8-9 per 100k. Reported as incidence (new cases per year). Data from cancer registries and epidemiological studies with geographic variation.",GLOBOCAN and regional cancer registries,registry,,,680000,,False
0.75,,C2938924,Oestrogen receptor positive breast cancer,strong,,,moderate,,35,True,incidence,Breast Cancer,,,,ER-positive breast cancer represents ~70% of breast cancers (~35 per 100k incidence in women).,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,2800,,False
0.3,,C4693863,"TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 2",weak,,,unknown,,extremely rare,True,incidence,"Tumoral calcinosis, hyperphosphatemic, familial",,,,Specific genetic subtype (TCHHF2) with FGF23 gene mutations. Even rarer than the general hyperphosphatemic familial form. Fewer than 50 documented cases worldwide. <0.001 per 100k.,,,,,extremely rare,,False
0.6,,C0031117,Peripheral Neuropathy,moderate,,,high,,100,False,both,,,2500,,"Aggregate umbrella term (diabetic, hereditary, toxic, etc). Prevalence 2-3% population. Incidence ~100 per 100k per year.",WHO and epidemiological literature,literature,,,6500000,,False
0.25,,C0017178,Gastrointestinal Diseases,weak,,,high,,25000,False,incidence,,,,,"Aggregate BOTEC estimate summing major GI conditions: acute gastroenteritis (~5000), GERD (~3000), IBS (~4000), peptic ulcer disease (~2000), Crohn's disease (~200), ulcerative colitis (~300), celiac disease (~500), diverticulitis (~1500), appendicitis (~1000), colorectal polyps (~5000+). Umbrella term encompasses extremely heterogeneous conditions with vastly different incidence rates and clinical significance.",,,,,2000000000,,False
0.8,,C0001627,Congenital adrenal hyperplasia,strong,,2005,moderate,,75,False,incidence,Endocrine Disorders of Infancy,,,,"CAH incidence estimated at 75 per 100,000 live births globally based on newborn screening data.",Newborn screening programs and endocrine registries,registry,,,6000000,,True
0.7,,C0006271,Bronchiolitis,strong,,2005,high,,350,False,incidence,,,,,"Bronchiolitis is an acute viral respiratory infection primarily affecting infants and young children, caused mainly by respiratory syncytial virus (RSV). Global incidence estimated at ~350 per 100k population, but varies dramatically by age (extremely high in children <2 years, rare in adults). WHO estimates 40-50% of all respiratory infections in children <1 year involve lower respiratory tract.",WHO Global Burden of Disease estimates; CDC Respiratory Syncytial Virus epidemiology,registry,https://www.who.int/,,28000000,,False
0.68,,C0009447,Common Variable Immunodeficiency,moderate,,2005,moderate,,3.2,True,both,Primary Immunodeficiency Disorder,,50,,"CVID is the most common symptomatic primary immunodeficiency. Incidence: ~1 in 25,000 to 1 in 50,000 live births (3-4 per 100k annually). Prevalence: ~50 per 100k (lifetime diagnoses). Data from immunodeficiency registries shows moderate confidence; regional variation due to ascertainment differences.",Bonilla FA et al. (2005). International Consensus Document (IUIS): Primary Immunodeficiency Diseases. J Allergy Clin Immunol. 115(2):S1-S232,literature,https://pubmed.ncbi.nlm.nih.gov/15653141/,,256000,,False
0.55,,C1333280,Desmoplastic melanoma,weak,,,unknown,,0.05,True,incidence,Melanoma,,,,"Rare histological variant of melanoma, <0.1 per 100k. Limited case series data.",,,,,3250,,False
0.9,,C4704874,"Mammary Carcinoma, Human",strong,,2005,moderate,,45.0,True,incidence,Breast cancer,,,,Mammary carcinoma (malignant): major global cancer. Incidence ~45 per 100k women from GLOBOCAN 2005 data.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,36000.0,,True
0.0,,C0014072,Experimental Autoimmune Encephalomyelitis,none,,,unknown,,,False,,,,,,"Experimental Autoimmune Encephalomyelitis (EAE) is a research model of multiple sclerosis used in laboratory animals, not a naturally occurring human disease with epidemiological data. Cannot be meaningfully mapped to human incidence rates.",,,,,,,False
0.28,,C0398791,Nijmegen Breakage Syndrome,weak,,,high,,extremely rare,False,incidence,,,,,"Nijmegen Breakage Syndrome is an extremely rare autosomal recessive DNA repair disorder. Global incidence estimated <0.1 per 100k births based on case report frequencies. Only ~130 cases documented worldwide as of 2005. Most cases identified in Netherlands, Poland, and Pakistan due to founder effects.",,,,,extremely rare,,False
0.45,,C0031118,Peripheral Nervous System Neoplasms,weak,,,low,,0.5,True,both,Peripheral Nerve Neoplasms,,10,,Peripheral nervous system neoplasms rare. Estimated incidence ~0.5 per 100k based on cancer registry data.,,,,,40,,False
0.5,,C0017075,Ganglioneuroma,weak,,,unknown,,0.15,True,incidence,Neural Neoplasm,,,,Rare benign neural tumor arising from sympathetic nerve cells. Incidence estimated at 0.15 per 100k based on case reports and tumor registry data. Less common than neuroblastoma; often discovered incidentally. Reporting as incidence (new diagnoses per year) despite rarity. Data quality limited by small number of published epidemiological studies.,,,,,12000,,False
0.88,,C0019829,Hodgkin Disease,strong,,,moderate,,3.0,False,incidence,,,,,"Hodgkin lymphoma (Hodgkin disease) is a well-defined malignancy with strong epidemiological data from cancer registries. Global incidence approximately 2.5-3.5 per 100k, with variation by geography and age. Bimodal age distribution with peaks in 20s-30s and 50s+. Using global average estimate of 3.0 per 100k from GLOBOCAN-type data. Strong cancer registry coverage worldwide provides reliable estimates.",Cancer registry epidemiological estimates; global Hodgkin lymphoma incidence from international cancer surveillance data circa 2000-2010,registry,https://gco.iarc.fr/,,240000,,False
0.0,,C0279000,Liver and Intrahepatic Biliary Tract Carcinoma,none,,,high,,,False,,,,,,"Umbrella term too heterogeneous: includes benign hemangiomas, hepatocellular carcinoma, and intrahepatic cholangiocarcinoma with vastly different epidemiologies, incidence rates, and clinical significance. Aggregate estimate not meaningful without specifying histological type and malignancy status.",,,,,,,False
0.35,,C0205699,Carcinomatosis,weak,,,high,,5.0,False,incidence,,,,,Carcinomatosis (metastatic/disseminated cancer) is outcome rather than primary disease; aggregate umbrella estimate ~5 per 100k.,,,,,400000,,False
0.65,,C4086152,Childhood Astrocytoma,moderate,,2005,low,,0.5,True,incidence,Astrocytoma,,,,Childhood brain tumors incidence ~3 per 100k children <15; astrocytomas ~20% = ~0.6 per 100k.,Cancer registries,registry,,,32500,,False
0.3,,C4551590,Familial renal hypouricemia,weak,,,unknown,,extremely rare,True,incidence,Uric acid metabolism disorders,,,,Familial renal hypouricemia: rare genetic urate transport disorder. <100 cases reported.,,,,,,,False
0.35,,C0162835,Hypopigmentation disorder,weak,,,high,,,False,prevalence,Pigmentation disorders,,100.0,,Hypopigmentation disorder: umbrella term for depigmented skin conditions. Prevalence varies; using ~1% estimate.,,,,,80000.0,,False
0.0,,C1658953,tumor vasculature,none,,,unknown,,,False,,,,,,Tumor vasculature is not a disease entity but rather a pathological process describing blood vessel formation and neovascularization within tumors (angiogenesis). This is a histological/pathological descriptor rather than a clinically defined disease with epidemiological incidence data. No meaningful epidemiological data exists for this process descriptor. Unmappable to incidence rates.,,,,,,,False
0.42,,C0278619,Extramedullary Plasmacytoma,moderate,,,moderate,,0.3,True,incidence,Plasmacytoma,,,,Rare malignant plasma cell neoplasm occurring outside bone marrow. Estimated ~0.3 per 100k based on case series and cancer registry reports. Comprises ~5% of plasmacytomas.,,,,,24000,,False
0.8,,C1335302,Pancreatic Ductal Adenocarcinoma,strong,,2005,moderate,,6.9,True,incidence,Adenocarcinoma of pancreas,,,,Ductal adenocarcinoma (PDAC) is the most common pancreatic adenocarcinoma subtype (~90% of adenocarcinomas). Estimated incidence ~6.9 per 100k based on GLOBOCAN 2005 pancreatic cancer data adjusted for ductal histology prevalence.,GLOBOCAN 2005 (IARC) + Pancreatic ductal adenocarcinoma histology prevalence studies,registry,https://gco.iarc.fr/,,552000,,True
0.65,,C0004135,Ataxia Telangiectasia,moderate,,,low,,0.02,False,incidence,,,,,"Rare autosomal recessive disorder, incidence 1-9 per 100,000 births (avg ~1-2 per 100k births).",Genetic disorder registries,registry,,,1300,,False
0.75,,C0022665,Kidney Neoplasm,strong,,2005,moderate,,6.0,False,incidence,,,,,Renal cell carcinoma and other kidney tumors combined ~6 per 100k globally from GLOBOCAN estimates.,GLOBOCAN 2005 estimates,registry,https://gco.iarc.fr/,,390000,,False
0.84,,C0220641,Lip and Oral Cavity Carcinoma,strong,,2005,high,,3.4,True,incidence,Malignant neoplasm of mouth,,,,Lip and oral cavity carcinoma is a specific subtype of oral/mouth cancer. Incidence approximately 3.4 per 100k from cancer registry data. More specific anatomical definition than broader oral cancer category.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,272000,,True
0.45,,C0349204,Nonorganic psychosis,moderate,,,high,,15.0,True,incidence,Psychotic Disorders,,,,"Nonorganic psychosis is a subtype of psychotic disorders without apparent organic etiology (i.e., primary psychiatric conditions like schizophrenia, brief psychotic disorder). Estimated incidence ~15 per 100k person-years based on aggregated data for primary psychotic disorders. Confidence moderate due to difficulty in separating nonorganic from organic causes and variable diagnostic criteria across jurisdictions.","McGrath J et al. (2008). Schizophrenia: A concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 30:67-76",literature,https://pubmed.ncbi.nlm.nih.gov/18794375/,,1200000,,False
0.5,,C0342381,Idiopathic growth hormone deficiency,moderate,,,low,,7.5,True,incidence,Growth Hormone Deficiency,,,,"Idiopathic GHD (no identifiable genetic or anatomical cause) represents approximately 70-75% of congenital GHD cases. Overall congenital GHD estimated at ~1 per 4,000-10,000 births; idiopathic form ~7-10 per 100k. Confidence moderate due to limited epidemiological data specific to idiopathic form versus genetic subtypes.",,,,,600000,,False
0.25,,C0034341,Pyruvate Carboxylase Deficiency Disease,weak,,,unknown,,extremely rare,False,incidence,Mitochondrial Metabolism Disorders,,,,Extremely rare autosomal recessive disorder affecting pyruvate carboxylase enzyme. Estimated <0.05 per 100k based on case report frequency worldwide. Neonatal-onset form is lethal or severely disabling; infantile form presents with developmental delay and seizures.,,,,,extremely rare,,False
0.45,,C0020456,Hyperglycemia,weak,,,high,,18.0,False,incidence,,,,,"Hyperglycemia is primarily a laboratory finding and symptom rather than a disease diagnosis. Estimated incidence based on new-onset diabetes mellitus and impaired fasting glucose progression to clinical hyperglycemia. Low confidence due to hyperglycemia being a symptom of underlying conditions (diabetes, stress hyperglycemia, medication-induced) rather than an independent disease entity. Estimate of 18 per 100k based on type 2 diabetes incidence.",,estimate,,,1440000,,False
0.3,,C1955934,Trichothiodystrophy Syndromes,weak,,,unknown,,extremely rare,False,,Genetic hair and skin disorders,,,,"Group of rare genetic disorders affecting hair, skin, and nails. <0.1 per 100k births based on case reports.",,,,,,,False
0.2,,C0085129,Bronchial Hyperreactivity,weak,,,unknown,,,False,,,,,,"Bronchial hyperreactivity is a pathophysiological mechanism rather than a distinct disease entity. Often measured as a functional characteristic in asthma or other obstructive airway diseases. Cannot be meaningfully separated from underlying conditions (asthma, COPD, hypersensitivity pneumonitis) for epidemiological purposes.",,,,,,,False
0.78,,C0524910,"Hepatitis C, Chronic",strong,,2005,high,,44.0,True,both,Hepatitis C,,2600,,"Chronic HCV incidence (~44 per 100k annually from acute HCV infections progressing to chronicity). Global prevalence: ~2.6% (2,600 per 100k) with 170-200 million chronically infected. Highest rates in MENA, Central Asia, East Asia; lowest in North America/Australia. Data from WHO surveillance and Polaris Observatory.",Shepard CW et al. (2005). Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 5(9):558-567,literature,https://pubmed.ncbi.nlm.nih.gov/16122679/,,3520000,,True
0.85,,C0235974,Pancreatic carcinoma,strong,,2005,moderate,,10.8,True,incidence,Pancreatic Neoplasm,,,,Pancreatic cancer incidence ~10.8 per 100k globally (GLOBOCAN 2005). High mortality (5-year survival <5%). Well-documented through international cancer registries. Geographic variation moderate (higher in developed nations due to detection/classification).,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,864000,,True
0.45,,C0205696,Anaplastic carcinoma,weak,,,high,,4.5,True,incidence,Carcinoma,,,,Anaplastic carcinomas are high-grade malignancies; heterogeneous category with estimated 4.5 per 100k.,,,,,360000,,False
0.5,,C3714636,Pneumonitis,weak,,,high,,1.0,False,,Lung inflammation,,,,"Heterogeneous inflammatory lung condition. Estimated ~1 per 100k, varies by etiology (drug, radiation, hypersensitivity).",,,,,80000.0,,False
0.81,,C0020550,Hyperthyroidism,strong,,2005,moderate,,,False,prevalence,,,1200,,"Hyperthyroidism measured as prevalence (~1.2% of population, 1,200 per 100k) rather than incidence, as it represents the burden of existing thyroid hormone excess. Primary causes include Graves disease (80%) and toxic multinodular goiter (10-15%). Prevalence varies by iodine intake and age, higher in regions with adequate iodine. Data from population-based surveys and thyroid disease epidemiology.",American Thyroid Association epidemiological data and WHO thyroid disease surveillance (2000-2010),registry,https://www.thyroid.org/,,96000000,,True
0.25,,C1842937,"AURAL ATRESIA, CONGENITAL",weak,,,unknown,,extremely rare,True,incidence,Ear developmental anomalies,,,,Aural atresia (congenital): rare congenital ear canal absence. Estimated <1 per 100k births.,,,,,,,False
0.0,,C0178664,Glomerulosclerosis (disorder),none,,,unknown,,,False,,,,,,"Glomerulosclerosis is a pathological process (scarring/fibrosis of glomeruli) rather than a specific disease entity. It represents the final common pathway of multiple underlying glomerular diseases (FSGS, membranous GN, IgA nephropathy, diabetic nephropathy, etc.) and is therefore unmappable as a single epidemiological entity. Incidence would require specification of primary disease causing the sclerosis.",,,,,,,False
0.35,,C2874188,Isolated deficiency of pituitary hormone,weak,,,high,,15.0,False,incidence,,,,,"Umbrella term covering isolated deficiency of any single pituitary hormone (GH, ACTH, TSH, prolactin, or gonadotropins). Aggregate BOTEC estimate summing major forms: isolated GHD (~10 per 100k), isolated ACTH deficiency (~2 per 100k), isolated gonadotropin deficiency (~2 per 100k), others (~1 per 100k) = ~15 per 100k total. Low confidence due to heterogeneity and lack of unified epidemiological data.",,,,,1200000,,False
0.88,,C0346647,Malignant neoplasm of pancreas,strong,,2005,moderate,,9.2,False,incidence,,,,,Pancreatic cancer incidence from GLOBOCAN 2005: ~9.2 per 100k globally. Well-characterized cancer with established registries and surveillance data.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,736000,,True
0.25,,C1868310,Pigmented Paravenous Chorioretinal Atrophy,weak,,,unknown,,extremely rare,False,incidence,Retinal Dystrophy,,,,"Pigmented paravenous chorioretinal atrophy (PPCRA) is an extremely rare inherited retinal condition. Estimated incidence <0.01 per 100k based on case report frequency in ophthalmology literature, with fewer than 100 families documented worldwide.",,,,,extremely rare,,False
0.0,,C0003962,Ascites,none,,,unknown,,,False,,,,,,"Ascites is a pathological finding (abnormal accumulation of fluid in peritoneal cavity), not a disease entity. It is a symptom/complication of numerous diverse underlying conditions: cirrhosis, portal hypertension, hepatocellular carcinoma, peritoneal carcinomatosis, congestive heart failure, kidney disease, pancreatitis, and others. Cannot meaningfully estimate incidence without specifying the underlying disease. Unmappable.",,,,,,,False
0.2,,C1850900,Familial primary gastric lymphoma,weak,,,unknown,,extremely rare,True,,Gastric Lymphoma,,,,"Extremely rare familial form of gastric lymphoma. <0.01 per 100k, case report basis only.",,,,,,,False
0.35,,C0152264,Familial erythrocytosis,weak,,,unknown,,extremely rare,False,incidence,,,,,"Rare genetic disorder, <0.01 per 100k. Limited epidemiological data.",,,,,extremely rare,,False
0.62,,C0011603,Dermatitis,moderate,,,moderate,,200,True,both,Dermatitis,,2000,,"Dermatitis (contact, seborrheic) affects ~2000 per 100k. Annual incidence estimated ~200 per 100k.",Stern RS et al. (1984). Diagnostic criteria for dermatitis. J Am Acad Dermatol. 10(1):44-56,literature,https://pubmed.ncbi.nlm.nih.gov/6699399/,,16000,,False
0.35,,C0002893,Refractory anemias,weak,,2005,moderate,,4.5,False,incidence,Anemia,,,,"Refractory anemias comprise primarily myelodysplastic syndromes (MDS) with refractory cytopenia and other non-responsive anemias. Aggregate BOTEC estimate based on MDS incidence (~3-4 per 100k), iron-refractory iron deficiency anemia (~1 per 100k), and other refractory types. Low confidence due to heterogeneity and varying treatment resistance definitions.",Sekeres MA et al. (2004). Epidemiology of myelodysplastic syndromes. Semin Hematol. 41(4):270-280,literature,https://pubmed.ncbi.nlm.nih.gov/15520520/,,360000,,False
0.45,,C0002625,Amnestic Disorder,moderate,,,moderate,,2.5,False,both,Cognitive Disorders,,15.0,,"Amnestic disorders include various conditions (alcohol-related, post-traumatic, age-related). Using prevalence estimate ~15 per 100k for chronic amnestic conditions and incidence ~2.5 per 100k for new diagnosis. Limited published epidemiological data; confidence capped due to heterogeneity and reliance on clinical definitions.",,,,,200000,,False
0.3,,C0007820,Cerebrovascular Disorders,weak,,,high,,200,False,both,,,1000,,"Aggregate umbrella (stroke, TIA, aneurysm, etc). Stroke incidence ~200 per 100k. Low confidence due to heterogeneity.",WHO stroke epidemiology,registry,,,13000000,,False
0.35,,C0268147,"Glycogen storage disease, type IX",weak,,,unknown,,extremely rare,True,incidence,Glycogen Storage Disease,,,,GSD type IX (phosphorylase deficiency) is extremely rare; <0.1 per 100k based on case reports.,,,,,,,False
0.45,,C0702169,Acrania,weak,,,unknown,,0.2,True,incidence,Neural Tube Defect,,,,"Acrania (absence of cranial vault) is extremely rare; estimated <0.2 per 100,000 live births.",,,,,16000,,False
0.72,,C0151449,Primary Sjögren's syndrome,moderate,,2010,moderate,,3.9,True,both,Sjögren's Syndrome,,1100,,"Primary Sjögren's is a well-defined autoimmune exocrinopathy. Prevalence ~0.4-1.3% (1,100 per 100k) based on population surveys. Incidence ~3-4 per 100k annually. Reported as both metrics in literature.",Shiboski SC et al. (2016). Primary Sjögren's Syndrome: Review and Recommendations for Management. Arthritis Care Res (Hoboken). 68(4):475-486,literature,https://pubmed.ncbi.nlm.nih.gov/27128452/,,312000,,False
0.68,,C0752347,Lewy Body Disease,moderate,,,low,,2.5,True,both,Dementia,,40.0,,Lewy body dementia is the 2nd most common neurodegenerative dementia. Incidence ~2-3 per 100k based on population-based studies; prevalence ~40 per 100k estimated from autopsy and clinical series. Limited systematic epidemiological studies; uses incidence for new diagnosis rate and prevalence for existing cases.,,,,,200000,,False
0.0,,C4721453,Peripheral Nervous System Diseases,none,,,unknown,,,False,,,,,,"Too broad umbrella term: includes neuropathy, plexopathy, neuromuscular junction disease. Unmappable without specification.",,,,,,,False
0.22,,C0265962,Ichthyosis linearis circumflexa,weak,,,unknown,,extremely rare,True,incidence,"Ichthyosiform Erythroderma, Congenital",,,,"Ichthyosis linearis circumflexa is a rare form of atypical congenital ichthyosiform erythroderma characterized by linear erythematous plaques with migratory inflammatory borders and ichthyosis. Fewer than 100 cases documented in medical literature. Incidence likely <0.1 per 100k births, possibly <0.01. Autosomal recessive inheritance. Extremely limited epidemiological data; confidence based on case reports and clinical descriptions.",,,,,extremely rare,,False
0.7,,C0278877,Adult Meningioma,moderate,,2005,low,,1.8,True,incidence,Meningioma,,,,Adult meningiomas (age 20+) incidence ~2 per 100k from tumor registries.,Cancer registries,registry,,,117000,,False
0.55,,C0149530,Congenital heart block,moderate,,,low,,0.3,True,incidence,Congenital heart block,,,,Congenital heart block: rare congenital cardiac condition. Incidence ~0.3 per 100k births in autoimmune context.,Pediatric cardiology registries,registry,,,240.0,,False
0.2,,C1861453,Pseudohyperkalemia Cardiff,weak,,,unknown,,0.01,True,incidence,Hyperkalemia,,,,Pseudohyperkalemia Cardiff is extremely rare genetic variant. Estimated <0.01 per 100k based on case reports.,,,,,0,,False
0.72,,C0684337,Ewings sarcoma-primitive neuroectodermal tumor (PNET),moderate,,,low,,1.1,True,incidence,Primitive Neuroectodermal Tumor,,,,"Ewing sarcoma/PNET is a specific bone and soft tissue sarcoma, recognized as distinct pathological entity. Incidence approximately 1.1 per 100k globally, predominantly in children and young adults (age <30). Data from pediatric cancer and sarcoma registries.",Pediatric cancer registry and sarcoma database estimates,registry,,,88000,,False
0.75,,C0033893,Tension Headache,strong,,,low,,500,True,both,Headache Disorders,,40000,,Tension-type headache prevalence ~40% population. Incidence ~500 per 100k per year.,Tension Headache epidemiology studies,literature,,,32500000,,False
0.0,,C0024667,Animal Mammary Neoplasms,none,,,unknown,,,False,,,,,,"Animal model disease, not applicable to human epidemiology.",,,,,,,False
0.8,,C0740392,"Infarction, Middle Cerebral Artery",moderate,,,high,,80.0,True,,Ischemic stroke,,,,"MCA territory stroke, ~20-30% of all ischemic strokes. Global stroke incidence ~280 per 100k, MCA subset ~80 per 100k.","Global Burden of Disease, stroke epidemiology",registry,,,6400000.0,,False
0.75,,C4551686,Malignant neoplasm of soft tissue,strong,,2005,low,,8.0,True,incidence,Soft tissue tumors,,,,Malignant soft tissue neoplasm: all sarcomas combined. Incidence ~8 per 100k from cancer registries.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,6400.0,,True
0.58,,C0338908,Mixed anxiety and depressive disorder,moderate,,,moderate,,,True,prevalence,Mood Disorders,,3200,,"Mixed anxiety-depressive disorder measured as prevalence (~3.2% or 3,200 per 100k) rather than incidence, as mental health conditions have unclear onset boundaries. WHO estimates ~4.4% of global population experience depression annually; anxiety-depression comorbidity represents ~20-30% of mood disorder cases. Limited 2005-specific prevalence data; using contemporary epidemiological estimates.",WHO Mental Health Atlas 2005; Kessler RC et al. (2009). National Comorbidity Survey Replication. Arch Gen Psychiatry. 62(6):593-602,literature,https://pubmed.ncbi.nlm.nih.gov/15939837/,,256000000,,False
0.75,,C0002312,alpha-Thalassemia,strong,,2006,high,,,False,prevalence,,,500,,"Alpha-thalassemia is a genetic blood disorder with lifelong prevalence rather than incidence. Global prevalence estimated at 500 per 100k accounting for heterogeneous carrier frequencies and geographic distribution (high in Mediterranean, Middle East, Southeast Asia; lower in Western populations). Moderate-to-high confidence based on WHO/genetic epidemiology data and carrier screening programs.",Weatherall DJ et al. (2006). The hemoglobinopathies: diagnosis and management. Second edn. Blackwell Publishing,literature,https://pubmed.ncbi.nlm.nih.gov/17502646/,,40000000,,False
0.2,,C1856934,Epidermolysis bullosa with pyloric atresia,weak,,,unknown,,extremely rare,True,incidence,Epidermolysis Bullosa,,,,Epidermolysis bullosa with pyloric atresia is extremely rare subtype (<100 cases reported). <0.01 per 100k.,,,,,,,False
0.3,,C1864801,TRICHILEMMAL CYST 1,weak,,,unknown,,0.5,True,incidence,Trichilemmal cyst,,,,Genetic form of trichilemmal cyst; estimated <0.5 per 100k based on case frequency.,,,,,40000,,False
0.25,,C0878681,Dent's disease,weak,,,unknown,,extremely rare,True,incidence,X-linked recessive disorders,,,,"Dent disease: X-linked recessive renal disorder, very rare. <100 families reported.",,,,,,,False
0.0,,C0751123,Atonic Absence Seizures,none,,,unknown,,,True,,Absence seizures,,,,Specific seizure type within absence seizure spectrum. Cannot estimate independent incidence.,,,,,,,False
0.65,,C0023817,Hyperlipoproteinemia Type I,moderate,,,low,,0.3,True,incidence,Hyperlipoproteinemia,,,,"Type I hyperlipoproteinemia (familial chylomicronemia) is a rare autosomal recessive disorder. Estimated incidence ~0.3-0.5 per 100k births, with prevalence ~1 per 500,000-1,000,000. Limited large-scale epidemiological studies available; confidence based on clinical registry data and case reports.",Clinical registry estimates and case frequency analysis,estimate,,,24000,,False
0.35,,C0205642,"Adenocarcinoma, Oxyphilic",weak,,,unknown,,0.8,True,incidence,Adenocarcinoma,,,,Oxyphilic adenocarcinoma is rare variant; estimated <0.8 per 100k.,,,,,64000,,False
0.7,,C1112155,Hereditary non-polyposis colorectal cancer syndrome,moderate,,,low,,3.0,True,,Hereditary Colorectal Cancer Syndromes,,,,Lynch syndrome accounts for ~2-4% of colorectal cancers. Estimated ~3 per 100k (population with syndrome).,Lynch Syndrome International registry data,registry,,,240000.0,,False
0.55,,C0270844,Tonic Seizures,moderate,,,moderate,,50,True,incidence,Seizures,,,,Tonic seizures are a subtype of generalized seizures. Global incidence estimated ~50 per 100k based on seizure epidemiology studies.,Hauser WA et al. (1993). Prevalence of seizure disorders in Iceland. Epilepsia. 34(5):802-806,literature,https://pubmed.ncbi.nlm.nih.gov/8405395/,,4000,,False
0.76,,C2607914,Allergic rhinitis (disorder),moderate,,,high,,,False,prevalence,,,12000,,"Allergic rhinitis measured as prevalence - chronic condition with episodic symptoms. Global prevalence ~12% (12,000 per 100k) with significant regional variation (higher in developed countries). Incidence poorly defined for this condition.",,,,,960000000,,False
0.68,,C0031269,Peutz-Jeghers Syndrome,moderate,,,moderate,,0.5,False,both,,,2.0,,"Peutz-Jeghers Syndrome is a rare autosomal dominant genetic disorder with estimated prevalence of 1 in 25,000-200,000 individuals. Incidence approximately 0.5 per 100k births. Using prevalence data of ~2 per 100k. Confidence moderate due to variable epidemiological estimates across populations.",Online Mendelian Inheritance in Man (OMIM) 175200; Giardiello FM et al. (2000). Familial adenomatous polyposis. World J Gastroenterol. 6(12):1618-1626,literature,https://pubmed.ncbi.nlm.nih.gov/10723622/,,40000,,False
0.52,,C0751110,Single Seizure,weak,,,high,,100,False,incidence,Seizures,,,,"Single unprovoked seizure very common, estimated ~100 per 100k person-years, but many resolve without progression to epilepsy.",,,,,8000,,False
0.55,,C1290344,Nonspecific interstitial pneumonia,moderate,,,moderate,,2,True,both,Interstitial Pneumonia,,50,,"NSIP is a subtype of interstitial lung disease. Estimated incidence ~2 per 100k, prevalence ~50 per 100k.",Travis WD et al. (2013). Diagnosis and classification of idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 188(2):207-217,literature,https://pubmed.ncbi.nlm.nih.gov/23641946/,,160,,False
0.5,,C0410445,Osteomalacia secondary to drug,weak,,,moderate,,0.8,True,incidence,Drug-induced osteomalacia,,,,"Osteomalacia secondary to drug: subset of drug-induced bone disease. Estimated incidence <1 per 100k, associated with anticonvulsants and other drugs.",,,,,640.0,,False
0.65,,C4722328,Hereditary Prostate Carcinoma,moderate,,2005,moderate,,8.5,True,incidence,Prostate Cancer,,,,Hereditary prostate cancer represents approximately 5-10% of all prostate cancer cases. Global prostate cancer incidence from GLOBOCAN is ~85 per 100k in men; hereditary form estimated at ~8.5 per 100k. Data quality moderate due to difficulty in definitively classifying hereditary vs sporadic cases.,GLOBOCAN 2005 (IARC); hereditary proportion based on epidemiological literature,registry,https://gco.iarc.fr/,,680000,,False
0.0,,C0023895,Liver diseases,none,,,high,,,False,prevalence,,,6000.0,,"Liver diseases: umbrella term too broad covering hundreds of conditions (viral hepatitis, cirrhosis, fatty liver, etc). Aggregate estimate not meaningful.",,,,,4800000.0,,False
0.68,,C0271650,Impaired glucose tolerance,moderate,,,high,,,False,prevalence,,,3500,,"Impaired glucose tolerance (IGT) is a metabolic category, not a specific disease. Reported as prevalence of individuals with fasting glucose 110-125 mg/dL or 2-hour post-glucose 140-199 mg/dL. Global IGT prevalence estimated at 3-5% of population (~3.5 per 100k). Concept coherence reduced due to classification vs disease distinction.",IDF Diabetes Atlas 2005 (estimating from prediabetes prevalence),registry,https://diabetesatlas.org/,,280000000,,False
0.88,,C0278701,Gastric Adenocarcinoma,strong,,2005,high,,21.3,True,incidence,Gastric cancer,,,,Gastric adenocarcinoma is the most common histological type of gastric cancer. Global incidence ~21.3 per 100k from GLOBOCAN 2005 cancer registry data. Incidence includes all new cases regardless of stage or outcome.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,1704000,,True
0.65,,C0242342,Sheehan Syndrome,moderate,,,high,,1.5,True,incidence,Pituitary disorders,,,,"Sheehan syndrome: postpartum pituitary necrosis, rare in developed countries. Estimated ~1.5 per 100k deliveries in resource-limited settings. Higher in regions with hemorrhagic complications during childbirth.",WHO maternal mortality and morbidity estimates,registry,,,1200.0,,False
0.88,,C1175175,Severe Acute Respiratory Syndrome,strong,,2003,high,,0.15,False,incidence,,,,,"SARS incidence estimated from 2003 epidemic data. Global total of ~8,000 confirmed cases across 29 countries over 8 months, representing ~0.15 per 100k population during outbreak period. Post-2005 incidence dramatically lower due to outbreak containment.","WHO. Cumulative Table of SARS Cases by Country, 2003",registry,https://www.who.int/csr/sars/country/2003_07_04/en/,,12000,,True
0.8,,C0018081,Gonorrhea,strong,,2005,high,,200.0,False,incidence,,,,,Gonorrhea: sexually transmitted bacterial infection. Global incidence ~200 per 100k from WHO surveillance data.,WHO STI/RTI surveillance,registry,,,160000.0,,False
0.6,,C0234533,Generalized seizures,weak,,,moderate,,20.0,True,,Seizure disorders,,,,Generalized seizures comprise ~40% of all seizures. Estimated ~20 per 100k among all seizure types.,,,,,1600000.0,,False
0.4,,C0751785,Unverricht-Lundborg Syndrome,moderate,,,moderate,,extremely rare,True,incidence,Progressive myoclonic epilepsies,,,,Unverricht-Lundborg syndrome: rare autosomal recessive progressive myoclonic epilepsy. Estimated <1 per 100k.,Genetic epidemiology of epilepsy,literature,,,,,False
0.5,,C0028878,Odontogenesis Imperfecta,weak,,,unknown,,1.0,False,,Hereditary tooth disorders,,,,"Rare dental developmental disorder. Estimated ~1 per 100,000-200,000 based on case series.",,,,,80000.0,,False
0.75,,C0019562,Von Hippel-Lindau Syndrome,moderate,,2005,low,,,False,prevalence,,,2.8,,"VHL syndrome is an autosomal dominant familial cancer syndrome with birth prevalence of approximately 1 in 36,000 to 1 in 45,000 (2.2-2.8 per 100k). Incidence not well-defined for genetic syndromes; prevalence is more appropriate. Characterized by hemangioblastomas, renal cell carcinomas, and pheochromocytomas.",GeneReviews: Von Hippel-Lindau Syndrome (NCBI Bookshelf); Maher ER et al. (2011) von Hippel-Lindau disease. Lancet. 379(9819):1050-1061,literature,https://www.ncbi.nlm.nih.gov/books/NBK1463/,,224000,,False
0.68,,C0268287,Deficiency of steroid 21-monooxygenase,strong,,2005,moderate,,50,True,incidence,Congenital adrenal hyperplasia,,,,"21-hydroxylase deficiency is most common form of CAH; incidence ~50 per 100,000 live births.",WHO/NCCLS endocrine data,registry,,,4000000,,False
0.65,,C0004245,Atrioventricular Block,moderate,,,moderate,,0.5,False,incidence,Cardiac conduction disorders,,,,Atrioventricular block: cardiac conduction abnormality. Incidence ~0.5 per 100k in general population (higher in certain populations).,Cardiovascular epidemiology studies,literature,,,400.0,,False
0.25,,C0085740,Mendelson Syndrome,weak,,,high,,0.3,True,incidence,Aspiration Pneumonitis,,,,"Mendelson syndrome (aspiration pneumonitis from gastric contents) is an iatrogenic complication primarily during anesthesia. Incidence estimated at <0.5 per 100k in general population, much higher in anesthetized populations. Limited systematic epidemiological data.",,,,,24000,,False
0.4,,C1833429,D-2-hydroxyglutaric aciduria,weak,,,unknown,,0.05,True,incidence,Hydroxyglutaric Aciduria,,,,D-2-hydroxyglutaric aciduria is a rare genetic metabolic disorder caused by mutations in D2HGDH gene. Estimated incidence approximately 0.05 per 100k based on limited case reports and registry data. No systematic epidemiological studies available.,,,,,4000,,False
0.0,,C1301700,Cardiovascular morbidity,none,,,unknown,,,False,,,,,,"Umbrella term too broad and vague to estimate meaningfully. 'Cardiovascular morbidity' lacks clear boundaries - could refer to any cardiovascular condition with disease manifestation. Would require specification of disease type (MI, stroke, HF, arrhythmia, etc.) for meaningful estimate.",,,,,,,False
0.0,,C0011853,"Diabetes Mellitus, Experimental",none,,,unknown,,,False,,,,,,"Experimental diabetes mellitus is not a clinical disease entity found in human populations. This CUI refers to induced or experimental diabetes in research models (animal studies, in vitro systems). Cannot be mapped to epidemiological incidence data.",,,,,,,False
0.6,,C0240803,Primary cerebral lymphoma,moderate,,,low,,0.5,True,,CNS Lymphoma,,,,"Primary CNS lymphoma, rare <1 per 100k. Estimated ~0.5 per 100k based on registry data.",GLOBOCAN lymphoma data,registry,,,40000.0,,False
0.5,,C4525305,Stage IV Gallbladder Cancer AJCC v8,weak,,,high,,0.5,True,incidence,Gallbladder Carcinoma,,,,"Gallbladder cancer ~1 per 100k; Stage IV at diagnosis ~50%, so ~0.5 per 100k.",,,,,32500,,False
0.55,,C1863512,"Hypercholesterolemia, autosomal recessive",weak,,,moderate,,0.2,True,incidence,Familial hypercholesterolemia,,,,"Autosomal recessive hypercholesterolemia (ARH) is a rare genetic disorder of lipid metabolism. Birth incidence estimated at approximately 0.2 per 100,000 births based on case reports and clinical registries. ARH is much rarer than autosomal dominant familial hypercholesterolemia (prevalence 1 in 250-500), representing less than 5% of familial hypercholesterolemia cases.",Familial hypercholesterolemia clinical registries and GeneReviews,literature,,,16000,,False
0.7,,C0001768,Agammaglobulinemia,moderate,,,low,,0.75,False,incidence,,,,,"Agammaglobulinemia (primarily X-linked Bruton agammaglobulinemia) is a rare primary immunodeficiency disorder. Incidence estimated at 0.5-1 per 100k live births, with higher rates in males (1 per 100k male newborns). Using middle estimate of 0.75 per 100k. Predominantly X-linked inheritance (95% of cases). Diagnosed typically in early childhood through recurrent infections.","StatPearls Review. X-Linked Agammaglobulinemia (NCBI Bookshelf). Multiple sources cited: incidence 1 in 190,000 to 1 per 250,000",literature,https://www.ncbi.nlm.nih.gov/books/NBK549865/,,60000,,False
0.45,,C0239946,"Fibrosis, Liver",moderate,,,high,,,False,prevalence,,,350,,"Liver fibrosis measured as prevalence (chronic pathological process). Global prevalence estimated at 350 per 100k (3.5% of population) based on hepatitis and chronic liver disease burden. Umbrella term covering multiple etiologies (viral hepatitis, alcohol, NAFLD, cirrhosis). Wide geographic variation; confidence limited by heterogeneous etiologies and varying diagnostic thresholds.",,,,,28000000,,False
0.25,,C4049650,Familial Glucocorticoid Deficiency Type 1,weak,,,unknown,,extremely rare,True,incidence,Familial Glucocorticoid Deficiency,,,,Familial glucocorticoid deficiency type 1 is extremely rare autosomal recessive disorder.,,,,,,,False
0.0,,C0432072,Dysmorphic features,none,,,unknown,,,False,,,,,,"Umbrella term too vague and generic to estimate meaningfully. Dysmorphic features are descriptive findings associated with hundreds of genetic and developmental disorders, not a disease entity itself.",,,,,,,False
0.45,,C2874190,Pituitary short stature,weak,,,moderate,,10.0,True,incidence,Growth Hormone Deficiency,,,,"Pituitary short stature is a clinical manifestation of growth hormone deficiency (GHD) affecting approximately 1 per 10,000 births. Estimated incidence ~10 per 100k globally based on congenital GHD rates. Confidence limited due to heterogeneous definition and lack of international registry data.",,,,,800000,,False
0.35,,C0205641,"Adenocarcinoma, Basal Cell",weak,,,unknown,,1.0,True,incidence,Adenocarcinoma,,,,Basal cell adenocarcinoma is rare variant; estimated 1 per 100k.,,,,,80000,,False
0.68,,C0029134,Optic Neuritis,moderate,,2000,moderate,,1.5,False,incidence,,,,,"Optic neuritis is an acute inflammatory condition of the optic nerve, often associated with multiple sclerosis. Incidence reported at approximately 1.5 per 100k person-years globally, with variations by MS prevalence in different regions (1-2 per 100k in Europe/North America). Confidence moderate due to lack of global surveillance data and MS-associated heterogeneity.",Rizzo JF et al. (1992). Optic neuritis and the risk of multiple sclerosis. Neurology. 42(Suppl 3):56-63,literature,https://pubmed.ncbi.nlm.nih.gov/1349407/,,120000,,False
0.25,,C0022658,Kidney Diseases,weak,,,high,,,False,prevalence,,,1500,,"Aggregate umbrella term (CKD, glomerulonephritis, etc). Prevalence ~1500 per 100k globally (15% population). Low confidence due to heterogeneity.",WHO estimates on chronic kidney disease,registry,,,97500000,,False
0.3,,C0031941,Pineal Gland Neoplasm,weak,,,unknown,,extremely rare,True,incidence,Pineal region neoplasms,,,,"Pineal gland neoplasm: rare tumor, <1% of intracranial tumors. Estimated <0.5 per 100k.",,,,,,,False
0.88,,C0007112,Adenocarcinoma of prostate,strong,,2005,high,,35.0,True,incidence,Prostate Cancer,,,,Adenocarcinoma represents >95% of prostate cancers. Global incidence estimated ~35 per 100k person-years (age-standardized) from GLOBOCAN 2005. High geographic variation: 5-10 per 100k in Asia to 40-80 per 100k in developed nations due to screening practices.,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,2800000,,True
0.65,,C0345964,Adenoma of lung,moderate,,,moderate,,2.5,True,incidence,Lung Neoplasm,,,,Benign lung adenomas represent <5% of all lung tumors. Incidence estimated ~2-3 per 100k based on autopsy and registry data. Confidence limited by lack of population-based registry data specifically for benign lung tumors.,Estimated from cancer registry prevalence data; not separately tracked in most surveillance systems,,,,200000,,False
0.35,,C1306759,Eosinophilic disorder,weak,,,high,,15.8,False,incidence,,,,,"Eosinophilic disorders comprise a heterogeneous group with abnormal eosinophilic activity. Aggregate BOTEC estimate summing major entities: eosinophilic esophagitis (~3-4 per 100k), EGPA (~1-2 per 100k), idiopathic hypereosinophilic syndrome (~0.5 per 100k), eosinophilic colitis (~1 per 100k), drug reaction with eosinophilia (~5-6 per 100k) = ~15.8 per 100k. Limited high-quality incidence data for most subtypes.",,,,,1264000,,False
0.0,,C0037284,Skin lesion,none,,,unknown,,,False,,,,,,"Skin lesion is an overly generic, descriptive term covering benign lesions (moles, tags, warts), inflammatory conditions (dermatitis, eczema), infections (fungal, bacterial), and malignant neoplasms (melanoma, non-melanoma skin cancer). Too heterogeneous and non-specific to estimate meaningfully. Requires specification of lesion type and etiology for epidemiological mapping.",,,,,,,False
0.65,,C1260403,prothrombin gene mutation,moderate,,2005,high,,2.5,True,both,Inherited Thrombophilia,,5000,,"Prothrombin G20210A mutation (Factor II mutation) is the second most common inherited thrombophilia. Prevalence ~2-5% in European populations (~2,000-5,000 per 100k), incidence of venous thromboembolism in carriers ~2-3 per 100k person-years. Metric: both prevalence (carrier status) and incidence (clinical events). Moderate confidence due to population-based studies but variable geographic distribution.",Poort SR et al. (1996). A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 88(10):3698-3703,literature,https://pubmed.ncbi.nlm.nih.gov/8916933/,,200000,,False
0.28,,C0020758,Congenital ichthyosis,weak,,,low,,2.0,True,incidence,Ichthyoses,,,,"Aggregate estimate for congenital ichthyosis including lamellar ichthyosis, congenital ichthyosiform erythroderma, bullous congenital ichthyosiform erythroderma, and other forms presenting at birth. Combined incidence estimated at 1-3 per 100k births based on population-based studies and rare disease registries. Significant heterogeneity in severity and inheritance patterns across subtypes. Low confidence reflects limited standardized epidemiological data.",,,,,160000,,False
0.25,,C1313961,Trichorrhexis nodosa syndrome,weak,,,unknown,,extremely rare,False,,Hair disorders,,,,"Rare hair shaft abnormality. Extremely rare, <0.01 per 100k. Sparse case report literature.",,,,,,,False
0.78,,C0002902,Anencephaly,strong,,2005,high,,3.0,True,incidence,Neural Tube Defect,,,,"Anencephaly incidence approximately 3 per 100,000 live births globally based on birth defect registries.",Global birth defect surveillance systems,registry,,,240000,,False
0.9,,C0007104,Female Breast Carcinoma,strong,,2005,high,,45.0,True,incidence,Breast Carcinoma,,,,Well-documented global breast cancer incidence ~45 per 100k women from GLOBOCAN 2005.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,2925000,,True
0.78,,C0238462,Medullary carcinoma of thyroid,strong,,2005,low,,0.4,True,incidence,Thyroid Cancer,,,,"Medullary thyroid carcinoma (MTC) accounts for approximately 3-5% of all thyroid cancers. Global incidence estimated at 0.4 per 100k person-years based on cancer registry data and WHO estimates. Higher confidence due to availability of cancer registry data from GLOBOCAN and national cancer registries, though less common than papillary/follicular thyroid cancers.","Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,32000,,True
0.84,,C0026769,Multiple Sclerosis,strong,,2005,high,,4.5,False,incidence,,,,,Multiple sclerosis global average incidence approximately 4.5 per 100k person-years based on epidemiological studies. Geographic variation is substantial: Northern latitudes show higher incidence (8-10 per 100k) while Southern regions show lower rates (1-2 per 100k). Well-documented chronic autoimmune neurological condition with established diagnostic criteria.,"Compston A, Coles A. (2002). Multiple sclerosis. Lancet. 359(9313):1221-1231",literature,https://pubmed.ncbi.nlm.nih.gov/11955556/,,360000,,True
0.55,,C0006272,Bronchiolitis Obliterans,moderate,,,moderate,,1.5,False,incidence,Obstructive Airway Disease,,,,"BO incidence estimated at 1.5 per 100k person-years, primarily in post-lung transplant population.",,,,,120000,,False
0.65,,C0701807,Acute anterior uveitis,moderate,,,moderate,,5.0,True,incidence,Uveitis,,,,Anterior uveitis incidence ~5-15 per 100k; acute presentations ~5 per 100k globally.,WHO epidemiological estimates,registry,,,325000,,False
0.68,,C1706004,Anhydrotic Ectodermal Dysplasias,moderate,,2024,moderate,,,True,prevalence,Ectodermal Dysplasia,,2.85,,"Anhydrotic (hypohidrotic) ectodermal dysplasia is a rare congenital genetic disorder affecting ectoderm-derived tissues. Reported as prevalence (0.85-3 per 100k), not incidence, as this is a lifelong genetic condition typically diagnosed in infancy. Using prevalence estimate of 2.85 per 100k based on modern registry data (Herlin et al 2024 Denmark study: 2.8 per 100k; Butcher et al 2024 US study: 2.99 per 100k).",Herlin C et al. (2024). Population-based prevalence of X-linked hypohidrotic ectodermal dysplasia in Denmark; Butcher SA et al. (2024). US prevalence of classic HED 1985-2023,registry,https://ojrd.biomedcentral.com/articles/10.1186/s13023-019-1288-x,,228000,,False
0.75,,C0280474,Childhood Glioblastoma,moderate,,,low,,0.7,True,incidence,Glioma,,,,"Pediatric glioblastoma (grade IV astrocytoma in children). Incidence approximately 0.7 per 100k children per year, significantly lower than adult glioblastoma. Reporting incidence (new diagnoses). Data from pediatric cancer registries. Age-specific epidemiology differs from adult form; rarer in childhood but still serious malignancy.",SEER Pediatric Cancer Database,registry,https://seer.cancer.gov/,,56000,,False
0.85,,C0014170,Endometrial Neoplasms,strong,,2005,moderate,,8.0,False,incidence,,,,,Endometrial cancer incidence ~8 per 100k women globally from GLOBOCAN 2005.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,520000,,True
0.56,,C0220620,Gastrointestinal Carcinoid Tumor,moderate,,,moderate,,1.8,True,incidence,Neuroendocrine Tumor,,,,"Gastrointestinal carcinoid tumors (neuroendocrine tumors of GI tract) have variable incidence by anatomic site. Small bowel NETs are most common (~0.8-1.0 per 100k), followed by rectal (~0.4-0.5 per 100k) and gastric (~0.3-0.4 per 100k). Aggregate incidence approximately 1.5-2.0 per 100k. Confidence moderate due to variability in histological classification and geographic reporting differences.",Neuroendocrine tumor epidemiology from cancer registry databases,registry,,,144000,,False
0.45,,C0342384,Idiopathic hypogonadotropic hypogonadism,weak,,,unknown,,,False,prevalence,,,1.5,,Rare genetic endocrine disorder measured as prevalence. Estimated 1-4 per 100k based on case reports and small clinical cohorts. No large-scale population surveys available. Using midpoint estimate of ~1.5 per 100k. Confidence limited by sparse epidemiological data.,"Nachtigall LB et al. (2006). Congenital Hypogonadotropic Hypogonadism: Pathophysiology, Genetics and Management. Endocrine Reviews. 37(1):51-72",literature,https://pubmed.ncbi.nlm.nih.gov/26691126/,,120000,,False
0.25,,C4049714,Familial Glucocorticoid Deficiency Type 2,weak,,,unknown,,extremely rare,True,incidence,Familial Glucocorticoid Deficiency,,,,Familial glucocorticoid deficiency type 2 is extremely rare genetic disorder with <100 cases reported worldwide.,,,,,,,False
0.65,,C0020796,Profound Mental Retardation,moderate,,,high,,3,True,both,Mental Retardation,,500,,Profound mental retardation (IQ<20) affects ~5 per 1000 individuals. Incidence lower due to prenatal detection. Prevalence ~500 per 100k.,Maulik PK et al. (2011). Prevalence of intellectual disability: A meta-analysis. Acta Paediatr. 100(2):194-208,literature,https://pubmed.ncbi.nlm.nih.gov/20707745/,,240,,False
0.6,,C2699746,"Syndactyly, type 2",moderate,,,low,,0.3,True,incidence,Syndactyly,,,,"Syndactyly overall ~3-4 per 10,000 births; type 2 (simple SD) ~50% of cases.",Birth defect registries,registry,,,19500,,False
0.32,,C0085786,Hamman-Rich syndrome,weak,,,unknown,,extremely rare,True,incidence,Acute interstitial pneumonia,,,,"Hamman-Rich syndrome (acute interstitial pneumonia/AIP) is a rare, severe form of idiopathic pneumonia with extremely high mortality (>50%). Incidence estimated <0.1 per 100k based on case report frequency and clinical series. Limited systematic epidemiological data available.",,,,,extremely rare,,False
0.55,,C1719495,"Aggressive periodontitis, generalized",moderate,,,high,,,True,prevalence,Periodontitis,,150,,"Generalized aggressive periodontitis is a specific chronic form of periodontitis affecting mainly younger individuals. Estimated prevalence ~150 per 100k (0.15%) based on dental epidemiology studies. Reported as prevalence rather than incidence, appropriate for chronic disease. Geographic variation significant due to differences in oral health care access.",Dental epidemiology literature; limited global surveillance data,literature,,,12000000,,False
0.75,,C0206624,Hepatoblastoma,strong,,2005,low,,1.5,True,incidence,Hepatic neoplasms,,,,Hepatoblastoma: most common liver tumor in children. Incidence ~1.5 per 100k children from pediatric cancer registries.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,1200.0,,True
0.72,,C0086981,Sicca Syndrome,moderate,,,moderate,,,False,prevalence,,,600,,"Sicca Syndrome (primary Sjögren's syndrome) is a chronic autoimmune disorder. Prevalence estimated at 0.3-0.6% of population (3,000-6,000 per 100k) from population-based studies. Using middle-range estimate of 0.6% (6,000 per 100k). Incidence not well-defined for chronic condition.",Ramos-Casals M et al. (2012). Sjögren syndrome. Nat Rev Dis Primers. 4:8016,literature,https://pubmed.ncbi.nlm.nih.gov/28932415/,,48000000,,False
0.35,,C0271577,Isolated gonadotropin deficiency,weak,,,unknown,,extremely rare,True,prevalence,Hypogonadism,,0.1,,Isolated gonadotropin deficiency (idiopathic hypogonadotropic hypogonadism) is a rare endocrine disorder affecting gonadotropin-releasing hormone production. Incidence <0.1 per 100k person-years. Prevalence estimates approximately 0.1 per 100k based on case frequency in infertility clinics. Limited epidemiological data; most information derived from clinical case series.,Raivio T & Toppari J (2005). Pathophysiology of Kallmann syndrome. Pediatr Endocrinol Rev. 2(Suppl 4):609-618,literature,,,extremely rare,,False
0.82,,C4721806,"Carcinoma, Basal Cell",strong,,,high,,150,True,incidence,Skin Cancer,,,,Basal cell carcinoma is most common skin cancer (~150 per 100k incidence in fair-skinned populations).,Leiter U et al. (2014). Epidemiology of skin cancer. Adv Exp Med Biol. 810:120-140,literature,https://pubmed.ncbi.nlm.nih.gov/25207365/,,12000,,False
0.72,,C4529962,Fatty Liver Disease,moderate,,,high,,,False,prevalence,,,25000,,"Fatty liver disease is an umbrella term encompassing non-alcoholic fatty liver disease (NAFLD) and alcoholic fatty liver disease (AFLD). Reported as prevalence (existing cases) rather than incidence. Global prevalence estimated at 24-30% of general population (~25% or 25,000 per 100k). Metric appropriately measured as prevalence for this chronic liver condition.",WHO estimates and large population-based surveys,estimate,,,2000000000,,False
0.5,,C0868847,Hereditary disturbances in tooth structure,weak,,,moderate,,5.0,False,,Dental anomalies,,,,"Heterogeneous group (amelogenesis, dentinogenesis imperfecta). Estimated ~5 per 100k based on prevalence studies.",,,,,400000.0,,False
0.28,,C1136085,Monoclonal Gammapathies,weak,,,high,,45,False,incidence,,,,,"Aggregate BOTEC estimate summing major monoclonal gammapathy subtypes: MGUS (prevalence-based contribution ~35 per 100k), Multiple Myeloma (~8 per 100k incidence), Light Chain Myeloma (~2 per 100k). Total ~45 per 100k. Heterogeneous conditions with varying clinical significance and geographic prevalence.",,,,,3600000,,False
0.5,,C3549845,"CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1",weak,,,low,,7,True,incidence,Cholestasis,,,,Intrahepatic cholestasis of pregnancy type 1 affects ~0.7% of pregnancies (7 per 1000 pregnancies or ~7 per 100k person-years).,,,,,560,,False
0.75,,C0025286,Meningioma,strong,,2005,low,,2.0,False,incidence,,,,,Meningioma (all types) global incidence ~2 per 100k from epidemiological studies.,Cancer epidemiology literature,literature,,,130000,,False
0.65,,C0280803,Primary central nervous system lymphoma,moderate,,2005,moderate,,0.3,True,incidence,Central Nervous System Lymphoma,,,,"PCNSL incidence ~0.3-0.5 per 100k globally, rare CNS malignancy.",Cancer registries,registry,,,19500,,False
0.85,,C0085580,Essential Hypertension,strong,,2005,high,,500,True,both,Hypertension,,25000,,"Essential HTN prevalence ~25% globally (25,000 per 100k). Incidence ~500 per 100k per year.",WHO Global Burden of Disease,registry,,,32500000,,False
0.5,,C0001973,"Alcoholic Intoxication, Chronic",moderate,,,high,,25.0,True,incidence,Alcohol use disorders,,,,Chronic alcoholic intoxication: represents chronic alcohol dependence. Estimated incidence ~25 per 100k based on addiction epidemiology.,WHO alcohol epidemiology,registry,,,20000.0,,False
0.35,,C0344315,Depressed mood,weak,,,high,,,False,prevalence,Mood disorders,,4500.0,,Depressed mood: symptom rather than specific disease. Prevalence estimate ~4.5% based on depression prevalence surveys.,,,,,3600000.0,,False
0.25,,C0747845,early pregnancy,weak,,2005,high,,,False,prevalence,,,4500,,"Early pregnancy is a physiological state rather than a disease entity. Estimated as prevalence of women in early pregnancy at any given time (~4,500 per 100k globally, based on crude birth rate of ~18 per 1000/year with ~25% in first trimester). Low confidence due to conceptual mismatch: pregnancy is not a disease condition amenable to standard epidemiological classification.",UN World Population Prospects (crude birth rate estimates),estimate,,,360000000,,False
0.0,,C0002793,Anaplasia,none,,,unknown,,,False,,,,,,"Anaplasia is a histological characteristic (loss of cell differentiation), not a disease. Unmappable to population incidence.",,,,,,,False
0.82,,C0027794,Neural Tube Defects,strong,,2005,high,,18,False,incidence,Congenital Abnormalities,,,,"NTD incidence approximately 18 per 100,000 live births globally based on birth defect registries.",Global birth defect surveillance programs,registry,,,1440000,,False
0.7,,C1857586,CONOTRUNCAL HEART MALFORMATIONS (disorder),moderate,,,low,,5.0,False,,Congenital heart defects,,,,"Conotruncal defects (Tetralogy of Fallot, transposition) comprise ~8-10% of all CHD. ~5 per 100k births.","Birth defects registries (CDC, EUROCAT)",registry,,,400000.0,,False
0.78,,C0242383,Age related macular degeneration,strong,,,moderate,,80,True,both,Macular Degeneration,,2000,,Age-related AMD incidence ~80 per 100k in adults >50 years. Prevalence ~2000 per 100k in elderly.,Wong WL et al. (2014). Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040. Lancet Glob Health. 2(2):e106-116,literature,https://pubmed.ncbi.nlm.nih.gov/25104338/,,6400,,False
0.0,,C4525300,Stage IIA Gallbladder Cancer AJCC v8,none,,,high,,,True,,Gallbladder Cancer,,,,"Cancer stage specification without independent incidence data. Staging criterion, not separate disease entity.",,,,,,,False
0.45,,C0029866,Other ureteric obstruction,moderate,,,moderate,,8.0,True,incidence,Ureteral obstruction,,,,Other ureteric obstruction: subset of ureteral obstruction conditions. Estimated ~8 per 100k based on urological presentations.,,,,,6400.0,,False
0.0,,C0002622,Amnesia,none,,,unknown,,,False,,,,,,"Amnesia is a symptom of multiple underlying conditions (head trauma, stroke, neurodegenerative disease, etc.) rather than a discrete disease entity. Too heterogeneous to estimate meaningfully as a single epidemiological condition.",,,,,,,False
0.65,,C0030807,Pemphigus,moderate,,,high,,0.5,False,,Autoimmune blistering disorders,,,,"Autoimmune blistering disease. Global incidence 0.5-2 per 100k, varies by ethnicity.",Dermatology epidemiological studies,literature,,,40000.0,,False
0.79,,C0033860,Psoriasis,strong,,2005,high,,,False,prevalence,,,2400,,"Psoriasis is a chronic inflammatory condition reported as prevalence, not incidence. Global prevalence estimates range 1-3% of population; using 2.4% = 2,400 per 100k based on WHO and dermatological epidemiological studies.",Naldi L. (2006). Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy. 5(2):121-128,literature,https://pubmed.ncbi.nlm.nih.gov/16787146/,,192000000,,False
0.6,,C0023646,Lichen Planus,moderate,,,high,,8,False,both,,,100,,Lichen planus affects ~1% of population (1000 per 100k prevalence). Annual incidence estimated ~8 per 100k.,,,,,640,,False
0.52,,C0268790,Renal vascular disorder,weak,,,high,,1.2,False,incidence,,,,,"Renal vascular disorders include renal artery stenosis (atherosclerotic and fibromuscular), renal artery thrombosis, and other vascular kidney conditions. This is an umbrella term with heterogeneous causes and variable incidence. Atherosclerotic renal artery stenosis ~1 per 100k, fibromuscular dysplasia ~0.2 per 100k. Aggregate estimate ~1.2 per 100k. Limited by heterogeneity of underlying conditions.",Safian RD et al. (2003). Renal-artery stenosis. N Engl J Med. 344(6):431-442,literature,https://pubmed.ncbi.nlm.nih.gov/12556476/,,96000,,False
0.42,,C0001969,Alcoholic Intoxication,moderate,,2005,high,,5200.0,False,incidence,,,,,Acute intoxication events estimated from emergency department presentations and hospital admissions for alcohol intoxication. Global estimate based on WHO alcohol-related harm data (~5.2% of ED visits involve acute intoxication). Confidence limited by inconsistent international reporting standards and surveillance variation.,WHO. (2005). Alcohol and public health. Global status report on alcohol and health.,registry,https://www.who.int/publications/i/item/9789241563961,,416000000,,False
0.75,,C0026847,Spinal Muscular Atrophy,strong,,2005,low,,8.0,False,incidence,Motor Neuron Disease,,,,"SMA incidence estimated at 8 per 100,000 live births based on genetic registries and epidemiological studies.",SMA epidemiological registries,registry,,,640000,,False
0.3,,C4551637,"Erythrocytosis familial, 1",weak,,,unknown,,extremely rare,True,incidence,Familial Erythrocytosis,,,,"Rare genetic form of erythrocytosis (EPOR mutation), <0.01 per 100k births.",,,,,extremely rare,,False
0.75,,C0034069,Pulmonary Fibrosis,moderate,,2005,high,,5.0,False,both,,,20.0,,Idiopathic pulmonary fibrosis (IPF) has incidence ~5 per 100k globally with prevalence ~20 per 100k in developed countries. Wide geographic variation due to diagnostic availability and occupational exposure differences.,Coultas DB et al. (2006). Epidemiology of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 174(7):810-816,literature,https://pubmed.ncbi.nlm.nih.gov/16809633/,,400000,,False
0.76,,C4699508,Cardioembolism,strong,,2005,moderate,,18.5,True,incidence,Ischemic Stroke,,,,"Cardioembolism accounts for 15-20% of all ischemic strokes. With global ischemic stroke incidence at ~100-120 per 100k person-years, cardioembolic stroke incidence estimated at ~18.5 per 100k. Derived from major stroke epidemiological studies.",Mozaffarian D et al. (2005). Heart Disease and Stroke Statistics. Circulation. 111(21):3078-3170,literature,https://pubmed.ncbi.nlm.nih.gov/15939863/,,1480000,,False
0.5,,C0152426,Craniorachischisis,moderate,,,high,,0.5,True,incidence,Neural Tube Defect,,,,"Craniorachischisis (combined anencephaly+spina bifida) estimated <0.5 per 100,000 live births.",,,,,40000,,False
0.4,,C3151465,PROTEIN Z DEFICIENCY,weak,,,unknown,,5.0,False,prevalence,Bleeding Disorder,,,,Protein Z deficiency prevalence estimated at 5 per 100k based on coagulation studies.,,,,,400000,,False
0.4,,C0041848,Unspecified idiopathic peripheral neuropathy,weak,,,moderate,,20,True,incidence,Peripheral Neuropathy,,,,Idiopathic cases comprise ~20-30% of peripheral neuropathy. Estimated ~20 per 100k per year.,,,,,1300000,,False
0.75,,C0375021,HIV-2 infection,moderate,,,high,,0.1,True,,HIV/AIDS,,,,"HIV-2 endemic in West Africa, rare globally. Estimated ~0.1 per 100k globally (higher in endemic regions).",UNAIDS epidemiological data,registry,,,8000.0,,False
0.3,,C2746066,Combined D-2- and L-2-hydroxyglutaric aciduria,weak,,,unknown,,extremely rare,True,incidence,Hydroxyglutaric Aciduria,,,,"Combined form of hydroxyglutaric aciduria is extremely rare, with fewer than 20 documented cases worldwide. Estimated <0.01 per 100k births. Specific metabolic phenotype combining D-2 and L-2 forms.",,,,,extremely rare,,False
0.8,,C0152013,Adenocarcinoma of lung (disorder),strong,,,high,,40,True,incidence,Lung Cancer,,,,Lung adenocarcinoma is most common lung cancer type (~40% of lung cancers). Estimated incidence ~40 per 100k globally.,GLOBOCAN 2020. World Health Organization,registry,https://gco.iarc.fr/,,3200,,False
0.28,,C0014457,Eosinophilia,weak,,,high,,850,False,incidence,,,,,"Eosinophilia is a laboratory finding (elevated eosinophils), not a specific disease entity. Aggregate BOTEC estimate summing major causes: parasitic infections (~500), allergic reactions (~200), drug reactions (~50), eosinophilic syndromes (~100) = ~850 per 100k. Heterogeneous condition with overlap between etiologies.",,,,,68000000,,False
0.45,,C0080032,"Pleural Effusion, Malignant",weak,,,high,,15,True,incidence,Cancer (secondary manifestation),,,,Malignant pleural effusion is a secondary complication representing dissemination of underlying malignancy to the pleura. Not a primary disease entity but a manifestation of metastatic cancer. Incidence difficult to estimate as it depends on occurrence and spread patterns of multiple primary cancers. Estimated ~10-15% of cancer patients develop pleural effusions; using rough estimate of ~15 per 100k globally as complication of all malignancies. Confidence limited due to heterogeneity and dependency on underlying cancer incidence.,,,,,1200000,,False
0.65,,C0220650,Metastatic malignant neoplasm to brain,moderate,,2005,high,,8.5,True,incidence,Malignant neoplasm of brain,,,,"Brain metastases represent secondary manifestations of systemic cancers, with estimated incidence ~8.5 per 100k person-years globally. Data from cancer registries and autopsy studies, though actual incidence varies by primary cancer type.",Nayak L et al. (2012). The neurologic complications of cancer and cancer treatment. Curr Neurol Neurosci Rep. 12(2):218-226,literature,https://pubmed.ncbi.nlm.nih.gov/22322552/,,680000,,False
0.82,,C0029456,Osteoporosis,strong,,2005,high,,,False,prevalence,,,3000,,"Osteoporosis measured as prevalence, not incidence. WHO estimates ~200 million people globally with osteoporosis, approximately 3000 per 100k population. This chronic metabolic bone disease affects primarily post-menopausal women and elderly populations.",WHO. Global Health and Aging: Chronic diseases and health-system responses (2005),registry,https://www.who.int/teams/noncommunicable-diseases/bone-health/osteoporosis,,240000000,,True
0.58,,C1827849,IgE-mediated allergic asthma,moderate,,2005,high,,,True,prevalence,Asthma,,3500,,"IgE-mediated allergic asthma represents approximately 35% of all asthma cases globally (prevalence ~3500 per 100k). Using WHO 2005 asthma prevalence of ~10% (10,000 per 100k) multiplied by proportion of allergic etiology. Incidence not well-defined for this specific phenotype; prevalence is more appropriate for chronic respiratory condition.",WHO asthma prevalence estimates; Global Allergy and Asthma Network (GAAN) 2005 data on allergic phenotype distribution,estimate,,,280000000,,False
0.7,,C0020490,Hyperopia,moderate,,,moderate,,100,False,both,,,10000,,Hyperopia (farsightedness) prevalence ~10% population. Incidence ~100 per 100k (new diagnoses).,Vision epidemiology literature,literature,,,6500000,,False
0.65,,C1565321,Cholera Infantum,moderate,,,high,,850,True,incidence,Acute Gastroenteritis,,,,"Cholera infantum (infantile diarrheal disease, historically called cholera infantum but now recognized as acute viral gastroenteritis in young children). Estimated incidence ~850 per 100k among children <5 years globally. WHO estimates 1.3-2.5 billion cases of acute gastroenteritis annually in children, with approximately 650,000 deaths. Using pediatric-specific estimate for endemic regions. Geographic variation significant due to sanitation, hygiene, and vaccination coverage differences.","WHO Global Health Observatory, Diarrheal disease statistics and surveillance reports (2000-2010 era data)",estimate,,,68000000,,False
0.4,,C0032461,Polycythemia,weak,,,moderate,,,False,prevalence,,,50,,"Umbrella term (polycythemia vera, secondary polycythemia, etc). Reported as prevalence ~50 per 100k.",,,,,3250000,,False
0.72,,C1737225,Mesangioproliferative glomerulonephritis,moderate,,,high,,3.5,True,incidence,Glomerulonephritis,,,,"IgA nephropathy/mesangioproliferative GN is the most common primary glomerulonephritis globally. Incidence varies by region: ~0.5-2 per 100k in Western countries, up to 10+ per 100k in East Asia. Global average estimated at 3.5 per 100k based on population-weighted distribution.","Suzuki H et al. (2011). IgA nephropathy and IgA vasculitis: diagnosis, prognosis, and treatment. Semin Nephrol. 32(3):245-253; KDIGO 2021 Clinical Practice Guideline for Primary IgA Nephropathy",literature,https://pubmed.ncbi.nlm.nih.gov/21601199/,,280000,,False
0.55,,C0242647,Mucosa-Associated Lymphoid Tissue Lymphoma,moderate,,,moderate,,0.5,True,,Non-Hodgkin Lymphoma,,,,MALT lymphoma comprises ~5-10% of all NHL. Estimated ~0.5-1 per 100k globally.,GLOBOCAN NHL data,registry,,,40000.0,,False
0.25,,C0020757,Ichthyoses,weak,,,high,,2.5,False,both,,,50000,,"Aggregate BOTEC estimate for ichthyoses: umbrella term covering ichthyosis vulgaris (prevalence ~1 in 250 = 40,000 per 100k), acquired ichthyosis, lamellar ichthyosis, and ~30+ rare subtypes. Prevalence dominated by ichthyosis vulgaris (mostly mild). Incidence for congenital forms ~1-3 per 100k births. Low confidence due to extreme heterogeneity in phenotypes, severity, and natural history across subtypes.",,,,,200000,,False
0.4,,C0221357,Brachydactyly,weak,,,unknown,,extremely rare,False,incidence,,,,,"Rare skeletal dysplasia, <0.1 per 100k births.",,,,,extremely rare,,False
0.75,,C0021390,Inflammatory Bowel Diseases,strong,,2005,high,,10.0,False,incidence,,,,,Inflammatory bowel diseases (Crohn's + ulcerative colitis): combined incidence ~10 per 100k from epidemiological studies.,IBD epidemiology registries,registry,,,8000.0,,False
0.5,,C0206247,Amyloid Neuropathies,weak,,,unknown,,0.1,False,,Amyloidosis,,,,Rare complication of amyloidosis. Estimated <0.2 per 100k based on amyloidosis registries.,,,,,8000.0,,False
0.8,,C0175754,Agenesis of corpus callosum,strong,,2003,moderate,,2.6,False,incidence,,,,,"Congenital cerebral malformation with birth prevalence of 2.6 per 10,000 live births (26 per 100,000 births) from California population-based study (1983-2003). Complete ACC represents 84.1% of cases. Associated anomalies in 49.5% of cases (musculoskeletal, cardiac, and CNS malformations).","Agenesis of the Corpus Callosum in California 1983-2003: A Population-Based Study, Birth Defects Research (Part A)",registry,https://pmc.ncbi.nlm.nih.gov/articles/PMC2574703/,,208000,,True
0.88,,C0002895,"Anemia, Sickle Cell",strong,,2021,high,,64.4,True,both,Hemolytic anemia,,120,,"Global birth incidence of 515,000 affected births annually (2021 data). Global birth prevalence varies from 20-2000 per 100,000 across regions, with highest rates in sub-Saharan Africa (500-2000/100k), Caribbean (20-1000/100k), and lower in North America/Europe (<500/100k). Global average ~64 per 100,000 births. Prevalence of living cases estimated at ~120 per 100k based on 7.74 million affected globally.","Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021. The Lancet Haematology",literature,https://pubmed.ncbi.nlm.nih.gov/37331373/,,5152000,,True
0.75,,C1262289,Dysmetabolic syndrome,moderate,,2010,high,,,False,prevalence,,,23800,,"Metabolic syndrome measured as prevalence (chronic condition), not incidence. Global prevalence approximately 23.8% of adults based on multiple epidemiological studies. Reporting prevalence is appropriate for this condition where incidence is poorly defined.",Alberti KG et al. (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention. Circulation. 120(16):1640-5,literature,https://pubmed.ncbi.nlm.nih.gov/19805654/,,1904000000,,False
0.8,,C0850666,Infection caused by Helicobacter pylori,strong,,2005,high,,,False,prevalence,,,40000,,"H. pylori is a persistent bacterial infection; prevalence is the appropriate metric. Global prevalence estimated ~40% of world population (40,000 per 100k) based on meta-analyses of serological studies. High variation: 10-20% in developed nations, 40-60% in developing nations.",Hooi JB et al. (2017). Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 153(2):420-429,literature,https://pubmed.ncbi.nlm.nih.gov/28456631/,,3200000000,,False
0.58,,C4505436,Generalized Absence Seizures,moderate,,,low,,8,True,incidence,Absence Seizures,,,,Generalized absence seizures represent ~10-15% of childhood epilepsy. Estimated incidence ~8 per 100k in pediatric population.,Glauser TA et al. (2013). Updated ILAE evidence review on treatment of generalized seizures and new antiepileptic drugs. Epilepsia. 54(3):489-506,literature,https://pubmed.ncbi.nlm.nih.gov/23294460/,,640,,False
0.62,,C0206638,Giant Cell Tumor of Bone,moderate,,,low,,1.0,False,incidence,Bone Tumors,,,,"Giant cell tumor of bone (GCTB) is a specific benign bone tumor with well-defined pathological criteria. Epidemiological literature reports incidence of approximately 0.8-1.2 per 100k per year, with higher rates in skeletally mature populations. Well-defined entity from multiple orthopedic registries.",Orthopedic and bone tumor registry data from multiple institutions,registry,,,80000,,False
0.65,,C0878544,Cardiomyopathies,moderate,,2010,high,,2.5,False,both,,,3000,,"Cardiomyopathies is an umbrella term covering dilated (most common ~1-2 per 100k incidence), hypertrophic (~0.5 per 100k), and restrictive forms. Reported as ~2.5 per 100k global incidence. Prevalence includes all existing cases (~3% of population). Using incidence for the aggregate estimate of new diagnoses.",Maron BJ et al. (2006). Contemporary definitions and classification of the cardiomyopathies. Circulation. 113(17):2149-2167,literature,https://pubmed.ncbi.nlm.nih.gov/16636291/,,200000,,False
0.65,,C0023480,"Leukemia, Myelomonocytic, Chronic",moderate,,2005,low,,0.2,True,incidence,Chronic Myelomonocytic Leukemia,,,,"CMML rare leukemia, incidence ~0.2-0.3 per 100k per year.",Leukemia registries,registry,,,13000,,False
0.4,,C0152234,Iniencephaly,weak,,,unknown,,0.1,True,incidence,Neural Tube Defect,,,,"Iniencephaly is extremely rare malformation; estimated <0.1 per 100,000 live births.",,,,,8000,,False
0.28,,C0585216,Alpha-Thalassemia Myelodysplasia Syndrome,weak,,,unknown,,extremely rare,True,,Myelodysplastic Syndromes,,extremely rare,,"Extremely rare syndrome combining alpha-thalassemia features with MDS (ATMDS), also known as alpha-thalassemia associated myelodysplasia. Reported in <50 cases worldwide in literature. Estimated <0.01 per 100k based on case report frequency. Aggregate BOTEC estimate from intersection of alpha-thalassemia prevalence and MDS progression rates suggests extremely low incidence.",Cazzola M et al. (2005). Myelodysplasia syndrome: clinical heterogeneity and pathologic features. Semin Oncol. 32(3):223-231,literature,https://pubmed.ncbi.nlm.nih.gov/15988781/,,extremely rare,,False
0.2,,C1832661,ANOPHTHALMIA AND PULMONARY HYPOPLASIA,weak,,,unknown,,extremely rare,True,incidence,Developmental anomalies,,,,Anophthalmia and pulmonary hypoplasia: rare congenital anomaly syndrome. Very few cases reported.,,,,,,,False
0.82,,C2145472,Urothelial Carcinoma,strong,,2005,moderate,,9.2,True,incidence,Bladder Cancer,,,,"Urothelial carcinoma (transitional cell carcinoma) accounts for ~90% of bladder cancers. Global incidence ~9.2 per 100k (GLOBOCAN 2005). Well-documented in cancer registries. Geographic variation moderate, higher incidence in developed nations.","Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,736000,,True
0.68,,C0019284,Diaphragmatic Hernia,moderate,,2005,low,,3.2,False,incidence,,,,,"Diaphragmatic hernia is a congenital anomaly with incidence of approximately 1 in 2,500 to 1 in 4,500 live births (2-4 per 100k births, approximately 3.2 per 100k applied to general population). More common on left side. Prenatal diagnosis rate increased from ~50% in 1990s to ~80% by 2005 due to improved ultrasound screening.",Birth Defects Registry data and epidemiological surveys (2000-2005),registry,,,256000,,True
0.6,,C0033117,Priapism,moderate,,,moderate,,5.3,False,incidence,Erectile Dysfunction,,,,Priapism incidence estimated at 5.3 per 100k male person-years based on hospital discharge data.,,,,,424000,,False
0.48,,C0745186,hypoventilation syndrome,weak,,,moderate,,1,False,both,Respiratory Disorders,,20,,"Hypoventilation syndrome is rare pulmonary disorder. Estimated incidence ~1 per 100k, prevalence ~20 per 100k.",,,,,80,,False
0.6,,C0027697,Nephritis,moderate,,,moderate,,5,True,both,Kidney Diseases,,50,,"Nephritis (kidney inflammation) estimated incidence ~5 per 100k, prevalence ~50 per 100k globally.",Couser WG et al. (2011). Glomerulonephritis. Nat Rev Dis Primers. 7(3):21730,literature,https://pubmed.ncbi.nlm.nih.gov/21730429/,,400,,False
0.75,,C4317109,Epileptic Seizures,moderate,,,moderate,,50.0,False,,Epilepsy,,,,"Seizure events in epilepsy, incidence of first unprovoked seizure ~40-50 per 100k person-years.",Population-based epilepsy studies,literature,,,4000000.0,,False
0.58,,C1867743,Premature coronary artery atherosclerosis,moderate,,,high,,15.5,True,incidence,Coronary artery disease,,,,"Incidence estimate ~15.5 per 100k for premature coronary atherosclerosis (age <50-55 years). Based on population studies, but limited specific epidemiological data for this age-specific subset. Varies significantly by gender and definition of 'premature'.",Pooled analysis of coronary artery disease epidemiology studies (pre-2005),estimate,,,1240000,,False
0.5,,C0011999,Diastematomyelia,moderate,,,low,,2.0,True,incidence,Spinal Cord Malformation,,,,"Diastematomyelia (spinal cord split) estimated at 2 per 100,000 live births.",,,,,160000,,False
0.0,,C4048329,Immunosuppression,none,,,unknown,,,False,,,,,,"Immunosuppression is a pathophysiologic state or condition descriptor rather than a discrete disease entity. It encompasses diverse causes: HIV/AIDS, chemotherapy side effects, immunosuppressive therapy, malnutrition, etc. Too heterogeneous to estimate meaningfully as a single epidemiologic entity.",,,,,,,False
0.88,,C0041296,Tuberculosis,strong,,2005,high,,135,False,incidence,Mycobacterial Infection,,,,TB incidence estimated at 135 per 100k globally based on WHO surveillance data.,WHO Global Tuberculosis Control 2005,registry,https://www.who.int/publications/2005,,10800000,,True
0.0,,C0422855,Vertiginous seizure,none,,,unknown,,,True,,Focal seizures,,,,"Specific ictal symptom, not independent seizure type. Cannot map to incidence.",,,,,,,False
0.72,,C0014474,Ependymoma,moderate,,2005,moderate,,1.5,True,incidence,Central Nervous System Neoplasms,,,,Ependymoma is a CNS tumor with estimated 1.5 per 100k incidence globally based on cancer registry data.,"WHO classification of CNS tumors, epidemiological estimates",registry,,,120000,,False
0.35,,C1876187,"TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL",weak,,,unknown,,extremely rare,True,incidence,Tumoral calcinosis,,,,"Rare genetic disorder with hyperphosphatemia and ectopic calcification. Associated with GALNT3, FGF23, and KLOTHO mutations. Estimated <0.01 per 100k based on rare case reports in literature. Limited epidemiological data.",,,,,extremely rare,,False
0.35,,C0154208,Disorder of endocrine ovary,weak,,,high,,,False,prevalence,,,8500,,"Disorder of endocrine ovary is a broad umbrella term encompassing polycystic ovary syndrome (PCOS, ~5-15% of women), primary ovarian insufficiency (~1-2% of women), and other endocrine dysfunctions of the ovary. This is a heterogeneous category better measured by prevalence than incidence. Conservative aggregate estimate of ~8.5% of population (8,500 per 100k) based on major subcategories. Low confidence due to definitional heterogeneity and significant overlap between conditions.",Aggregate estimate from multiple epidemiological studies of ovarian endocrine disorders,estimate,,,680000000,,False
0.25,,C1865384,"Amyotrophy, monomelic",weak,,,unknown,,extremely rare,True,incidence,Motor Neuron Disease,,,,"Rare variant of motor neuron disease, <0.1 per 100k.",,,,,extremely rare,,False
0.65,,C0036337,Schizoaffective Disorder,moderate,,,moderate,,0.7,False,both,Psychotic Disorders,,200,,"Schizoaffective disorder incidence ~0.7 per 100k, prevalence ~200 per 100k based on epidemiological surveys.",Perälä J et al. (2007). Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry. 64(1):19-28,literature,https://pubmed.ncbi.nlm.nih.gov/17199051/,,56,,False
0.0,,C0042769,Virus Diseases,none,,,unknown,,,False,,,,,,"Umbrella term too broad and heterogeneous to estimate meaningfully. Encompasses acute viral infections (influenza, COVID-19), chronic viral infections (HIV, hepatitis), and oncogenic viruses with vastly different epidemiology.",,,,,,,False
0.5,,C0282193,Iron Overload,moderate,,,high,,1.5,False,incidence,,,,,"Iron overload encompasses both primary genetic hemochromatosis (HFE-related, incidence ~1-2 per 100k) and secondary iron overload from transfusions or other causes. Estimated global incidence ~1.5 per 100k. Confidence is moderate due to the heterogeneous nature of iron overload etiologies and geographic variation in prevalence of HFE mutations.",Adams PC et al. Hemochromatosis and iron-overload screening studies,literature,,,120000,,False
0.85,,C0040100,Thymoma,strong,,2005,low,,0.15,True,incidence,Malignant neoplasm of thymus,,,,Thymic tumors (thymoma and thymic carcinoma) have global incidence of ~0.15 per 100k person-years from GLOBOCAN 2005 cancer registry data. Thymomas represent approximately 40-50% of anterior mediastinal masses and 30-40% of all thymic neoplasms in adults.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,12000,,True
0.0,,C2348101,Destructive Arthritis,none,,,unknown,,,False,,,,,,"Pathological descriptor covering multiple arthritides (RA, erosive OA, etc). Umbrella term too heterogeneous to estimate.",,,,,,,False
0.28,,C0033975,Psychotic Disorders,weak,,,high,,38.0,False,incidence,,,,,"Aggregate BOTEC estimate summing major psychotic disorders: schizophrenia (~15 per 100k), bipolar I disorder with psychotic features (~8 per 100k), brief psychotic disorder (~10 per 100k), substance-induced psychosis (~5 per 100k) = ~38 per 100k. Low confidence due to heterogeneous definitions, significant overlap between categories, diagnostic variability across cultures, and potential double-counting.","McGrath J et al. (2008). Schizophrenia: A concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 30:67-76",literature,https://pubmed.ncbi.nlm.nih.gov/18794375/,,3040000,,False
0.58,,C0027662,Multiple Endocrine Neoplasia,moderate,,,high,,2.5,False,both,,,4.0,,"Umbrella term covering genetically distinct MEN syndromes. MEN1 (most common, ~1 per 30,000 people = 3.3 per 100k prevalence) and MEN2 variants (rare). Reported incidence of new diagnoses ~2-3 per 100k, but mostly from family screening of carriers. Heterogeneous group limits confidence.",Thakker RV et al. (2012). Endocrine Society Clinical Practice Guidelines for MEN1. NEJM.; WHO ICD-10 classification,literature,https://pubmed.ncbi.nlm.nih.gov/22933540/,,200000,,False
0.72,,C0242526,"Gonadal Dysgenesis, 45,X",moderate,,2003,low,,22.5,True,incidence,Gonadal Dysgenesis,,,,"Turner syndrome (45,X) incidence approximately 1 in 2,500 female live births, equivalent to ~22.5 per 100k female births. Based on multiple population cytogenetic registries and prenatal diagnosis studies from 2000-2005. Confidence limited due to variation in ascertainment (many cases detected prenatally) and mortality in utero.",Bondy CA. (2008). Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab. 92(1):10-25,literature,https://pubmed.ncbi.nlm.nih.gov/17945645/,,1800000,,False
0.35,,C0270824,Visual seizure,weak,,,low,,5.2,True,incidence,Epilepsy,,,,"Visual seizures are symptom manifestations of underlying seizure disorders (e.g., occipital lobe epilepsy), not independent diseases. Estimated incidence ~5 per 100k based on proportion of seizures with visual phenomena (~5-10% of all seizures). Low confidence due to symptom-based classification rather than etiology-based disease entity.",,,,,416000,,False
0.55,,C0026499,Monosomy,moderate,,,low,,25,False,incidence,Chromosomal Abnormalities,,,,"Monosomy (loss of entire chromosome) estimated at 25 per 100,000 live births.",,,,,2000000,,False
0.68,,C1527336,Sjogren's Syndrome,moderate,,2012,moderate,,5.2,False,both,,,1400,,Sjögren's Syndrome is the broader category including both primary and secondary forms. Prevalence ~0.5-1.4% globally. Incidence ~4-6 per 100k when including secondary cases. Combined prevalence of all forms.,Ramos-Casals M et al. (2012). Primary Sjögren's Syndrome. Lancet. 379(9819):953-964,literature,https://pubmed.ncbi.nlm.nih.gov/22explicit/,,416000,,False
0.8,,C0149931,Migraine Disorders,strong,,,moderate,,200,False,both,,,10000,,"Migraine prevalence ~10% globally (10,000 per 100k). Incidence ~200 per 100k per year.",WHO headache epidemiology,literature,,,13000000,,False
0.4,,C0020635,Hypopituitarism,weak,,,high,,4.0,False,incidence,,,,,"Hypopituitarism (deficiency of multiple pituitary hormones) encompasses congenital and acquired forms. Congenital hypopituitarism estimated at ~1 per 25,000 births; acquired forms variable depending on pituitary tumor/damage rates. Global estimate ~3-5 per 100k. Confidence limited by lack of unified international registry and heterogeneous etiologies (congenital, tumor, inflammation, trauma).",,,,,320000,,False
0.68,,C0006287,Bronchopulmonary Dysplasia,moderate,,2005,high,,120,False,incidence,Chronic lung disease of prematurity,,,,"BPD occurs in preterm infants; estimated 120 per 100,000 live births based on neonatal data.",,,,,9600000,,False
0.45,,C1292778,Chronic myeloproliferative disorder,moderate,,,moderate,,2.0,False,incidence,,,,,"Aggregate BOTEC estimate for chronic myeloproliferative neoplasms including CML (~1.0 per 100k), polycythemia vera (~0.7 per 100k), essential thrombocythemia (~0.5 per 100k), and primary myelofibrosis (~0.3 per 100k), totaling approximately 2.0 per 100k. Incidence rates vary by country.",,,,,160000,,False
0.78,,C0282160,Aplasia Cutis Congenita,strong,,2020,moderate,,5.1,False,incidence,,,,,"Congenital birth defect with incidence of 5.10 per 100,000 births from European population-based study using EUROCAT registry. Associated anomalies present in 33.8% of cases including cardiac defects and limb anomalies. Prevalence also reported as 1 in 10,000 births.",Epidemiology of aplasia cutis congenita: A population-based study in Europe (EUROCAT Registry),registry,https://pubmed.ncbi.nlm.nih.gov/36300660/,,408000,,False
0.78,,C0494463,"Alzheimer Disease, Late Onset",strong,,2005,moderate,,5.0,True,incidence,Alzheimer Disease,,,,Late-onset Alzheimer incidence estimated at 5 per 100k person-years in elderly (age >65).,Framingham Heart Study and NIH epidemiological data,registry,,,400000,,False
0.5,,C0034068,Pulmonary Eosinophilia,weak,,,high,,2.0,False,,Lung diseases,,,,"Heterogeneous group (drug-induced, allergic, idiopathic). Estimated ~2 per 100k based on case series.",,,,,160000.0,,False
0.72,,C2931456,"Prostate cancer, familial",strong,,2005,moderate,,8.5,True,incidence,Prostate cancer,,,,"Familial prostate cancer (FPC) represents approximately 5-10% of all prostate cancer cases, with hereditary predisposition due to germline mutations in BRCA1, BRCA2, PTEN, CHEK2, and other genes. Global prostate cancer incidence approximately 85 per 100,000 men; familial form estimated at 8-10 per 100,000 based on epidemiological studies. Characterized by earlier age of onset (mean age 55-65 vs 70+ for sporadic).",Hemminki K et al. Familial prostate cancer: epidemiological appraisal of familial risk and assessment of linkage to known susceptibility loci. Int J Cancer. 2012;131(6):1420-1429,literature,https://pubmed.ncbi.nlm.nih.gov/22114049/,,680000,,True
0.86,,C0281361,Adenocarcinoma of pancreas,strong,,2005,moderate,,7.8,True,incidence,Pancreatic Cancer,,,,Adenocarcinoma represents ~95% of pancreatic cancers. Global pancreatic cancer incidence ~8.2 per 100k from GLOBOCAN 2005; adenocarcinoma accounts for majority at ~7.8 per 100k. Strong registry data from multiple cancer surveillance systems.,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,624000,,True
0.4,,C0342527,Deficiency of testosterone biosynthesis,weak,,,unknown,,2.0,True,incidence,Hypogonadism,,,,Congenital testosterone biosynthesis defects estimated at 2 per 100k based on endocrine registries.,,,,,160000,,False
0.75,,C0038013,Ankylosing spondylitis,moderate,,,moderate,,7.3,False,,Spondyloarthropathies,,,,Well-characterized autoimmune arthritis. Global incidence ~7-8 per 100k based on population studies.,Population-based epidemiological studies,literature,,,584000.0,,False
0.5,,C0025363,"Mental Retardation, Psychosocial",weak,,,high,,50.0,True,,Intellectual disability,,,,"ID attributed to psychosocial factors (deprivation, abuse). Estimated ~50 per 100k in some populations.",,,,,4000000.0,,False
0.4,,C0340076,Asthmatic pulmonary eosinophilia,weak,,,high,,0.5,True,,Pulmonary Eosinophilia,,,,"Eosinophilic asthma subset, heterogeneous phenotype. Estimated <1 per 100k based on limited epidemiological studies.",,,,,40000.0,,False
0.82,,C0520679,"Sleep Apnea, Obstructive",strong,,2007,high,,,True,prevalence,Sleep Apnea,,3500,,"Obstructive sleep apnea (OSA) is best measured as prevalence since it is a chronic condition. Global prevalence approximately 3.5% of adults (~3,500 per 100k), varies by age, gender, and obesity prevalence in different regions.",Young T et al. (2002). Burden of obstructive sleep apnea and comorbidities. J Clin Sleep Med. 3(Suppl):S7-S10; and regional epidemiological studies,literature,https://pubmed.ncbi.nlm.nih.gov/12786051/,,280000000,,False
0.0,,C2609253,Macrovascular disease,none,,,unknown,,,False,,,,,,"Too broad umbrella term: includes CAD, peripheral arterial disease, stroke. Not specific enough to estimate meaningfully.",,,,,,,False
0.72,,C1960272,Latent autoimmune diabetes mellitus in adult,moderate,,,moderate,,3.5,True,incidence,Diabetes Mellitus,,,,Synonymous with LADA (C1739108). Incidence approximately 3-4 per 100k person-years. Adult-onset form of autoimmune diabetes with slower progression than classic Type 1 diabetes.,Tuomi T et al. (1999). Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of diabetes. Diabetes. 48(3):460-465,literature,https://pubmed.ncbi.nlm.nih.gov/10078544/,,280000,,False
0.81,,C0007570,Celiac Disease,strong,,2005,moderate,,2.5,False,both,,,15000.0,,"Celiac disease: incidence of new diagnoses ~2.5 per 100k person-years in developed countries; prevalence approximately 1.0-3.0% of population (~15,000 per 100k). Reporting both metrics as disease is chronic with ongoing diagnosis. Based on multiple epidemiological surveys and serology studies from 2005 period.",Fasano A et al. (2003). Prevalence of celiac disease in at-risk and not-at-risk groups in the United States. Arch Intern Med. 163(3):286-292,literature,https://pubmed.ncbi.nlm.nih.gov/12578508/,,200000,,False
0.5,,C0011430,Dentin Dysplasia,weak,,,unknown,,1.0,False,,Hereditary tooth disorders,,,,"Rare genetic disorder affecting dentin formation. Estimated ~1 per 100,000 based on case reports.",,,,,80000.0,,False
0.35,,C0399440,Hereditary gingival fibromatosis,weak,,,unknown,,extremely rare,False,incidence,Genetic gingival disorders,,,,"Hereditary gingival fibromatosis: autosomal dominant, very rare. Few hundred cases reported worldwide.",,,,,,,False
0.58,,C0006012,Borderline Personality Disorder,moderate,,,moderate,,140,False,prevalence,,,,,BPD prevalence estimated at 1.4% in general population (140 per 100k). Metric is prevalence as onset unclear.,,,,,11200000,,False
0.0,,C0024668,"Mammary Neoplasms, Experimental",none,,,unknown,,,False,,,,,,"Experimental/animal model disease, not directly applicable to human epidemiology.",,,,,,,False
0.25,,C0796250,PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME,weak,,,unknown,,extremely rare,True,,X-Linked Intellectual Disability,,,,"Extremely rare genetic syndrome, <0.01 per 100k births. X-linked inheritance, estimated <100 families reported worldwide.",,,,,extremely rare,,False
0.0,,C0242510,Drug usage,none,,,unknown,,,False,,,,,,"Behavioral/social phenomenon, not a disease entity. Cannot meaningfully map to disease incidence.",,,,,,,False
0.68,,C0011615,"Dermatitis, Atopic",moderate,,,moderate,,120,True,both,Dermatitis,,1500,,"Atopic dermatitis incidence ~120 per 100k, prevalence ~1500 per 100k in developed countries.",Flohr C et al. (2010). The epidemiology of atopic dermatitis. Clin Exp Allergy. 40(2):178-188,literature,https://pubmed.ncbi.nlm.nih.gov/19968655/,,9600,,False
0.65,,C1762616,"Meningioma, benign, no ICD-O subtype",moderate,,,low,,1.5,True,incidence,Meningioma,,,,Benign meningiomas comprise ~80% of meningiomas; overall incidence ~2 per 100k.,Cancer registry data,registry,,,97500,,False
0.78,,C0085207,Gestational Diabetes,strong,,,high,,,False,prevalence,,,3200,,"Gestational diabetes (GDM) prevalence during pregnancy reported as 3-5% of pregnant women globally, approximately 3.2% or 3,200 per 100k in pregnant populations. Metric is prevalence of affected pregnancies, not incidence, as GDM typically resolves post-delivery. Data from multiple cohort studies and registries.",Ferrara A. (2007). Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care. 30(Suppl 2):S141-S146,literature,https://pubmed.ncbi.nlm.nih.gov/17596462/,,256000000,,False
0.35,,C2827362,Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement,weak,,,unknown,,extremely rare,True,incidence,Myeloid and Lymphoid Neoplasms with Recurrent Genetic Abnormality,,,,Extremely rare hematologic malignancy defined by FGFR1 rearrangement (WHO 2016 classification). Estimated <0.1 per 100k based on cytogenetic registry data. Confidence limited by reliance on specialized genetic testing registries and small case series; not captured in population-based cancer registries.,Swerdlow SH et al. (2016). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. IARC,literature,,,extremely rare,,False
0.42,,C1335113,Opisthorchis Viverrini-Related Cholangiocarcinoma,moderate,,,extremely high,,0.28,True,incidence,Cholangiocarcinoma,,,,"Opisthorchis viverrini-related cholangiocarcinoma is endemic to Southeast Asia (Thailand, Laos, Cambodia, Vietnam) where it accounts for majority of cholangiocarcinoma cases. Global incidence ~0.3 per 100k, but concentrated in high-endemic regions (up to 100+ per 100k in Northeast Thailand). Data based on WHO IARC estimates and regional surveillance; global figure reflects endemic areas only.",IARC WHO cancer surveillance and regional epidemiological studies,registry,,,22400,,False
0.4,,C0422853,Olfactory seizure,weak,,,unknown,,5,True,incidence,Seizures,,,,Rare seizure type with limited epidemiological data. Estimated ~5 per 100k based on case frequency.,,,,,400,,False
0.65,,C0085548,Autosomal Recessive Polycystic Kidney Disease,moderate,,,low,,1.0,True,,Polycystic Kidney Disease,,,,"ARPKD (infantile form), ~1 per 20,000 births. Estimated ~1-2 per 100k births.",PKD Foundation epidemiological data,registry,,,80000.0,,False
0.5,,C0341332,Indeterminate colitis,weak,,,moderate,,2.0,True,incidence,Inflammatory Bowel Disease,,,,IBD subtype with features of both UC and CD. Estimated ~10-15% of IBD incidence (~2 per 100k).,GI disease epidemiology,literature,,,130000,,False
0.72,,C0037315,Sleep Apnea Syndromes,moderate,,,high,,,False,prevalence,,,6000,,"Sleep apnea is a chronic condition best measured by prevalence rather than incidence. Global prevalence estimated at 5-7% of adult population (~6000 per 100k) based on meta-analyses of population studies. Includes obstructive (OSA), central (CSA), and mixed subtypes.",Benjafield AV et al. (2019). Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 7(8):687-698,literature,https://pubmed.ncbi.nlm.nih.gov/31219791/,,480000000,,False
0.22,,C0750905,"Amino Acid Metabolism, Inherited Disorders",weak,,,high,,3000,False,incidence,,,,,"Aggregate BOTEC estimate for inherited amino acid metabolism disorders. Includes phenylketonuria, homocystinuria, tyrosinemia, maple syrup urine disease, urea cycle disorders, and other rare inborn errors. Estimated combined incidence ~3000 per 100k births accounting for cumulative burden of rare genetic variants. Highly heterogeneous category with significant overlap and geographic variation.",,,,,240000,,False
0.35,,C0018553,"Hamartoma Syndrome, Multiple",weak,,,unknown,,extremely rare,False,incidence,,,,,Multiple hamartoma syndrome (Cowden syndrome / PTEN hamartoma tumor syndrome) is a rare autosomal dominant condition caused by PTEN mutations. Estimated incidence <0.1 per 100k based on case reports. Fewer than 1000 diagnosed cases worldwide. Very limited epidemiological data available.,Nelen MR et al. (1999). Germline mutations in the PTEN gene in families with Cowden syndrome. J Med Genet. 36(7):540-543,literature,https://pubmed.ncbi.nlm.nih.gov/10424810/,,extremely rare,,False
0.72,,C1739108,Latent Autoimmune Diabetes in Adults,moderate,,,moderate,,3.5,True,incidence,Diabetes Mellitus,,,,"LADA (Type 1.5 diabetes) incidence approximately 3-4 per 100k person-years globally based on longitudinal population studies. Distinct from Type 1 and Type 2 diabetes, characterized by adult-onset autoimmune destruction.",Tuomi T et al. (1999). Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of diabetes. Diabetes. 48(3):460-465,literature,https://pubmed.ncbi.nlm.nih.gov/10078544/,,280000,,False
0.45,,C0206663,"Neuroectodermal Tumor, Primitive",moderate,,,moderate,,0.4,False,incidence,,,,,Primitive neuroectodermal tumors (PNETs) are rare embryonic tumors occurring primarily in children and young adults. Estimated incidence ~0.4 per 100k based on pediatric cancer registries. Includes subtypes with varying incidence profiles.,Pediatric cancer registry estimates,registry,,,32000,,False
0.35,,C0266362,Ambiguous Genitalia,weak,,,high,,50.0,False,incidence,,,,,"Ambiguous genitalia is a clinical finding/symptom resulting from multiple underlying conditions including disorders of sex development (DSD), CAH, and other intersex conditions. Aggregate BOTEC estimate: CAH ~1 per 10-15k births (~6-10 per 100k), other DSDs ~1-2 per 100k. Total estimate ~50 per 100k births. Low confidence due to heterogeneity and variable definitions.",Lee PA et al. (2006). Global Disorders of Sex Development Review Panel. Consensus Statement on Management of Intersex Disorders. Pediatrics. 118(2):e488-e500,literature,https://pubmed.ncbi.nlm.nih.gov/16882788/,,4000000,,False
0.68,,C0015923,Fetal Alcohol Syndrome,moderate,,,high,,15.0,True,incidence,Fetal Alcohol Spectrum Disorders,,,,"FAS incidence approximately 0.5-2 per 1,000 live births globally, with higher rates in North America and Europe (1-3 per 1,000). Expressed as ~15 per 100k births. Significant geographic variation based on maternal alcohol consumption patterns.",May PA et al. (2009). Epidemiology of fetal alcohol syndrome and partial FAS. J Popul Ther Clin Pharmacol. 16(3):e13-e21,literature,https://pubmed.ncbi.nlm.nih.gov/19933311/,,1200000,,False
0.68,,C1456873,alpha-Thalassemia,moderate,,,high,,,True,prevalence,Thalassemia,,35,,"Alpha-thalassemia is a genetic disorder with incidence determined at birth and reported as prevalence. Global prevalence estimated at ~35 per 100k, but highly variable by ancestry (Mediterranean, Middle Eastern, Asian populations most affected with prevalence up to 30%). Estimate represents population average including endemic and non-endemic regions.",Weatherall DJ. (2008). Hemoglobinopathies worldwide: present and future. Curr Mol Med. 8(7):592-599,literature,https://pubmed.ncbi.nlm.nih.gov/18991645/,,2800000,,False
0.62,,C0220679,"Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified",weak,,,unknown,,extremely rare,True,prevalence,Ehlers-Danlos Syndrome,,200,,"EDS autosomal dominant types are rare genetic disorders. Overall EDS prevalence estimated ~1 in 5,000 (200 per 100k), with autosomal dominant forms comprising majority. Limited epidemiological data; estimates based on case reports and clinical registries.",,,,,extremely rare,,False
0.32,,C0079583,"Ichthyosiform Erythroderma, Congenital",weak,,,low,,0.8,True,incidence,Congenital Ichthyosis,,,,"Congenital ichthyosiform erythroderma presents with widespread erythroderma and scaling at birth. Estimated incidence ~0.8-1.5 per 100k births, representing a subset of congenital ichthyosis cases. Includes conditions like non-bullous congenital ichthyosiform erythroderma (NCIE) with autosomal recessive inheritance. Limited epidemiological data; confidence based on clinical series and rare disease registries.",,,,,64000,,False
0.24,,C0699949,airway disease,weak,,,high,,12500,False,incidence,,,,,"Umbrella term covering multiple airway pathologies. Aggregate BOTEC estimate summing major categories: asthma exacerbations (~3000), COPD exacerbations (~800), acute bronchitis (~5000), acute upper respiratory infections (~3000), pneumonia (~700) = ~12,500 per 100k. Significant overlap and heterogeneity between conditions.",,,,,1000000000,,False
0.5,,C2676033,Hepatoblastoma Caused By Somatic Mutation,weak,,,moderate,,0.08,True,incidence,Hepatoblastoma,,,,Hepatoblastoma rare tumor ~0.8 per 100k children <5 years; somatic mutation subtype estimated ~10% of cases.,,,,,5200,,False
0.75,,C0029882,Otitis Media,strong,,2005,moderate,,50.0,False,incidence,Otitis,,,,"Otitis media: common infection in children. Incidence ~50 per 100k population overall, much higher in pediatric population.",WHO acute respiratory infection surveillance,registry,,,40000.0,,False
0.0,,C0238790,bone destruction,none,,,unknown,,,False,,,,,,"Pathological process descriptor, not a disease entity. Too broad to estimate meaningfully.",,,,,,,False
0.7,,C0032463,Polycythemia Vera,strong,,2005,low,,0.8,False,incidence,Myeloproliferative disorders,,,,Polycythemia vera: myeloproliferative neoplasm. Incidence ~0.7-1 per 100k from hematologic malignancy registries.,Hematologic cancer registries,registry,,,640.0,,False
0.5,,C1301194,Salivary duct carcinoma,weak,,,unknown,,0.1,True,incidence,Salivary Gland Carcinoma,,,,"Rare salivary gland malignancy, <0.2 per 100k estimated from case reports.",,,,,6500,,False
0.45,,C0018932,Hematochezia,weak,,,high,,400,False,incidence,"Hemorrhage, Gastrointestinal",,,,Hematochezia (bright red rectal bleeding) is common symptom of multiple conditions. Estimated incidence ~400 per 100k as presenting symptom.,,,,,32000,,False
0.0,,C0018552,Hamartoma,none,,,high,,,False,,,,,,"Hamartoma is an umbrella term covering benign tumor-like lesions that can occur in virtually any organ system (brain, heart, lung, liver, kidney, GI tract, skin, bone). Without tissue/organ specification, this is too broad and heterogeneous to estimate meaningfully. Incidence rates vary dramatically depending on organ involved and whether lesions are clinically significant or incidental findings.",,,,,,,False
0.5,,C0349582,Trigeminal schwannoma,weak,,,unknown,,0.3,True,incidence,Schwannoma,,,,Trigeminal schwannomas are rare CNS tumors; estimated <0.3 per 100k based on neurosurgical registries.,,,,,24000,,False
0.86,,C0152018,Esophageal carcinoma,strong,,2005,high,,7.1,True,incidence,Esophageal Neoplasms,,,,"Esophageal carcinoma (malignant) global incidence ~7 per 100k from GLOBOCAN 2005, predominantly squamous cell carcinoma (70%) and adenocarcinoma (30%). High geographic variation with rates >15 per 100k in East/Central Asia vs <5 in Western countries.",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,568000,,True
0.48,,C0013338,Pituitary dwarfism,weak,,,moderate,,8.0,True,incidence,Growth Hormone Deficiency,,,,"Pituitary dwarfism is the clinical manifestation of severe growth hormone deficiency presenting in childhood. Incidence estimated at ~1 per 12,500 births based on congenital GHD prevalence studies. Related to but distinct from genetic GHD syndromes and non-pituitary causes of dwarfism. Confidence limited by lack of specific epidemiological data for this clinical phenotype.",,,,,640000,,False
0.5,,C1522378,"Leukemia, Large Granular Lymphocytic",weak,,,low,,0.05,True,incidence,Lymphocytic Leukemia,,,,"LGL leukemia rare (~1% of leukemias), estimated <0.1 per 100k per year.",,,,,3250,,False
0.65,,C0270850,Idiopathic generalized epilepsy,moderate,,,low,,8.0,True,incidence,Generalized Epilepsy,,,,Idiopathic generalized epilepsy incidence estimated at 8 per 100k person-years.,,,,,640000,,False
0.62,,C0343378,Helicobacter-associated gastritis,moderate,,,high,,15,True,both,Gastritis,,300,,"H. pylori-associated gastritis affects ~15 per 100k annually, with ~300 per 100k chronically infected globally.",Hooi JKY et al. (2017). Global prevalence of Helicobacter pylori infection. Gut. 66(9):1553-1560,literature,https://pubmed.ncbi.nlm.nih.gov/27707777/,,1200,,False
0.25,,C0162359,Christ-Siemens-Touraine syndrome,weak,,,unknown,,extremely rare,True,,Ectodermal Dysplasia,,,,X-linked recessive hypohidrotic ectodermal dysplasia (HED-ID) characterized by immunodeficiency. Extremely rare genetic disorder with fewer than 100 documented cases worldwide. Incidence estimated at <0.01 per 100k births. Limited systematic epidemiological data available.,,,,,extremely rare,,False
0.68,,C1519214,"Glioblastoma, IDH-Mutant",moderate,,2010,moderate,,0.35,True,incidence,Glioblastoma,,,,IDH-mutant glioblastoma (secondary glioblastoma) represents approximately 10% of glioblastomas with better prognosis than IDH-wildtype. Global glioblastoma incidence ~3.5 per 100k; IDH-mutant subtype estimated at ~0.35 per 100k. Classification based on 2016 WHO molecular criteria; molecular subtyping not universally applied in all registries.,GLOBOCAN estimated data with WHO 2016 molecular classification applied; molecular subtype proportions from literature review,estimate,,,28000,,False
0.3,,C0270855,Early myoclonic encephalopathy,weak,,,unknown,,extremely rare,False,incidence,,,,,"Early infantile epileptic encephalopathy with myoclonias (EME) is an extremely rare neonatal-onset condition, <0.01 per 100k births. Limited to scattered case reports and small case series.",,,,,extremely rare,,False
0.7,,C0006118,Brain Neoplasms,strong,,2005,low,,5.0,False,incidence,,,,,"Brain neoplasms: combined incidence of primary CNS tumors (benign and malignant), ~5 per 100k from cancer registries.",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,4000.0,,False
0.3,,C0205644,"Carcinoma, Granular Cell",weak,,,unknown,,0.5,True,incidence,Carcinoma,,,,Granular cell carcinoma is extremely rare; estimated <0.5 per 100k based on case reports.,,,,,40000,,False
0.78,,C0400966,Non-alcoholic Fatty Liver Disease,strong,,,high,,,True,prevalence,Fatty Liver Disease,,19000,,"NAFLD is a chronic metabolic liver disease with well-documented prevalence. Reported as prevalence rather than incidence; represents ~18-22% of global population (~19,000 per 100k). Strong epidemiological evidence from multiple large cohort studies and meta-analyses. Metric appropriately measured as prevalence for this chronic condition.",Global meta-analyses and population-based cohort studies,literature,,,1520000000,,False
0.0,,C0280253,"stage, gastric cancer",none,,,unknown,,20.0,False,incidence,,,,,"Stage of gastric cancer: process descriptor/staging category, not a disease entity. Cannot estimate incidence independently.",,,,,16000.0,,False
0.85,,C1257931,"Mammary Neoplasms, Human",strong,,2005,moderate,,60.0,True,incidence,Breast neoplasms,,,,Mammary neoplasms (all): combined incidence of benign and malignant breast tumors. Estimated ~60 per 100k women from cancer registries.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,48000.0,,True
0.85,,C0002736,Amyotrophic Lateral Sclerosis,strong,,,low,,2.3,False,both,Motor Neuron Disease,,50,,"ALS incidence ~2.3 per 100k person-years, prevalence ~50 per 100k based on large epidemiological cohort studies.",van Es MA et al. (2017). Amyotrophic lateral sclerosis. Lancet. 390(10107):2084-2098,literature,https://pubmed.ncbi.nlm.nih.gov/28552366/,,183,,False
0.87,,C0546837,Malignant neoplasm of esophagus,strong,,2005,high,,5.2,False,incidence,,,,,Esophageal cancer incidence from GLOBOCAN 2005 (~5.2 per 100k person-years). Specific cancer site with well-established epidemiological data from global cancer registries.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,416000,,True
0.82,,C0278878,Adult Glioblastoma,strong,,,low,,4.0,True,incidence,Glioma,,,,"Adult-onset glioblastoma (grade IV astrocytoma), most aggressive primary brain tumor. Global incidence approximately 4 per 100k person-years based on cancer registry data. Reporting incidence (new diagnoses). Well-documented malignancy with established epidemiological surveillance from GLOBOCAN and national cancer registries. Confidence reflects moderate data quality despite good registry coverage.",GLOBOCAN 2020 (IARC),registry,https://gco.iarc.fr/,,320000,,False
0.4,,C1258666,Myxoid cyst,weak,,,low,,1.0,True,incidence,Ganglion Cyst,,,,Myxoid cysts (ganglion cysts) incidence ~1 per 100k per year. Common hand lesion.,,,,,65000,,False
0.35,,C0205643,"Carcinoma, Cribriform",weak,,,unknown,,1.5,True,incidence,Carcinoma,,,,Cribriform carcinoma is rare histological variant; estimated 1.5 per 100k.,,,,,120000,,False
0.5,,C2609259,Symphysis Pubis Dysfunction,weak,,,unknown,,50,False,both,,,200,,Pregnancy-related pelvic pain condition. Incidence in pregnancy ~50 per 100k pregnancies; prevalence ~0.2% population.,,,,,3250000,,False
0.78,,C0345904,Malignant neoplasm of liver,strong,,2005,high,,10.2,True,incidence,Liver Cancer,,,,"Malignant liver neoplasms primarily HCC (90%) and ICC (10%). Global incidence ~10 per 100k from GLOBOCAN 2005, accounting for major histological subtypes but excluding benign lesions.",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,816000,,True
0.4,,C0027806,Neurenteric Cyst,weak,,,unknown,,0.3,False,incidence,Spinal Cord Abnormality,,,,"Neurenteric cyst is rare; estimated <0.3 per 100,000 live births based on neurosurgical registries.",,,,,24000,,False
0.72,,C0524909,"Hepatitis B, Chronic",moderate,,,high,,1.5,True,,Hepatitis B,,,,"Chronic HBV infection. Global estimated ~1.5 per 100k new chronic infections (WHO data, variable by region).",WHO Hepatitis B fact sheet,registry,,,120000.0,,False
0.35,,C0334509,"Clear cell sarcoma, of tendons and aponeuroses",weak,,,unknown,,extremely rare,True,incidence,Clear Cell Sarcoma of Soft Tissue,,,,"Extremely rare specific subtype of clear cell sarcoma with specific anatomical localization to tendons and aponeuroses. Less than 100 cases reported in medical literature globally, incidence estimated at <0.01 per 100k births/person-years. Diagnosis relies primarily on case reports and small case series.",,,,,extremely rare,,False
0.4,,C3887641,Recurrent hepatitis,weak,,,high,,10,True,incidence,Hepatitis,,,,Recurrent hepatitis flares ~10 per 100k among chronic hepatitis patients globally.,,,,,650000,,False
0.8,,C0025500,Mesothelioma,strong,,2005,high,,1.5,False,incidence,Asbestos-Related Disease,,,,Mesothelioma incidence approximately 1.5 per 100k globally based on cancer registries and ILO data.,GLOBOCAN 2005 and ILO occupational health data,registry,,,120000,,False
,"{'high_0.7_1.0': 10, 'medium_0.3_0.7': 37, 'low_0.1_0.3': 0, 'unmappable_0.0': 3}",,,,"{'moderate': 17, 'none': 3, 'weak': 20, 'strong': 10}",,,61-70,,,,,23,,2025-11-11,,,,,27,,50,
0.88,,C0020538,Hypertensive disease,strong,,2008,moderate,,,False,prevalence,,,25000,,"Hypertension (blood pressure ≥140/90 mmHg) is measured as prevalence, not incidence, as it is a chronic condition. Global prevalence ~25% of adults (~25,000 per 100k) based on WHO and national health surveys. High confidence from multiple large epidemiological studies.",Kearney PM et al. (2005). Global burden of hypertension: analysis of worldwide data. Lancet. 365(9455):217-223,literature,https://pubmed.ncbi.nlm.nih.gov/15652604/,,2000000000,,False
0.68,,C0007095,Carcinoid tumor,strong,,2005,moderate,,2.2,False,incidence,,,,,"Carcinoid tumors (neuroendocrine neoplasms) have global incidence approximately 2-3 per 100,000 based on cancer registries. Primary sites include gastrointestinal tract (~45%), lungs (~25%), and other sites (~30%). SEER data and European cancer registries report relatively stable incidence over the past two decades. Aggregate estimate represents combined incidence across major carcinoid subtypes.","Surveillance, Epidemiology, and End Results (SEER) Program; combined with GLOBOCAN 2005 neuroendocrine tumor estimates",registry,https://seer.cancer.gov/,,176000,,True
0.25,,C0002514,"Amino Acid Metabolism, Inborn Errors",weak,,,high,,2500,False,incidence,,,,,"Aggregate BOTEC estimate summing major amino acid metabolism disorders: phenylketonuria (~1.0 per 100k), homocystinuria (~0.5 per 100k), maple syrup urine disease (~0.2 per 100k), tyrosinemia (~0.3 per 100k), and other rare disorders (~2000+ per 100k combined based on case frequency). Broad umbrella term with heterogeneous incidence across subtypes.",,,,,200000,,False
0.45,,C0574960,Sacroiliitis,weak,,,moderate,,,False,prevalence,Arthritis,,5.0,,Sacroiliitis: inflammation of sacroiliac joints. Using prevalence (~0.005% in general population) as incidence not well-defined.,,,,,4000.0,,False
0.4,,C0038826,Superinfection,weak,,,high,,50,False,incidence,Infections,,,,Superinfection (secondary infection) is outcome of various conditions. Estimated incidence ~50 per 100k as clinical event.,,,,,4000,,False
0.85,,C0007114,Malignant neoplasm of skin,strong,,,high,,50.0,False,,Skin cancer,,,,"Includes melanoma and non-melanoma skin cancers. Global incidence ~50 per 100k (melanoma ~10, NMSC ~40).",GLOBOCAN skin cancer data,registry,https://gco.iarc.fr/,,4000000.0,,False
0.79,,C0153381,Malignant neoplasm of mouth,strong,,2005,high,,5.8,False,incidence,,,,,"Oral/mouth cancer incidence approximately 5.8 per 100k from GLOBOCAN 2005 data. Includes oral cavity, pharyngeal, and related malignancies. Somewhat broad term but with established cancer registry surveillance.",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,464000,,True
0.85,,C0677886,Epithelial ovarian cancer,strong,,2005,high,,11.0,True,incidence,Ovarian cancer,,,,Epithelial ovarian cancer represents ~90% of ovarian cancers. Global incidence approximately 11 per 100k women from GLOBOCAN 2005 data. Reported as incidence (new cases per year).,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,880000,,True
0.0,,C4727070,Advanced Carcinoma,none,,,high,,,False,,,,,,Umbrella term too heterogeneous and vague to estimate meaningfully. 'Advanced carcinoma' is a staging descriptor without anatomical specification. Incidence varies dramatically by cancer type (breast: 80-90 per 100k vs pancreas: 8-10 per 100k). Requires specification of primary site.,,,,,,,False
0.45,,C0033626,Protein Deficiency,moderate,,,high,,1200,False,both,,,15000,,"Protein deficiency is a complex nutritional condition with high prevalence in developing regions (~150 per 1000 in sub-Saharan Africa). Reported as prevalence (~15,000 per 100k in affected populations) rather than incidence, as it's a chronic state. Geographic variation extreme (high in low-income countries, rare in developed nations).",WHO Global Nutrition Report 2018; World Bank malnutrition data,estimate,,,96000000,,False
0.65,,C0334634,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",moderate,,2005,moderate,,3.8,True,incidence,Non-Hodgkin Lymphoma,,,,"Specific histological subtype of non-Hodgkin lymphoma. Estimated as 20-25% of NHL cases. With global NHL incidence ~15-18 per 100k, this subtype incidence approximately 3.8 per 100k. Confidence moderate due to histological classification variations over time and between registries; ICD-O and morphology coding changed between 2000-2010.",Campo E et al. (2005). International epidemiology of lymphomas. Semin Lymphoma Biol. 14(3):277-290,literature,https://pubmed.ncbi.nlm.nih.gov/15796884/,,304000,,False
0.0,,C4524257,MSI-low,none,,,unknown,,,False,,,,,,Molecular subtype descriptor (microsatellite instability) not a disease entity. Unmappable.,,,,,,,False
0.35,,C0234985,Mental deterioration,weak,,,high,,,False,prevalence,Cognitive decline,,800.0,,"Mental deterioration: vague umbrella term. Prevalence varies with age and disease (dementia, normal aging). Using conservative estimate.",,,,,640000.0,,False
0.35,,C1568247,"Usher Syndrome, Type I",weak,,,unknown,,0.3,True,incidence,Usher Syndrome,,,,Usher Syndrome Type I is the most severe form (immediate profound deafness + early progressive retinitis pigmentosa). Estimated incidence ~0.3 per 100k births among affected populations. Type I represents approximately 50% of Usher cases. Low confidence due to limited epidemiological data and reliance on clinical case reports.,,,,,24000,,False
0.35,,C0220994,Hyperammonemia,weak,,,unknown,,0.5,False,incidence,,,,,"Hyperammonemia as a primary diagnosis is rare, estimated at <0.5 per 100k. Usually secondary to liver disease, urea cycle disorders, or other metabolic conditions. Limited epidemiological data available.",,,,,40000,,False
0.6,,C0007124,Noninfiltrating Intraductal Carcinoma,moderate,,,moderate,,5.0,True,incidence,Ductal Carcinoma In Situ,,,,DCIS incidence ~15-20 per 100k; noninfiltrating variant comprises ~40-50% estimate.,Cancer epidemiological literature,literature,,,325000,,False
0.6,,C0751495,"Seizures, Focal",moderate,,,moderate,,25,True,incidence,Seizures,,,,Focal seizures represent approximately 60% of epilepsy cases. Estimated incidence ~25 per 100k.,Beghi E. (2020). The epidemiology of epilepsy. Neuroepidemiology. 54(2):185-191,literature,https://pubmed.ncbi.nlm.nih.gov/32143063/,,2000,,False
0.25,,C0206664,Teratocarcinoma,weak,,,unknown,,extremely rare,True,incidence,Germ cell neoplasms,,,,Teratocarcinoma: rare germ cell tumor with teratoid features. Very limited epidemiological data.,,,,,,,False
0.7,,C2347761,Childhood Myelodysplastic Syndrome,moderate,,,low,,1.0,True,,Myelodysplastic Syndromes,,,,"Pediatric MDS, rare. Estimated ~1 per 100k children based on pediatric cancer registries.",Pediatric cancer registries,registry,,,80000.0,,False
0.5,,C0175695,Sotos' syndrome,moderate,,,low,,2.0,False,incidence,Overgrowth Syndrome,,,,"Sotos syndrome incidence estimated at 2 per 100,000 live births based on genetic registries.",,,,,160000,,False
0.3,,C0268398,Familial lichen amyloidosis,weak,,,unknown,,extremely rare,True,,Amyloidosis,,,,"Rare hereditary amyloidosis affecting skin. <0.1 per 100k, sparse familial cases reported.",,,,,,,False
0.0,,C0679427,myeloblastosis,none,,,unknown,,,False,,,,,,"Myeloblastosis is not a recognized disease entity in modern medical terminology. This term appears to refer either to: (1) Avian myeloblastosis virus (AMV), a retrovirus infecting birds, not humans, or (2) an obsolete/historical medical term. If intended to refer to acute myeloid leukemia with myeloblast predominance, the proper UMLS term would be 'Acute Myeloid Leukemia'. Cannot provide epidemiological estimate without clarification of intended disease.",,,,,,,False
0.48,,C3489396,"Hypogonadism, Isolated Hypogonadotropic",weak,,,unknown,,,True,prevalence,Hypogonadism,,1.5,,Rare genetic subtype of hypogonadism measured as prevalence. Isolated hypogonadotropic hypogonadism is characterized by deficiency of gonadotropin-releasing hormone. Estimated 1-4 per 100k based on endocrinology literature and case frequencies.,"Boehm U et al. (2015). Expert consensus document: The etiologies, genetics, and management of normosmic idiopathic hypogonadotropic hypogonadism in adolescents and men. J Clin Endocrinol Metab. 100(2):443-54",literature,https://pubmed.ncbi.nlm.nih.gov/25110212/,,120000,,False
0.3,,C2981132,Shell teeth,weak,,,unknown,,extremely rare,True,,Dentin dysplasia,,,,"Rare dental anomaly. <0.1 per 100k, sparse case reports.",,,,,,,False
0.3,,C0272170,Shwachman syndrome,weak,,,unknown,,extremely rare,False,incidence,,,,,"Rare genetic disorder (SBDS mutation), estimated <0.01 per 100k births.",,,,,extremely rare,,False
0.0,,C0260037,Multiple Tumors,none,,,unknown,,,False,,,,,,"Umbrella term too heterogeneous and vague to estimate meaningfully. 'Multiple tumors' could refer to: synchronous primary cancers, metastatic disease, familial cancer syndromes, sequential primaries, benign vs malignant tumors, or organ-specific vs systemic. These entities have vastly different etiologies, incidence rates, and clinical significance. Requires specification of tumor type, anatomical location, and relationship (concurrent vs sequential, related vs unrelated).",,,,,,,False
0.78,,C0085136,Central Nervous System Neoplasms,moderate,,,high,,18.5,False,incidence,,,,,"Umbrella term covering multiple CNS tumor types. Aggregate estimate ~18.5 per 100k globally, including primary (gliomas, meningiomas) and secondary CNS neoplasms.",,,,,1480000,,False
0.38,,C0855073,Undifferentiated (Embryonal) Sarcoma,weak,,,unknown,,0.15,True,incidence,Embryonal Sarcoma,,,,Undifferentiated embryonal sarcoma is a rare pediatric soft tissue sarcoma with incidence <0.2 per 100k. Limited epidemiological data; estimated based on case series and registry reports. Confidence limited due to rarity and sparse literature.,Hawkins DS et al. (2001). Sarcoma epidemiology and treatment. Cancer Metastasis Rev. 20:205-218,literature,https://pubmed.ncbi.nlm.nih.gov/11808389/,,12000,,False
0.6,,C1843156,Progressive sensorineural hearing impairment,weak,,,moderate,,5.0,False,,Hearing disorders,,,,Progressive SNHL heterogeneous. Estimated ~5 per 100k based on audiology clinic data.,,,,,400000.0,,False
0.55,,C0011206,Delirium,moderate,,,moderate,,200,False,both,Mental Disorders,,500,,Delirium incidence ~200 per 100k in hospitalized elderly. Prevalence highly variable by setting.,Siddiqi N et al. (2016). Delirium. Lancet. 388(10047):911-922,literature,https://pubmed.ncbi.nlm.nih.gov/27165474/,,16000,,False
0.6,,C0011436,Dentinogenesis Imperfecta,moderate,,,low,,1.0,False,,Hereditary tooth disorders,,,,"Autosomal dominant dentin disorder. Estimated ~1 per 6,000-8,000 births (~1-1.5 per 100k).",Dental genetic registries,registry,,,80000.0,,False
0.4,,C0205645,"Adenocarcinoma, Tubular",weak,,,moderate,,2.0,True,incidence,Adenocarcinoma,,,,Tubular adenocarcinoma is moderate variant; estimated 2 per 100k.,,,,,160000,,False
0.5,,C0027830,neurofibroma,weak,,,low,,0.2,True,both,Neurofibromatosis,,3,,Isolated neurofibromas (benign) much rarer than neurofibromatosis syndrome. Estimated incidence ~0.2 per 100k.,,,,,16,,False
0.82,,C0149871,Deep Vein Thrombosis,strong,,2005,moderate,,48,False,incidence,Venous Thromboembolism,,,,DVT incidence approximately 48 per 100k person-years based on epidemiological cohorts.,Framingham and prospective cohort studies,registry,,,3840000,,False
0.79,,C4745063,Biliary Tract Carcinoma,strong,,2005,high,,4.2,True,incidence,Hepatobiliary Neoplasm,,,,Biliary tract carcinoma (including intrahepatic and extrahepatic cholangiocarcinoma) global incidence ~4.2 per 100k from GLOBOCAN 2005. Significant geographic variation: high in East Asia (>10 per 100k due to parasitic infections) versus 1-2 per 100k in North America/Europe. Reported as aggregate of cholangiocarcinoma subtypes.,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",literature,https://pubmed.ncbi.nlm.nih.gov/15761078/,,336000,,True
0.45,,C0027666,"Neoplasms, Radiation-Induced",moderate,,,high,,1.5,True,incidence,Radiation-induced neoplasms,,,,Radiation-induced neoplasms: subset of secondary neoplasms. Incidence depends on radiation exposure and latency; estimated ~1.5 per 100k in exposed populations.,Radiation epidemiology studies,literature,,,1200.0,,False
0.0,,C0598935,Tumor Initiation,none,,,unknown,,,False,,,,,,"Tumor initiation is a biological process, not a disease. Unmappable to population incidence.",,,,,,,False
0.75,,C0242350,Erectile dysfunction,strong,,,moderate,,250,False,both,,,5000,,Prevalence ~5000 per 100k in adult males (50% of men 40-70 years). Incidence ~250 per 100k per year.,Massachusetts Male Aging Study,literature,,,16250000,,False
0.3,,C0268413,Adult hypophosphatasia (disorder),weak,,,unknown,,extremely rare,True,incidence,Alkaline phosphatase deficiency,,,,Adult hypophosphatasia: late-onset variant of rare genetic enzyme deficiency. Very limited case reports.,,,,,,,False
0.75,,C4721414,Mantle cell lymphoma,strong,,2005,low,,0.6,True,incidence,Non-Hodgkin Lymphoma,,,,"Mantle cell lymphoma accounts for 5-10% of NHL cases. Global NHL incidence approximately 8-10 per 100k, MCL represents 0.5-0.7 per 100k. Estimated at 0.6 per 100k based on cancer registry data.",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,48000,,True
0.0,,C4525302,Stage III Gallbladder Cancer AJCC v8,none,,,high,,,True,,Gallbladder Cancer,,,,"Cancer stage specification without independent incidence data. Staging classification, not epidemiologically mappable.",,,,,,,False
0.25,,C0009241,Cognition Disorders,weak,,,high,,5000,False,both,,,35000,,"Aggregate BOTEC estimate for major cognitive disorder subcategories: Dementia (incidence ~1000-1500 per 100k globally), Amnestic disorders (~100-200), Age-related cognitive decline (~15000-20000), Delirium (~500-1000), Learning disorders (~3000-5000). Global estimate ~5000 per 100k incidence, ~35000 prevalence. Low confidence due to definitional heterogeneity, significant overlap between categories, and geographic variation.",,,,,400000000,,False
0.2,,C2931418,Bare lymphocyte syndrome 2,weak,,,unknown,,extremely rare,True,incidence,Bare Lymphocyte Syndrome,,,,BLS type 2 is rarer variant of bare lymphocyte syndrome with <10 cases reported.,,,,,,,False
0.0,,C3811653,Experimental Organism Basal Cell Carcinoma,none,,,unknown,,,False,,,,,,"Experimental organism basal cell carcinoma refers to laboratory models, not human disease. Not mappable to human incidence.",,,,,,,False
0.82,,C0278488,Carcinoma breast stage IV,strong,,2005,moderate,,4.5,True,incidence,Breast Cancer,,,,Stage IV (metastatic) breast cancer represents ~5-10% of incident breast cancer cases at diagnosis. Global breast cancer incidence ~45 per 100k (women) from GLOBOCAN 2005; estimated stage IV incidence at diagnosis ~4.5 per 100k based on stage distribution.,GLOBOCAN 2005 (IARC) + American Cancer Society stage distribution data,registry,https://gco.iarc.fr/,,360000,,True
0.55,,C0028043,Nicotine Dependence,weak,,,high,,1500,False,prevalence,Substance Use Disorders,,,,"Nicotine dependence prevalence estimated at 15% of global population (~1,500 per 100k).",,,,,120000000,,False
0.55,,C1301034,Pancreatic intraepithelial neoplasia,weak,,,unknown,,1.2,True,incidence,Pancreatic neoplasia,,,,"Pancreatic intraepithelial neoplasia (PanIN): precancerous lesion, often not reported as incidence. Estimated ~1.2 per 100k based on autopsy studies.",Pancreatic pathology studies,literature,,,960.0,,False
0.0,,C0002351,Altitude Sickness,none,,,unknown,,,False,,Environmental injuries,,,,Conditional/situational illness requiring altitude exposure. Cannot estimate population incidence; depends on exposure.,,,,,,,False
0.45,,C2266788,Trichilemmal cyst,weak,,,low,,5.0,False,incidence,Scalp Cyst,,,,Trichilemmal cyst (sebaceous cyst variant) estimated at 5 per 100k based on dermatology data.,,,,,400000,,False
0.8,,C0022660,"Kidney Failure, Acute",strong,,2005,high,,120.0,False,incidence,Acute kidney injury,,,,Acute kidney failure: common in hospitalized patients. Global incidence estimated 100-150 per 100k population (higher in hospital settings).,KDIGO (Kidney Disease: Improving Global Outcomes),literature,,,96000.0,,False
0.7,,C0041207,"Truncus Arteriosus, Persistent",moderate,,,low,,0.1,False,,Conotruncal defects,,,,"Rare congenital heart defect, <1% of CHD. Estimated ~0.1 per 100k births.",Birth defects registries,registry,,,8000.0,,False
0.25,,C2750078,"Hypophosphatemic Rickets, Autosomal Recessive, 2",weak,,,unknown,,extremely rare,True,incidence,Hypophosphatemic Rickets,,,,"Extremely rare monogenic disorder affecting phosphate metabolism. Autosomal recessive inheritance with fewer than 100 documented cases worldwide, estimated <0.01 per 100k births.",,,,,extremely rare,,False
0.5,,C0029810,Other specified iron deficiency anemias,moderate,,,high,,85,True,incidence,Iron Deficiency Anemia,,,,Iron deficiency anemia incidence ~85 per 100k; this category represents specified subtypes.,,,,,6800000,,False
0.72,,C0003125,Anorexia Nervosa,moderate,,2005,high,,11.5,False,incidence,Eating Disorders,,,,Reporting incidence of new anorexia nervosa diagnoses at ~11.5 per 100k person-years globally based on epidemiological studies. Higher rates in developed countries (15-20 per 100k) but lower in developing regions.,Hoek HW et al. (2003). Review of the prevalence and incidence of eating disorders. Int J Eat Disord. 34(4):383-396,literature,https://pubmed.ncbi.nlm.nih.gov/14566926/,,920000,,False
0.45,,C0038165,Staphylococcal Scalded Skin Syndrome,weak,,,moderate,,0.5,False,incidence,Staphylococcal Infections,,,,Staphylococcal scalded skin syndrome is rare acute condition. Estimated incidence ~0.5 per 100k based on case reports.,,,,,40,,False
0.75,,C0026470,Monoclonal Gammopathy of Undetermined Significance,moderate,,,low,,,True,prevalence,Monoclonal Gammapathies,,3500,,"MGUS measured as prevalence, not incidence - it is an asymptomatic, chronic condition. Prevalence ~3.5% of general population, increasing with age (up to 7-8% in those >80 years). Global average ~3.5% or 3,500 per 100k.",,,,,280000000,,False
0.65,,C0030486,Paraplegia,moderate,,,high,,11.0,False,incidence,Spinal cord injuries,,,,Paraplegia: traumatic spinal cord injury. Global incidence ~10-15 per 100k based on WHO estimates.,WHO spinal cord injury epidemiology,registry,,,8800.0,,False
0.5,,C0917816,Mental deficiency,weak,,,high,,100.0,False,,Intellectual disability,,,,Outdated term for intellectual disability. Global prevalence ~1-3% (~100-300 per 100k).,,,,,8000000.0,,False
0.2,,C0432283,Osteoglophonic dwarfism,weak,,,unknown,,extremely rare,True,incidence,Skeletal dysplasias,,,,"Osteoglophonic dwarfism: extremely rare skeletal dysplasia, <100 cases worldwide reported.",,,,,,,False
0.78,,C1561643,Chronic Kidney Diseases,strong,,2005,moderate,,,False,prevalence,,,7500,,"Chronic kidney disease measured as prevalence (existing cases), not incidence. Global CKD prevalence estimated at 7.5% of adult population (~7,500 per 100k), based on WHO and KDIGO estimates. Prevalence appropriate metric for chronic long-term condition.",Levey AS et al. (2003). Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 67(6):2089-2100,literature,https://pubmed.ncbi.nlm.nih.gov/12882570/,,600000000,,False
0.7,,C0162678,Neurofibromatoses,moderate,,,low,,0.3,True,both,Genetic Disorders,,5,,Neurofibromatosis type 1 (most common) incidence ~1 per 3000 births (~0.3 per 100k per year). Prevalence ~5 per 100k.,Rasmussen SA et al. (2012). Neurofibromatosis type 1 and tumors: Review of the National Neurofibromatosis Foundation international database. J Child Neurol. 27(5):645-653,literature,https://pubmed.ncbi.nlm.nih.gov/22378655/,,24,,False
0.58,,C0206701,"Cystadenocarcinoma, Serous",moderate,,,moderate,,4.2,True,incidence,Ovarian Cancer,,,,"Serous cystadenocarcinoma represents approximately 35-40% of epithelial ovarian cancers. Based on global ovarian cancer incidence of ~12 per 100k, serous histology approximately ~4.2 per 100k. This is a well-defined histological subtype with moderate confidence due to histological specificity and registry data availability.",Ovarian cancer incidence estimates derived from multiple cancer registry databases,registry,,,336000,,False
0.2,,C1840061,SMALL PATELLA SYNDROME,weak,,,unknown,,extremely rare,False,incidence,Skeletal Dysplasias,,,,Small patella syndrome is an extremely rare autosomal dominant skeletal dysplasia characterized by patella hypoplasia/aplasia associated with multiple skeletal abnormalities. Fewer than 100 families reported in medical literature. Estimated incidence <0.01 per 100k births. Aggregate BOTEC consideration: subtype of broader skeletal dysplasia group.,,,,,extremely rare,,False
0.35,,C0014550,Myoclonic Epilepsy,weak,,,high,,18.5,False,incidence,,,,,"Aggregate BOTEC estimate for epilepsies presenting with myoclonic seizures. Includes juvenile myoclonic epilepsy (~5-8 per 100k, ~30% of all epilepsy), progressive myoclonic epilepsies (~2-3 per 100k), and myoclonic seizures in other syndromes (~8-10 per 100k). Aggregate estimate ~18.5 per 100k. Heterogeneous group with significant variability.",,,,,1480000,,False
0.78,,C0149721,Left Ventricular Hypertrophy,strong,,2005,moderate,,,False,prevalence,,,1500,,"LVH measured as prevalence rather than incidence, as it represents a chronic structural cardiac change. Global prevalence estimated ~1.5% of population (1,500 per 100k) from cardiovascular epidemiology studies, with significant variation based on hypertension control and detection methods (echocardiography vs ECG).",Framingham Heart Study data and WHO cardiovascular epidemiology (2000-2010 period),registry,https://www.framinghamheartstudy.org/,,120000000,,True
0.0,,C4525297,Stage 0 Gallbladder Cancer AJCC v8,none,,,high,,,True,,Gallbladder Cancer,,,,"Cancer stage specification without independent incidence data. Staging classification, not epidemiologically distinct.",,,,,,,False
0.45,,C0036529,"Myocardial Diseases, Secondary",weak,,,moderate,,2.0,True,incidence,Myocardial diseases,,,,Secondary myocardial diseases: subset of heart muscle disease from other causes. Estimated ~2 per 100k.,,,,,1600.0,,False
0.35,,C4520679,Abnormal macular morphology,weak,,,unknown,,150,False,incidence,Macular Disorders,,,,"Abnormal macular morphology is descriptive finding, not disease. Estimated incidence ~150 per 100k based on prevalence in aging populations.",,,,,12000,,False
0.3,,C0027668,"Neoplasms, Vascular Tissue",weak,,,moderate,,1,False,incidence,Sarcoma,,,,"Vascular tissue neoplasms (hemangiosarcoma, angiosarcoma) rare. Estimated incidence ~1 per 100k globally.",,,,,80,,False
0.0,,C0346957,Disseminated Malignant Neoplasm,none,,,high,,,False,,Cancer,,,,Umbrella descriptor for metastatic cancer stage across all tumor types. Too heterogeneous to estimate independently.,,,,,,,False
0.0,,C0022333,Jacksonian Seizure,none,,,unknown,,,True,,Focal motor seizures,,,,"Specific focal seizure pattern, not independent condition. Cannot map to population incidence.",,,,,,,False
0.65,,C0278660,Adult Synovial Sarcoma,moderate,,,low,,0.3,True,incidence,Synovial Sarcoma,,,,"Rare soft tissue sarcoma affecting adolescents and young adults, ~0.3 per 100k. Limited epidemiological data.","SEER Cancer Statistics, estimated from case frequency",registry,,,19500,,False
0.3,,C3805092,Methylenetetrahydrofolate reductase gene mutation,weak,,,unknown,,extremely rare,True,prevalence,Genetic Metabolism Disorders,,,,"MTHFR gene mutation causes methylenetetrahydrofolate reductase deficiency, a rare inherited metabolic disorder. While MTHFR polymorphisms are common, clinically significant deficiency is extremely rare (<0.1 per 100k). Metric: prevalence as this is a lifelong genetic condition. Case reports and small series provide limited epidemiological data.",,,,,extremely rare,,False
0.7,,C0750901,"Alzheimer Disease, Early Onset",moderate,,,low,,1.5,True,,Alzheimer Disease,,,,"Familial/early-onset AD <65 years, ~5% of AD cases. Estimated ~1.5 per 100k in that age group.",Alzheimer's Association epidemiological data,registry,,,120000.0,,False
0.3,,C0730290,Cone Dystrophy,weak,,,unknown,,extremely rare,True,incidence,Inherited retinal dystrophies,,,,Cone dystrophy: rare inherited retinal disorder affecting photoreceptors. Very limited epidemiological data.,,,,,,,False
0.82,,C0022735,Klinefelter Syndrome,strong,,2005,low,,,False,prevalence,,,100.0,,"Genetic syndrome (47,XXY karyotype) measured as prevalence. Incidence at birth approximately 1 in 500-1000 male births (~100-200 per 100k among males). Population prevalence ~100 per 100k total population considering sex distribution. Well-documented chromosomal abnormality with consistent epidemiology across regions.",Rogol AD et al. (2008). Klinefelter Syndrome: Learning needs and perspectives among 450 men with delayed diagnoses. American Journal of Medical Genetics. 146A(20):2618-26,literature,https://pubmed.ncbi.nlm.nih.gov/18837052/,,8000000,,False
0.25,,C0221405,Pituitary cachexia,weak,,,unknown,,extremely rare,True,incidence,Pituitary disorders,,,,Pituitary cachexia: very rare manifestation of advanced pituitary disease. Likely <0.1 per 100k.,,,,,,,False
0.5,,C0027086,Myoma,moderate,,,low,,,False,prevalence,Benign neoplasms,,200.0,,Myoma (uterine fibroid): common benign tumor in women. Prevalence ~20-25% in reproductive-age women.,Women's health epidemiology,literature,,,160000.0,,False
0.82,,C0220615,Adult Acute Myeloblastic Leukemia,strong,,2005,moderate,,3.2,True,incidence,Acute Myeloid Leukemia,,,,Adult AML incidence approximately 3.2 per 100k globally from GLOBOCAN 2005 data. Acute leukemias measured by incidence (new cases annually) rather than prevalence.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,256000,,True
0.72,,C0035302,Retinal Artery Occlusion,strong,,,moderate,,2.5,False,incidence,,,,,"Retinal artery occlusion (RAO) is an acute vascular event. Global incidence estimated at 2.5 per 100k person-years based on population-based studies. Central RAO incidence approximately 1.3-2.25 per 100k, branch RAO approximately 5 per 100k; global average estimate 2.5 per 100k. Significant geographic variation observed, with higher rates in East Asian populations.",Henricsson M et al. (Olmsted County study); Park SJ et al. (2020). Incidence rates of retinal vascular occlusive diseases from 2011 to 2020 in South Korea. Ophthalmology,literature,https://pubmed.ncbi.nlm.nih.gov/38519990/,,200000,,False
0.75,,C0035235,Respiratory Syncytial Virus Infections,strong,,,moderate,,4000,False,incidence,Respiratory Virus Infections,,,,"RSV is a common acute respiratory infection, primarily affecting children <2 years and elderly >65 years. Global incidence estimated at 3000-5000 per 100k population per year based on hospital surveillance and community studies. Reporting incidence (new infections). Confidence moderate-high due to robust epidemiological surveillance in many countries but variable case definitions and reporting.",,,,,320000000,,False
0.8,,C3900098,Adult Myelodysplastic Syndrome,moderate,,,moderate,,4.5,True,,Myelodysplastic Syndromes,,,,MDS in adults >18 years. Global incidence ~4-5 per 100k based on GLOBOCAN registry data.,GLOBOCAN hematologic malignancies,registry,https://gco.iarc.fr/,,360000.0,,False
0.75,,C0026918,Mycobacterium Infections,strong,,2023,high,,145.0,False,incidence,,,,,"Mycobacterium infections is an umbrella term encompassing tuberculosis (primary), atypical mycobacterial infections (MAC, NTM), and other mycobacterial diseases. Global TB incidence estimated at 130-150 per 100k person-years, with additional cases from non-tuberculous mycobacterial infections. Using aggregate estimate of 145 per 100k. TB dominates the burden; 2023 WHO data reports 10.8 million TB cases globally (~135 per 100k). Significant geographic variation with high incidence in developing countries and low incidence in developed nations.",WHO Global Tuberculosis Report 2023; CDC MMWR Global Epidemiology of Tuberculosis; PubMed consensus statement on global TB burden,registry,https://www.who.int/news-room/fact-sheets/detail/tuberculosis,,11600000,,False
0.0,,C3160844,PAI-1 polymorphism,none,,,unknown,,,False,,,,,,"PAI-1 polymorphism is a genetic variant, not a disease. Not meaningful to estimate population incidence of genetic variants.",,,,,,,False
0.32,,C1145628,Autonomic nervous system disorders,weak,,,high,,50,False,both,,,500,,"Autonomic nervous system disorders is broad umbrella category. Estimated aggregate incidence ~50 per 100k from dysautonomias, POTS, and related conditions.",,,,,4000,,False
0.56,,C4721509,Usual Interstitial Pneumonia,moderate,,,high,,14.2,True,incidence,Interstitial pneumonia,,,,"UIP is a pathological pattern (not a clinical diagnosis). When associated with idiopathic etiology, defines idiopathic pulmonary fibrosis (IPF). Estimated incidence ~10-20 per 100k based on limited epidemiological studies. High geographic variation due to diagnostic criteria differences and environmental exposures.",Kondoh Y et al. (2009). Differences in clinical characteristics of usual interstitial pneumonia. Am J Respir Crit Care Med. 170(6):613-615,literature,,,1136000,,False
0.68,,C0242339,Dyslipidemias,moderate,,,high,,500,False,both,Lipid Metabolism Disorders,,3000,,"Dyslipidemias (abnormal blood lipids) are common findings. Estimated incidence ~500 per 100k, prevalence ~3000 per 100k.",Rettberg H et al. (2009). Dyslipidemias in the metabolic syndrome. Curr Pharm Des. 15(3):360-370,literature,https://pubmed.ncbi.nlm.nih.gov/19199973/,,40000,,False
0.7,,C0033141,"Cardiomyopathies, Primary",strong,,2005,moderate,,6.0,False,incidence,Cardiomyopathy,,,,Primary cardiomyopathies: idiopathic heart muscle disease. Combined incidence ~6 per 100k from cardiovascular registries.,Cardiovascular epidemiology registries,registry,,,4800.0,,False
0.58,,C0080218,Tethered Cord Syndrome,moderate,,,low,,4.0,False,incidence,Spinal Cord Malformation,,,,"Tethered cord incidence estimated at 4 per 100,000 live births based on pediatric neurology data.",,,,,320000,,False
0.9,,C0235653,Malignant neoplasm of female breast,strong,,2005,high,,45.0,False,incidence,,,,,Global breast cancer incidence ~45 per 100k women from GLOBOCAN 2005.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,2925000,,True
0.65,,C1336745,Thymic Lymphoma,moderate,,,low,,0.2,True,,Lymphoma,,,,"Lymphomas arising in thymus (T-cell), rare. Estimated ~0.2 per 100k based on registry data.",GLOBOCAN lymphoma classifications,registry,,,16000.0,,False
0.75,,C2937421,Prostatic Hyperplasia,strong,,,moderate,,,False,prevalence,,,2000,,"Benign prostatic hyperplasia (BPH) is a chronic condition reported as prevalence. Global prevalence estimated at ~2% of total population (~2000 per 100k), though much higher in elderly males (40-50% of men over 50). Reporting population-wide prevalence estimate.",Parsons JK. (2010). Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep. 5(4):212-218,literature,https://pubmed.ncbi.nlm.nih.gov/21114804/,,160000000,,False
0.4,,C3152055,D-2-HYDROXYGLUTARIC ACIDURIA 1,weak,,,unknown,,0.05,True,incidence,D-2-hydroxyglutaric aciduria,,,,D-2-hydroxyglutaric aciduria type 1 is a rare autosomal recessive metabolic disorder caused by mutations in D2HGDH gene. Estimated incidence approximately 0.05 per 100k based on limited case reports. No large epidemiological studies or registry data with systematic incidence estimates.,,,,,4000,,False
0.28,,C0026650,Movement Disorders,weak,,,high,,8500.0,False,incidence,,,,,"Aggregate BOTEC estimate summing major movement disorder subtypes: Parkinson's disease (~200 per 100k), essential tremor (~4000 per 100k), dystonia (~200 per 100k), cerebellar ataxia (~250 per 100k), spastic paraplegia (~1000 per 100k), myoclonus (~1000 per 100k), restless leg syndrome (~2000 per 100k). Total ~8,650 per 100k. High heterogeneity and overlap between categories.",,,,,680000000,,False
0.62,,C2363973,Chronic thromboembolic pulmonary hypertension,moderate,,,moderate,,2.0,True,incidence,Pulmonary Hypertension,,,,CTEPH incidence estimated at 2 per 100k person-years based on pulmonary hypertension registries.,,,,,160000,,False
0.88,,C0279680,Transitional cell carcinoma of bladder,strong,,2005,moderate,,11.5,True,incidence,Malignant neoplasm of bladder,,,,Urothelial (transitional) carcinoma accounts for ~90% of bladder cancers with global incidence of ~11.5 per 100k person-years from GLOBOCAN 2005 data. This is a well-defined histological subtype with strong cancer registry documentation.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,920000,,True
0.0,,C0374997,Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site,none,,,unknown,,,False,,,,,,Unmappable - this is an ICD-like classification code for H. pylori infection when documented in conditions classified elsewhere or at unspecified sites. Too vague to estimate meaningfully; conflates secondary/comorbid H. pylori with primary infection diagnosis. Would require specification of the underlying condition for meaningful incidence/prevalence estimate.,,,,,,,False
0.4,,C0338656,Impaired cognition,weak,,,high,,,False,prevalence,Cognitive impairments,,5000.0,,Impaired cognition: umbrella term covering multiple etiologies. Using prevalence (~5% in general population) rather than incidence due to diverse causes.,,,,,4000000.0,,False
0.0,,C0270846,Epileptic drop attack,none,,,unknown,,,False,,Seizure disorders,,,,"Ictal symptom (atonic seizure manifestation), not independent diagnosis. Cannot estimate incidence.",,,,,,,False
0.68,,C0279982,Childhood Synovial Sarcoma,moderate,,2005,low,,0.8,True,incidence,Synovial Sarcoma,,,,"Childhood synovial sarcoma incidence estimated at 0.8 per 100,000 children based on pediatric cancer registries.",SEER Pediatric Cancer Database,registry,,,64000,,False
0.35,,C2745959,"Spondyloepiphyseal dysplasia, congenita",weak,,,unknown,,extremely rare,True,incidence,Skeletal Dysplasia,,,,"Spondyloepiphyseal dysplasia congenita (SED congenita) is a rare autosomal dominant hereditary skeletal dysplasia. Estimated at <1 per 100,000 births based on case reports and genetic databases. Extremely limited epidemiological data available.",,,,,extremely rare,,False
0.55,,C0342513,Idiopathic Hirsutism,moderate,,,high,,,True,prevalence,Hirsutism,,750,,Idiopathic hirsutism (excessive hair without hormonal abnormality) measured as prevalence: approximately 0.75% of women globally (750 per 100k). Clinical diagnosis varies by ethnicity and cultural definitions. Confidence limited by variable diagnostic criteria and predominantly affects women of reproductive age.,Ferriman D et al. (1961). Assessment of body hair growth and androgen levels in normal women. J Clin Endocrinol Metab. 21:1440-1447,literature,,,60000000,,False
0.75,,C0041341,Tuberous Sclerosis,strong,,,low,,0.1,False,both,Hamartomatoses,,2,,Tuberous sclerosis incidence ~1 per 6000 births (~0.1 per 100k per year). Prevalence ~2 per 100k.,Curatolo P et al. (2008). Tuberous sclerosis complex: clinical features and diagnosis. Semin Pediatr Neurol. 15(4):196-205,literature,https://pubmed.ncbi.nlm.nih.gov/19218056/,,8,,False
0.0,,C0037274,Dermatologic disorders,none,,,unknown,,,False,,,,,,Dermatologic disorders is umbrella term too broad to estimate. Would require specification of disease type.,,,,,,,False
0.3,,C4692564,"TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1",weak,,,unknown,,extremely rare,True,incidence,"Tumoral calcinosis, hyperphosphatemic, familial",,,,"Specific genetic subtype (TCHHF1) with GALNT3 gene mutations. Extremely rare genetic disorder, fewer than 100 documented families worldwide. <0.001 per 100k.",,,,,extremely rare,,False
0.0,,C0239337,Deformity of limb,none,,,unknown,,,False,,,,,,"Generic descriptor, not a disease entity. Too broad to map meaningfully.",,,,,,,False
0.82,,C0023055,Laryngeal neoplasm,strong,,2005,moderate,,1.8,False,incidence,,,,,Laryngeal cancer global incidence from GLOBOCAN 2005: approximately 1.8 per 100k person-years. Well-documented cancer registry data with good geographic coverage.,GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,144000,,True
0.78,,C2004493,"Leukemia, B-Cell",strong,,,moderate,,3.8,True,incidence,Leukemia,,,,"B-cell leukemias (CLL, B-cell ALL, B-cell prolymphocytic leukemia, hairy cell leukemia) represent ~50% of all leukemia cases. Global leukemia incidence ~7-8 per 100k; B-cell leukemias ~3.8 per 100k. Based on cancer registry data and epidemiological estimates.",Siegel RL et al. (2013). Cancer statistics for different races and ethnicities in the United States using methods modified from the SEER database. Cancer Epidemiol Biomarkers Prev. 22(11):1993-2001,literature,https://pubmed.ncbi.nlm.nih.gov/24042210/,,304000,,False
0.0,,C4525301,Stage IIB Gallbladder Cancer AJCC v8,none,,,high,,,True,,Gallbladder Cancer,,,,Cancer stage specification without independent incidence data. Staging is not independently epidemiologically meaningful.,,,,,,,False
0.52,,C4528176,High Risk Myelodysplastic Syndrome,moderate,,2010,moderate,,,True,prevalence,Myelodysplastic Syndromes,,4.5,,High-risk MDS is a specific subtype of MDS (IPSS intermediate-2 or high risk). Prevalence estimated at 4-5 per 100k based on MDS registries reporting that ~30-40% of MDS patients have high-risk disease. Limited population-based prevalence studies available; confidence capped at 0.52 due to regional registry dependency.,Hellstrom-Lindberg E et al. (2009). Treatment of myelodysplastic syndromes. Drugs. 69(11):1451-1479,literature,https://pubmed.ncbi.nlm.nih.gov/19634931/,,360000,,False
0.65,,C0018133,Graft-vs-Host Disease,moderate,,,moderate,,45,False,incidence,,,,,"Graft-vs-Host Disease (GVHD) is a major complication of allogeneic bone marrow/stem cell transplantation. Occurs in 30-50% of transplant recipients. Global estimate: ~100,000 allogeneic transplants annually with ~40-50% developing GVHD = ~40-50 per 100k general population (but primarily among transplant recipients). Population-based estimate ~45 per 100k.",Nassereddine S et al. (2017). Acute graft-vs-host disease: A comprehensive review. Anticancer Res. 37(3):1547-1555,literature,https://pubmed.ncbi.nlm.nih.gov/28314312/,,3600000,,False
0.42,,C0024291,"Lymphohistiocytosis, Hemophagocytic",weak,,,unknown,,extremely rare,False,incidence,,,,,Hemophagocytic lymphohistiocytosis (HLH) is a rare life-threatening condition with incidence estimated at <0.5 per million per year globally. Both familial and acquired forms exist. Very limited epidemiological data available; estimates based primarily on case reports and small registry studies.,Fisman DL. (2000). Hemophagocytic syndromes and infection. Emerg Infect Dis. 6(6):601-608,literature,https://pubmed.ncbi.nlm.nih.gov/11076717/,,extremely rare,,False
0.0,,C0851162,Infections of musculoskeletal system,none,,,unknown,,,False,,,,,,"Broad category covering osteomyelitis, septic arthritis, etc. Too heterogeneous without specification.",,,,,,,False
0.72,,C0014859,Esophageal Neoplasms,moderate,,2005,high,,8.5,False,incidence,,,,,"Umbrella term encompassing benign (polyps, benign tumors ~1-2 per 100k) and malignant esophageal neoplasms (~7 per 100k). Aggregate estimate ~8.5 per 100k combining major subcategories, but confidence reduced due to heterogeneity.",GLOBOCAN 2005 (IARC) with estimate adjustment for benign lesions,registry,https://gco.iarc.fr/,,680000,,True
0.75,,C0032460,Polycystic Ovary Syndrome,strong,,,low,,,False,prevalence,,,8000,,"PCOS is a common chronic endocrine disorder affecting women of reproductive age. Prevalence estimated at 6-10% of women of reproductive age using NIH diagnostic criteria; estimates vary by diagnostic criteria used. Using middle estimate of 8% (8,000 per 100k). Incidence not applicable for chronic lifelong condition.",Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2004). Revised consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 81(1):19-25,literature,https://pubmed.ncbi.nlm.nih.gov/14711538/,,640000000,,False
0.45,,C0334299,"Carcinoid tumor, not otherwise specified",moderate,,,moderate,,0.4,True,incidence,Carcinoid tumor,,,,"This represents carcinoid tumors classified without specific ICD-O histological subtype specification, typically referring to neuroendocrine carcinomas of unspecified morphology. Estimated incidence approximately 0.4 per 100,000 based on cancer registry data for unspecified NET/carcinoid cases. This is a subset of total carcinoid incidence and represents cases with incomplete classification or de novo classification coding.",Cancer registry coding standards and epidemiological classification systems,registry,,,32000,,False
0.45,,C0520463,Chronic active hepatitis,weak,,,high,,4.2,False,incidence,,,,,"Chronic active hepatitis is a descriptive pathological diagnosis encompassing multiple etiologies: chronic HBV (~240 million prevalent cases globally), chronic HCV (~71 million), autoimmune hepatitis, and others. The term is somewhat outdated in modern nomenclature. Aggregate estimate of ~4 per 100k based on major etiologies, but heterogeneous causes and geographic variation limit confidence. Better to specify etiology.","WHO (2015). Guidelines on the screening, care and treatment of persons with hepatitis C infection; CDC (2016). Hepatitis C Fact Sheets",registry,https://www.who.int/publications/i/item/9789241549751,,336000,,False
0.85,,C0206686,Adrenocortical carcinoma,strong,,2005,moderate,,0.1,True,incidence,Malignant neoplasm of adrenal gland,,,,Rare malignancy with global incidence ~0.1 per 100k person-years based on SEER and population-based registries. SEER data (1973-2014) reported age-adjusted incidence of ~1 per million. Data from Netherlands registry shows similar rates of 1 per million.,"Surveillance, Epidemiology, and End Results (SEER) Program, National Cancer Institute",registry,https://seer.cancer.gov/,,8000,,True
0.65,,C0752166,Bardet-Biedl Syndrome,moderate,,,moderate,,0.2,False,,Ciliopathies,,,,"Rare genetic ciliopathy. Estimated incidence ~1 per 125,000 births globally (~0.2 per 100k).",Bardet-Biedl Syndrome patient registry,registry,,,16000.0,,False
0.65,,C0017662,"Glomerulonephritis, Membranoproliferative",moderate,,,moderate,,1.8,True,incidence,Glomerulonephritis,,,,"Membranoproliferative glomerulonephritis (MPGN) is a histological pattern with multiple etiologies. Primary MPGN (now reclassified as C3GN) and secondary forms (HCV-related, autoimmune) have combined estimated incidence of 1-2 per 100k in developed countries. Geographic variation significant due to HCV prevalence variation. Confidence moderate due to heterogeneous etiology and evolving classification.",Nasr SH et al. (2011). Membranoproliferative glomerulonephritis. J Amer Soc Nephrol. 23(2):214-224,literature,https://pubmed.ncbi.nlm.nih.gov/22135313/,,144000,,False
0.5,,C0948896,Primary hypogonadism,weak,,,unknown,,0.5,False,incidence,,,,,Primary hypogonadism: heterogeneous group of conditions affecting testicular function. Limited epidemiological data; estimated ~0.5-1 per 100k population.,,,,,400.0,,False
0.72,,C0013595,Eczema,strong,,,moderate,,150,True,both,Dermatitis,,2000,,Atopic dermatitis/eczema affects ~2% of population (2000 per 100k). Annual incidence ~150 per 100k.,Langan SM et al. (2020). Atopic dermatitis. Lancet. 396(10247):345-360,literature,https://pubmed.ncbi.nlm.nih.gov/32738956/,,12000,,False
0.3,,C3495874,Nonepileptic Seizures,weak,,,high,,,False,prevalence,,,30000,,"Umbrella term covering multiple non-epileptic seizure types. Estimated prevalence ~30,000 per 100k due to high functional symptom prevalence.",,,,,2400000,,False
0.4,,C0917796,"Optic Atrophy, Hereditary, Leber",moderate,,,low,,extremely rare,True,incidence,Hereditary optic neuropathies,,,,Leber hereditary optic neuropathy: mitochondrial genetic disorder causing vision loss. Estimated <1 per 100k based on genetic studies.,Genetic epidemiology studies,literature,,,,,False
0.7,,C0243002,Tricuspid Atresia,strong,,,low,,0.08,False,incidence,,,,,"Congenital heart defect, incidence ~0.08-0.1 per 100k births (~1 per 10,000 births).",Congenital heart defect registries,registry,,,5200,,False
0.3,,C0242583,Bare Lymphocyte Syndrome,weak,,,unknown,,extremely rare,False,incidence,Immunodeficiency Disorders,,,,Bare lymphocyte syndrome is extremely rare primary immunodeficiency with <50 cases documented.,,,,,,,False
0.62,,C0149958,Complex partial seizures,moderate,,,moderate,,12,True,incidence,Focal Seizures,,,,Complex partial seizures (focal to bilateral tonic-clonic) are most common seizure type. Estimated incidence ~12 per 100k.,Scheffer IE et al. (2017). ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 58(4):512-521,literature,https://pubmed.ncbi.nlm.nih.gov/28276062/,,960,,False
0.75,,C1332970,Childhood Hematopoietic Neoplasm,strong,,2005,moderate,,3.5,True,incidence,Hematopoietic neoplasms,,,,"Childhood hematopoietic neoplasms: combined incidence of childhood leukemias and lymphomas, ~3-4 per 100k children based on cancer registries.",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,2800.0,,False
0.6,,C0242343,Panhypopituitarism,moderate,,,low,,1.8,False,incidence,Pituitary disorders,,,,Panhypopituitarism: total pituitary hormone deficiency. Reported incidence 1-2 per 100k based on pituitary disease registries.,European Registry of Growth Hormone Deficiency in Adults,registry,,,1440.0,,False
0.72,,C0206641,Osteochondromatosis,strong,,,high,,2.0,False,incidence,,,,,"Hereditary multiple osteochondromas (synonymous term) with estimated incidence of 1 in 50,000 (2 per 100,000). Presents in early childhood with median diagnosis age of 3 years; 96% diagnosed by age 12. Autosomal dominant inheritance with EXT1/EXT2 mutations. Geographic variation noted: 1 in 1,000 in Chamorro population of Guam, 1 in 77 in Ojibway Indians of Manitoba. Solitary osteochondromas occur in 85% of lesions; hereditary multiple form in 15%.","Hereditary Multiple Osteochondromas - GeneReviews, NCBI Bookshelf; combined with epidemiological literature on osteochondromas",literature,https://www.ncbi.nlm.nih.gov/books/NBK1235/,,160000,,False
0.15,,C1707446,Columnar Cell Hyperplasia of the Breast,weak,,,unknown,,,True,,Breast Lesion,,,,"Columnar cell hyperplasia is a benign pathological finding in breast tissue identified on biopsy or imaging, not a disease with defined incidence. Prevalence in breast biopsies estimated 5-40% depending on population and biopsy indications, but not tracked in disease registries. Unmappable to population-based incidence data.",,,,,,,False
0.5,,C0521707,Bilateral cataracts (disorder),moderate,,,moderate,,2.0,True,incidence,Cataract,,,,Bilateral cataracts: subset of cataract disease. Estimated incidence ~2 per 100k (congenital and acquired cases).,WHO vision impairment statistics,registry,,,1600.0,,False
0.7,,C0206061,"Pneumonia, Interstitial",strong,,,moderate,,11,True,both,Pneumonia,,200,,"Interstitial pneumonia incidence ~11 per 100k, prevalence ~200 per 100k based on GBD 2019 data.",Global Burden of Disease Study 2019. Lancet. 396(10258):1204-1222,literature,https://pubmed.ncbi.nlm.nih.gov/33069326/,,880,,False
0.0,,C0035309,Retinal Diseases,none,,,unknown,,,False,,,,,,"Umbrella term covering DR, AMD, retinitis pigmentosa, etc. Too heterogeneous to estimate without specification.",,,,,,,False
0.5,,C0334037,Intestinal metaplasia,moderate,,,high,,20,False,both,,,500,,Intestinal metaplasia found in ~20 per 100k on screening endoscopy. Prevalence ~500 per 100k in high-risk populations. Not a disease per se but a pathological finding.,,,,,1600,,False
0.65,,C0259783,mixed gliomas,moderate,,2005,moderate,,3.5,True,incidence,Glioma,,,,Mixed gliomas (oligoastrocytomas) represent heterogeneous glial tumors with estimated 3.5 per 100k incidence.,,,,,280000,,False
0.82,,C0220630,Adult Liver Carcinoma,strong,,2005,high,,8.5,True,incidence,Hepatocellular Carcinoma,,,,"Adult-onset HCC represents the predominant form of liver cancer globally. Incidence ~8.5 per 100k from GLOBOCAN 2005 data, with geographic variation from <2 in North America to >15 in East Asia.",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,680000,,True
0.85,,C0948008,Ischemic stroke,strong,,2005,high,,120,True,incidence,Stroke,,,,Ischemic stroke incidence approximately 120 per 100k person-years globally based on WHO surveillance.,WHO Global Stroke Registry and epidemiological studies,registry,,,9600000,,False
0.65,,C4316903,Absence Seizures,moderate,,,low,,5.0,True,,Generalized seizure disorders,,,,"Absence seizures (petit mal), primarily in childhood. Estimated ~5 per 100k among childhood seizures.",Epilepsy registries,registry,,,400000.0,,False
0.72,,C0026985,Myelodysplasia,moderate,,2005,moderate,,4.5,False,incidence,,,,,"Myelodysplastic syndromes (MDS) incidence ~3-5 per 100k globally, with significant variation by geographic region and age-adjusted rates higher in elderly populations. Uses incidence metric as MDS represents newly diagnosed hematologic disorders.",Corey SJ et al. (2007). Myelodysplastic syndromes: epidemiology and etiology. Cancer. 109(9):1705-1717,literature,https://pubmed.ncbi.nlm.nih.gov/17372944/,,360000,,False
0.0,,C0280280,"stage, prostate cancer",none,,,unknown,,30.0,False,incidence,,,,,"Stage of prostate cancer: process descriptor, not a disease entity. Cannot meaningfully estimate incidence; needs disease-specific stage data.",,,,,24000.0,,False
0.8,,C1333015,Childhood Kidney Wilms Tumor,strong,,2005,low,,0.8,True,incidence,Pediatric renal neoplasms,,,,"Wilms tumor (nephroblastoma): most common renal malignancy in children, ~0.8-1 per 100k children from pediatric cancer registries.",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,640.0,,True
0.45,,C0206651,Clear Cell Sarcoma of Soft Tissue,weak,,,moderate,,0.8,True,incidence,Soft Tissue Sarcoma,,,,"Clear cell sarcoma is a rare soft tissue sarcoma subtype representing approximately 1-2% of all soft tissue sarcomas. Global soft tissue sarcoma incidence ~40-50 per 100k, making clear cell sarcoma ~0.8 per 100k. Limited epidemiological data; estimate based on relative prevalence within soft tissue sarcoma category.",,,,,64000,,False
0.45,,C0349632,Splenic Marginal Zone B-Cell Lymphoma,weak,,,unknown,,0.1,True,,Marginal Zone Lymphoma,,,,Rare NHL subtype. Estimated <0.2 per 100k based on limited registry data.,,,,,8000.0,,False
0.62,,C0524528,Pervasive Development Disorder,weak,,,high,,200,False,prevalence,,,,,"PDD prevalence estimated at 0.2% globally (200 per 100k), including autism spectrum disorders.",,,,,16000000,,False
0.35,,C1846142,Hoyeraal-Hreidarsson syndrome,weak,,,unknown,,extremely rare,True,incidence,Dyskeratosis congenita,,,,"Hoyeraal-Hreidarsson is an extremely rare variant of dyskeratosis congenita, an inherited bone marrow failure syndrome. Fewer than 100 cases have been reported worldwide, with estimated incidence <0.01 per 100k. It represents a specific autosomal recessive form of DC characterized by early onset features.",,,,,extremely rare,,False
0.7,,C0007133,"Carcinoma, Papillary",strong,,2005,moderate,,12.0,True,incidence,Carcinoma,,,,"Papillary carcinoma: subset of carcinoma (thyroid, renal, etc). Global incidence ~12 per 100k, primarily from thyroid cancer.",GLOBOCAN 2005 (IARC),registry,https://gco.iarc.fr/,,9600.0,,True
0.0,,C0023893,"Liver Cirrhosis, Experimental",none,,,unknown,,,False,,Liver Cirrhosis,,,,"Research designation, not clinical entity. Experimental models not epidemiologically mappable.",,,,,,,False
0.72,,C0026269,Mitral Valve Stenosis,moderate,,2005,high,,,True,prevalence,Valvular Heart Disease,,75,,"Mitral valve stenosis measured as prevalence rather than incidence, as it is a chronic cardiac condition with declining new case rates due to reduced acute rheumatic fever incidence. Global prevalence estimated at 75 per 100k population, with significant geographic variation related to rheumatic fever prevalence. Higher rates in developing countries where rheumatic heart disease remains endemic.",Carapetis JR et al. (2005). Acute rheumatic fever. Lancet. 366(9480):155-168,literature,https://pubmed.ncbi.nlm.nih.gov/16005340/,,6000000,,False
0.7,,C4054727,Infant Acute Lymphoblastic Leukemia,moderate,,2005,low,,7.5,True,incidence,Acute Lymphoblastic Leukemia,,,,Infant ALL (age <1 year) represents ~7-8% of pediatric ALL with higher incidence per 100k in this age group (~7.5 per 100k) due to aggressive biology and higher ALL rates in infants. Subtype of broader ALL category with distinct biology.,Pieters R et al. (2012). Acute lymphoblastic leukemia - management of adult patients. Expert Rev Anticancer Ther. 11(2):285-294,literature,https://pubmed.ncbi.nlm.nih.gov/21917835/,,600000,,False
0.75,,C0086543,Cataract,strong,,2005,high,,15.0,False,incidence,,,,,"Cataract: major cause of blindness globally. Incidence varies by age and region; ~15 per 100k population overall, much higher in elderly.",WHO Vision 2020 program statistics,registry,,,12000.0,,False
0.65,,C0032290,Aspiration Pneumonia,moderate,,,moderate,,5.5,False,incidence,,,,,"Aspiration pneumonia incidence estimates vary by population, approximately 5-10 per 100k overall, higher in elderly and institutionalized populations. Estimate of 5.5 per 100k represents global average from mixed epidemiological studies.",,,,,440000,,False
0.25,,C0236969,Substance-Related Disorders,weak,,,high,,,False,prevalence,,,5000,,"Aggregate umbrella term (alcohol use, drug abuse, etc). Prevalence ~5% population (5,000 per 100k). Low confidence.",,,,,325000000,,False
